1	es	NNS	O	e	nsubj	16	SENT_1	[p1l12t331r94b383],
2	in	IN	O	in	_	0	SENT_1	[p1l127t305r210b382],
3	plasma	NN	O	plasma	nn	5	SENT_1	[p1l239t304r546b405],
4	troponin	NN	O	troponin	nn	5	SENT_1	[p1l576t305r950b405],
5	levels	NNS	O	level	prep_in	1	SENT_1	[p1l979t304r1230b400],
6	,	,	O	,	_	0	SENT_1	[p1l979t304r1230b400],
7	although	IN	O	although	mark	11	SENT_1	[p1l1265t304r1647b405],
8	no	DT	O	no	det	9	SENT_1	[p1l1678t330r1782b383],
9	increases	NNS	O	increase	nsubjpass	11	SENT_1	[p1l1814t305r2147b383, p1l12t459r96b511],
10	were	VBD	O	be	auxpass	11	SENT_1	[p1l152t458r355b512],
11	seen	VBN	O	see	dep	5	SENT_1	[p1l416t458r604b511],
12	with	IN	O	with	_	0	SENT_1	[p1l659t432r855b512],
13	subcutaneous	JJ	O	subcutaneous	amod	15	SENT_1	[p1l916t432r1508b511],
14	ICD	NN	O	icd	nn	15	SENT_1	[p1l1567t438r1731b511],
15	shocks	NNS	O	shock	prep_with	11	SENT_1	[p1l1792t432r2148b512],
16	}	VBP	O	}	_	0	SENT_1	[p1l1792t432r2148b512],

1	Transvenous	JJ	MISC	transvenous	amod	2	SENT_2	[p1l8t566r555b639],
2	systems	NNS	O	system	nsubj	3	SENT_2	[p1l616t577r952b661],
3	have	VBP	O	have	_	0	SENT_2	[p1l1012t560r1203b640],
4	intense	JJ	O	intense	amod	7	SENT_2	[p1l1260t561r1571b639],
5	intracardiac	JJ	O	intracardiac	amod	7	SENT_2	[p1l1628t560r2148b639],
6	ﬁeld	NN	O	ﬁeld	nn	7	SENT_2	[p1l12t688r202b767],
7	strengths	NNS	O	strength	dobj	3	SENT_2	[p1l231t688r652b789],
8	,	,	O	,	_	0	SENT_2	[p1l231t688r652b789],
9	Whereas	IN	O	whereas	mark	13	SENT_2	[p1l681t688r1028b767],
10	subcutaneous	JJ	O	subcutaneous	amod	12	SENT_2	[p1l1060t688r1639b767],
11	ICD	NN	O	icd	nn	12	SENT_2	[p1l1668t694r1830b767],
12	shocks	NNS	O	shock	nsubj	13	SENT_2	[p1l1860t688r2145b768],
13	attenuate	VBP	O	attenuate	dep	3	SENT_2	[p1l11t833r410b895],
14	in	IN	O	in	_	0	SENT_2	[p1l439t817r524b894],
15	extracardiac	JJ	O	extracardiac	amod	16	SENT_2	[p1l555t816r1083b895],
16	tissues	NNS	O	tissue	prep_in	13	SENT_2	[p1l1113t817r1429b895],
17	.	.	O	.	_	0	SENT_2	[p1l1113t817r1429b895],

1	Accordingly	RB	O	accordingly	advmod	4	SENT_3	[p1l1461t816r1998b917],
2	,	,	O	,	_	0	SENT_3	[p1l1461t816r1998b917],
3	we	PRP	O	we	nsubj	4	SENT_3	[p1l2029t843r2148b896],
4	anticipate	VBP	O	anticipate	_	0	SENT_3	[p1l11t945r434b1045],
5	that	IN	O	that	complm	17	SENT_3	[p1l478t944r651b1023],
6	the	DT	O	the	det	7	SENT_3	[p1l691t944r824b1023],
7	concern	NN	O	concern	nsubjpass	17	SENT_3	[p1l869t970r1212b1023],
8	raised	VBN	O	raise	partmod	7	SENT_3	[p1l1255t944r1515b1023],
9	by	IN	O	by	_	0	SENT_3	[p1l1559t944r1657b1045],
10	Kleijn	NNP	PERSON	Kleijn	agent	8	SENT_3	[p1l1696t944r1947b1045],
11	and	CC	O	and	_	0	SENT_3	[p1l1989t944r2148b1023],
12	van	NNP	PERSON	van	nn	14	SENT_3	[p1l7t1098r158b1151],
13	der	FW	PERSON	der	nn	14	SENT_3	[p1l206t1072r342b1151],
14	Veldt	NNP	PERSON	Veldt	conj_and	10	SENT_3	[p1l383t1072r603b1151],
15	may	MD	O	may	aux	17	SENT_3	[p1l644t1098r825b1173],
16	be	VB	O	be	auxpass	17	SENT_3	[p1l868t1072r964b1151],
17	mitigated	VBN	O	mitigate	ccomp	4	SENT_3	[p1l1012t1072r1426b1173],
18	with	IN	O	with	_	0	SENT_3	[p1l1469t1072r1665b1152],
19	respect	NN	O	respect	prep_with	17	SENT_3	[p1l1713t1089r2022b1173],
20	to	TO	O	to	_	0	SENT_3	[p1l2065t1089r2147b1151],
21	the	DT	O	the	det	23	SENT_3	[p1l12t1200r144b1279],
22	subcutaneous	JJ	O	subcutaneous	amod	23	SENT_3	[p1l178t1200r759b1280],
23	ICD	NN	O	icd	prep_to	17	SENT_3	[p1l792t1206r974b1279],
24	.	.	O	.	_	0	SENT_3	[p1l792t1206r974b1279],

1	Moreover	RB	O	moreover	advmod	4	SENT_4	[p1l1010t1208r1428b1296],
2	,	,	O	,	_	0	SENT_4	[p1l1010t1208r1428b1296],
3	we	PRP	O	we	nsubj	4	SENT_4	[p1l1462t1227r1579b1280],
4	believe	VBP	O	believe	_	0	SENT_4	[p1l1614t1200r1900b1279],
5	there	EX	O	there	expl	6	SENT_4	[p1l1934t1200r2148b1279],
6	is	VBZ	O	be	ccomp	4	SENT_4	[p1l11t1330r77b1408],
7	little	JJ	O	little	amod	8	SENT_4	[p1l122t1329r320b1408],
8	evidence	NN	O	evidence	nsubj	6	SENT_4	[p1l365t1329r733b1408],
9	to	TO	O	to	aux	10	SENT_4	[p1l777t1346r859b1408],
10	suggest	VB	O	suggest	infmod	8	SENT_4	[p1l905t1346r1235b1430],
11	that	IN	O	that	complm	13	SENT_4	[p1l1274t1329r1447b1408],
12	ICD	NN	O	icd	nn	13	SENT_4	[p1l1484t1335r1649b1408],
13	shocks	NNS	O	shock	dep	10	SENT_4	[p1l1695t1329r1986b1409],
14	in	IN	O	in	dep	13	SENT_4	[p1l2031t1330r2147b1407],
15	—	CD	NUMBER	—	num	17	SENT_4	[p1l2031t1330r2147b1407],
16	crease	NN	O	crease	nn	17	SENT_4	[p1l12t1483r277b1536],
17	mortality	NN	O	mortality	pobj	14	SENT_4	[p1l321t1457r741b1558],
18	.	.	O	.	_	0	SENT_4	[p1l321t1457r741b1558],

1	In	IN	O	in	_	0	SENT_5	[p1l788t1465r877b1535],
2	our	PRP$	O	we	poss	3	SENT_5	[p1l921t1483r1068b1536],
3	study	NN	O	study	prep_in	15	SENT_5	[p1l1110t1457r1341b1558],
4	of	IN	O	of	_	0	SENT_5	[p1l1380t1457r1481b1536],
5	the	DT	O	the	det	7	SENT_5	[p1l1505t1457r1639b1536],
6	prognostic	JJ	O	prognostic	amod	7	SENT_5	[p1l1681t1458r2149b1558],
7	importance	NN	O	importance	prep_of	3	SENT_5	[p1l11t1586r511b1686],
8	of	IN	O	of	_	0	SENT_5	[p1l573t1585r673b1664],
9	defibrillator	NN	O	defibrillator	nn	10	SENT_5	[p1l716t1585r1243b1664],
10	shocl	NN	O	shocl	prep_of	7	SENT_5	[p1l1302t1585r1660b1681],
11	<	JJR	O	<	amod	12	SENT_5	[p1l1302t1585r1660b1681],
12	s	NNS	O	s	dep	10	SENT_5	[p1l1302t1585r1660b1681],
13	,2	CD	NUMBER	,2	dep	12	SENT_5	[p1l1302t1585r1660b1681],
14	we	PRP	O	we	nsubj	15	SENT_5	[p1l1715t1612r1834b1665],
15	found	VBD	O	find	_	0	SENT_5	[p1l1895t1585r2148b1664],
16	that	IN	O	that	complm	22	SENT_5	[p1l12t1713r186b1792],
17	ventricular	JJ	O	ventricular	amod	18	SENT_5	[p1l225t1713r699b1792],
18	tachycardia	NN	O	tachycardia	nsubj	22	SENT_5	[p1l745t1713r1241b1814],
19	and	CC	O	and	_	0	SENT_5	[p1l1288t1713r1447b1792],
20	fibrillation	NN	O	fibrillation	conj_and	18	SENT_5	[p1l1496t1713r1969b1792],
21	are	VBP	O	be	cop	22	SENT_5	[p1l2018t1739r2148b1792],
22	likely	JJ	O	likely	ccomp	15	SENT_5	[p1l11t1841r244b1942],
23	to	TO	O	to	aux	24	SENT_5	[p1l279t1858r362b1920],
24	occur	VB	O	occur	xcomp	22	SENT_5	[p1l403t1867r643b1920],
25	in	IN	O	in	_	0	SENT_5	[p1l679t1842r763b1919],
26	patients	NNS	O	patient	nsubj	27	SENT_5	[p1l800t1842r1144b1942],
27	dying	VBG	O	die	prep_in	24	SENT_5	[p1l1186t1841r1427b1942],
28	from	IN	O	from	_	0	SENT_5	[p1l1463t1841r1674b1920],
29	heart	NN	O	heart	nn	30	SENT_5	[p1l1714t1841r1942b1920],
30	failure	NN	O	failure	prep_from	27	SENT_5	[p1l1976t1841r2147b1920, p1l12t1995r172b2065],
31	,	,	O	,	_	0	SENT_5	[p1l1976t1841r2147b1920, p1l12t1995r172b2065],
32	rather	RB	O	rather	_	0	SENT_5	[p1l229t1969r490b2048],
33	than	IN	O	than	_	0	SENT_5	[p1l538t1969r736b2048],
34	harmful	JJ	O	harmful	amod	35	SENT_5	[p1l787t1969r1145b2049],
35	effects	NNS	O	effect	conj_negcc	27	SENT_5	[p1l1197t1969r1479b2048],
36	of	IN	O	of	_	0	SENT_5	[p1l1534t1969r1634b2048],
37	the	DT	O	the	det	38	SENT_5	[p1l1667t1969r1801b2048],
38	shocks	NNS	O	shock	prep_of	35	SENT_5	[p1l1854t1969r2145b2049],
39	themselves	PRP	O	themselves	advmod	38	SENT_5	[p1l12t2099r510b2178],
40	.	.	O	.	_	0	SENT_5	[p1l12t2099r510b2178],

1	We	PRP	O	we	nsubj	2	SENT_6	[p1l138t2235r272b2306],
2	agree	VBP	O	agree	dep	74	SENT_6	[p1l304t2253r536b2328],
3	with	IN	O	with	_	0	SENT_6	[p1l565t2227r761b2307],
4	Buga	NNP	LOCATION	Buga	prep_with	2	SENT_6	[p1l792t2234r1008b2328],
5	et	FW	O	et	nn	6	SENT_6	[p1l1040t2244r1118b2306],
6	al.	FW	O	al.	dobj	2	SENT_6	[p1l1145t2227r1243b2306],
7	that	WDT	O	that	dobj	16	SENT_6	[p1l1282t2227r1456b2306],
8	antitachycardia	NN	O	antitachycardium	nn	9	SENT_6	[p1l1483t2227r2149b2328],
9	pacing	NN	O	pacing	nsubj	16	SENT_6	[p1l11t2356r302b2456],
10	(	CD	NUMBER	(	num	12	SENT_6	[p1l366t2361r594b2447],
11	ATP	NN	O	atp	nn	12	SENT_6	[p1l366t2361r594b2447],
12	)	NN	O	)	dep	9	SENT_6	[p1l366t2361r594b2447],
13	may	MD	O	may	aux	16	SENT_6	[p1l661t2381r842b2456],
14	occasionally	RB	O	occasionally	advmod	16	SENT_6	[p1l901t2355r1435b2456],
15	be	VB	O	be	cop	16	SENT_6	[p1l1495t2355r1591b2434],
16	useful	JJ	O	useful	rcmod	6	SENT_6	[p1l1654t2355r1943b2451],
17	,	,	O	,	_	0	SENT_6	[p1l1654t2355r1943b2451],
18	but	CC	O	but	_	0	SENT_6	[p1l2013t2355r2153b2434],
19	most	JJS	O	most	amod	21	SENT_6	[p1l12t2500r229b2562],
20	ICD	NN	O	icd	nn	21	SENT_6	[p1l271t2489r435b2562],
21	recipients	NNS	O	recipient	nsubj	24	SENT_6	[p1l484t2484r900b2584],
22	do	VBP	O	do	aux	24	SENT_6	[p1l951t2483r1054b2562],
23	not	RB	O	not	neg	24	SENT_6	[p1l1104t2500r1247b2562],
24	have	VB	O	have	conj_but	2	SENT_6	[p1l1290t2483r1481b2562],
25	monomorphic	JJ	O	monomorphic	amod	28	SENT_6	[p1l1529t2483r2149b2584],
26	ventricular	JJ	O	ventricular	amod	28	SENT_6	[p1l7t2611r480b2690],
27	tachycardia	NN	O	tachycardia	nn	28	SENT_6	[p1l512t2611r1072b2712],
28	}	NN	O	}	dobj	24	SENT_6	[p1l512t2611r1072b2712],
29	with	IN	O	with	_	0	SENT_6	[p1l1102t2611r1299b2690],
30	ablation	NN	O	ablation	prep_with	28	SENT_6	[p1l1332t2611r1683b2690],
31	representing	VBG	O	represent	partmod	30	SENT_6	[p1l1718t2628r2147b2712, p1l11t2740r154b2840],
32	the	DT	O	the	det	33	SENT_6	[p1l206t2739r341b2818],
33	standard	NN	O	standard	dobj	31	SENT_6	[p1l398t2739r787b2818],
34	of	IN	O	of	_	0	SENT_6	[p1l843t2739r944b2818],
35	care	NN	O	care	prep_of	33	SENT_6	[p1l981t2765r1160b2818],
36	for	IN	O	for	_	0	SENT_6	[p1l1215t2739r1342b2818],
37	many	JJ	O	many	amod	38	SENT_6	[p1l1393t2745r1692b2840],
38	.3	NN	NUMBER	.3	prep_for	31	SENT_6	[p1l1393t2745r1692b2840],
39	The	DT	O	the	det	42	SENT_6	[p1l1745t2739r1908b2818],
40	only	JJ	O	only	amod	42	SENT_6	[p1l1964t2739r2152b2840],
41	randomized	JJ	O	randomized	amod	42	SENT_6	[p1l12t2867r536b2946],
42	comparison	NN	O	comparison	nsubj	49	SENT_6	[p1l587t2868r1100b2968],
43	of	IN	O	of	_	0	SENT_6	[p1l1151t2867r1251b2946],
44	empiric	JJ	O	empiric	amod	45	SENT_6	[p1l1283t2868r1609b2968],
45	ATP	NN	O	atp	prep_of	42	SENT_6	[p1l1656t2873r1834b2945],
46	versus	CC	O	versus	prep	45	SENT_6	[p1l1878t2893r2145b2946],
47	shock	NN	O	shock	nn	48	SENT_6	[p1l13t2995r267b3075],
48	therapy	NN	O	therapy	dep	46	SENT_6	[p1l311t2995r634b3096],
49	showed	VBD	O	show	rcmod	38	SENT_6	[p1l680t2995r1004b3074],
50	that	IN	O	that	complm	53	SENT_6	[p1l1053t2995r1227b3074],
51	ATP	NN	ORGANIZATION	atp	nsubjpass	53	SENT_6	[p1l1266t3001r1444b3073],
52	was	VBD	O	be	auxpass	53	SENT_6	[p1l1487t3022r1651b3074],
53	associated	VBN	O	associate	ccomp	49	SENT_6	[p1l1701t2995r2148b3074],
54	with	IN	O	with	_	0	SENT_6	[p1l7t3123r201b3202],
55	nearly	RB	O	nearly	quantmod	56	SENT_6	[p1l231t3123r490b3224],
56	double	JJ	O	double	num	58	SENT_6	[p1l517t3123r799b3202],
57	the	DT	O	the	det	58	SENT_6	[p1l830t3123r961b3202],
58	number	NN	O	number	prep_with	53	SENT_6	[p1l992t3123r1327b3202],
59	of	IN	O	of	_	0	SENT_6	[p1l1355t3123r1455b3202],
60	adverse	JJ	O	adverse	amod	62	SENT_6	[p1l1466t3123r1776b3202],
61	cardiacrhythm	NN	O	cardiacrhythm	nn	62	SENT_6	[p1l1807t3123r2147b3202, p1l12t3251r332b3352],
62	events	NNS	O	event	prep_of	58	SENT_6	[p1l370t3268r634b3330],
63	and	CC	O	and	_	0	SENT_6	[p1l674t3251r833b3330],
64	a	DT	O	a	det	67	SENT_6	[p1l869t3278r913b3330],
65	42	CD	PERCENT	42	number	66	SENT_6	[p1l947t3257r1134b3330],
66	%	NN	PERCENT	%	amod	67	SENT_6	[p1l947t3257r1134b3330],
67	increase	NN	O	increase	dep	72	SENT_6	[p1l1170t3252r1525b3330],
68	in	IN	O	in	_	0	SENT_6	[p1l1561t3252r1645b3329],
69	mortality	NN	O	mortality	prep_in	67	SENT_6	[p1l1682t3251r2149b3352],
70	.4	CD	NUMBER	.4	num	69	SENT_6	[p1l1682t3251r2149b3352],
71	These	DT	O	these	det	72	SENT_6	[p1l8t3379r266b3458],
72	deaths	NNS	O	death	rcmod	38	SENT_6	[p1l324t3379r599b3458],
73	probably	RB	O	probably	advmod	74	SENT_6	[p1l653t3379r1025b3480],
74	occurred	VBD	O	occur	_	0	SENT_6	[p1l1075t3379r1448b3458],
75	in	IN	O	in	_	0	SENT_6	[p1l1501t3380r1583b3457],
76	response	NN	O	response	prep_in	74	SENT_6	[p1l1636t3405r2012b3480],
77	to	TO	O	to	_	0	SENT_6	[p1l2066t3396r2147b3458],
78	the	DT	O	the	det	80	SENT_6	[p1l12t3507r144b3586],
79	high	JJ	O	high	amod	80	SENT_6	[p1l204t3507r400b3608],
80	incidence	NN	O	incidence	prep_to	74	SENT_6	[p1l461t3507r860b3586],
81	of	IN	O	of	_	0	SENT_6	[p1l921t3507r1020b3586],
82	nonsustained	JJ	O	nonsustained	amod	84	SENT_6	[p1l1061t3507r1634b3586],
83	ventricular	JJ	O	ventricular	amod	84	SENT_6	[p1l1689t3507r2151b3586],
84	tachycardia	NN	O	tachycardia	prep_of	80	SENT_6	[p1l12t3635r499b3736],
85	observed	VBN	O	observe	partmod	84	SENT_6	[p1l539t3635r907b3714],
86	in	IN	O	in	_	0	SENT_6	[p1l943t3636r1025b3713],
87	primary	JJ	O	primary	amod	89	SENT_6	[p1l1059t3636r1399b3736],
88	prevention	NN	O	prevention	nn	89	SENT_6	[p1l1429t3636r1870b3736],
89	populations	NNS	O	population	prep_in	85	SENT_6	[p1l1905t3661r2147b3736, p2l11t20r347b99],
90	.5	CD	NUMBER	.5	nsubj	74	SENT_6	[p1l1905t3661r2147b3736, p2l11t20r347b99],

1	Pacing	NN	O	pacing	nsubjpass	10	SENT_7	[p2l396t21r685b121],
2	for	IN	O	for	_	0	SENT_7	[p2l733t20r856b99],
3	bradycardia	NN	O	bradycardium	nn	6	SENT_7	[p2l905t20r1412b121],
4	and	CC	O	and	_	0	SENT_7	[p2l1461t20r1620b99],
5	cardiac	JJ	O	cardiac	nn	6	SENT_7	[p2l1672t20r1983b99],
6	resynchronization	NN	O	resynchronization	prep_for	1	SENT_7	[p2l2033t46r2147b99, p2l13t148r701b249],
7	must	MD	O	must	aux	10	SENT_7	[p2l746t165r960b227],
8	also	RB	O	also	advmod	10	SENT_7	[p2l999t148r1168b227],
9	be	VB	O	be	auxpass	10	SENT_7	[p2l1215t148r1311b227],
10	considered	VBN	O	consider	_	0	SENT_7	[p2l1357t148r1813b227],
11	in	IN	O	in	_	0	SENT_7	[p2l1857t149r1940b226],
12	balance	NN	O	balance	prep_in	10	SENT_7	[p2l1986t148r2147b227, p2l11t302r230b355],
13	.	.	O	.	_	0	SENT_7	[p2l1986t148r2147b227, p2l11t302r230b355],

1	Patients	NNS	O	patient	nsubj	8	SENT_8	[p2l277t277r619b355],
2	with	IN	O	with	_	0	SENT_8	[p2l659t276r852b355],
3	symptomatic	JJ	O	symptomatic	amod	4	SENT_8	[p2l895t277r1445b377],
4	bradycardia	NNS	O	bradycardium	prep_with	1	SENT_8	[p2l1486t276r1982b377],
5	are	VBP	O	be	cop	8	SENT_8	[p2l2020t302r2147b355],
6	clearly	RB	O	clearly	advmod	8	SENT_8	[p2l12t404r286b505],
7	not	RB	O	not	neg	8	SENT_8	[p2l343t421r484b483],
8	candidates	NNS	O	candidate	_	0	SENT_8	[p2l541t404r1003b483],
9	for	IN	O	for	_	0	SENT_8	[p2l1069t404r1192b483],
10	subcutaneous	JJ	O	subcutaneous	amod	11	SENT_8	[p2l1254t404r1847b483],
11	ICDs	NNS	O	icd	prep_for	8	SENT_8	[p2l1910t410r2143b500],
12	,	,	O	,	_	0	SENT_8	[p2l1910t410r2143b500],
13	and	CC	O	and	_	0	SENT_8	[p2l11t532r170b611],
14	those	DT	O	those	nsubjpass	33	SENT_8	[p2l206t532r439b611],
15	with	IN	O	with	_	0	SENT_8	[p2l470t532r667b611],
16	end	NN	O	end	nn	20	SENT_8	[p2l704t532r1117b633],
17	—	CD	NUMBER	—	num	20	SENT_8	[p2l704t532r1117b633],
18	stage	NN	O	stage	nn	20	SENT_8	[p2l704t532r1117b633],
19	heart	NN	O	heart	nn	20	SENT_8	[p2l1153t532r1382b611],
20	failure	NN	O	failure	prep_with	14	SENT_8	[p2l1412t532r1714b628],
21	,	,	O	,	_	0	SENT_8	[p2l1412t532r1714b628],
22	who	WP	O	who	nsubj	24	SENT_8	[p2l1752t532r1935b612],
23	may	MD	O	may	aux	24	SENT_8	[p2l1972t558r2153b633],
24	be	VB	O	be	rcmod	14	SENT_8	[p2l12t660r110b739],
25	at	IN	O	at	_	0	SENT_8	[p2l150t677r229b739],
26	risk	NN	O	risk	prep_at	24	SENT_8	[p2l264t660r429b740],
27	for	IN	O	for	_	0	SENT_8	[p2l465t660r589b739],
28	asystole	NN	O	asystole	prep_for	26	SENT_8	[p2l626t660r987b761],
29	,	,	O	,	_	0	SENT_8	[p2l626t660r987b761],
30	should	MD	O	should	aux	33	SENT_8	[p2l1035t660r1324b739],
31	not	RB	O	not	neg	33	SENT_8	[p2l1364t677r1508b739],
32	be	VB	O	be	auxpass	33	SENT_8	[p2l1544t660r1640b739],
33	considered	VBN	O	consider	conj_and	8	SENT_8	[p2l1682t660r2148b739],
34	for	IN	O	for	_	0	SENT_8	[p2l12t788r136b867],
35	any	DT	O	any	det	36	SENT_8	[p2l181t814r331b889],
36	type	NN	O	type	prep_for	33	SENT_8	[p2l375t805r558b889],
37	of	IN	O	of	_	0	SENT_8	[p2l607t788r707b867],
38	ICD	NN	O	icd	nn	39	SENT_8	[p2l735t794r899b867],
39	therapy	NN	O	therapy	prep_of	36	SENT_8	[p2l948t788r1272b889],
40	without	IN	O	without	_	0	SENT_8	[p2l1311t788r1652b867],
41	supportive	JJ	O	supportive	amod	42	SENT_8	[p2l1697t789r2148b889],
42	data	NNS	O	datum	prep_without	33	SENT_8	[p2l12t916r219b995],
43	.	.	O	.	_	0	SENT_8	[p2l12t916r219b995],

1	Furthermore	RB	O	furthermore	advmod	11	SENT_9	[p2l265t916r841b1012],
2	,	,	O	,	_	0	SENT_9	[p2l265t916r841b1012],
3	in	IN	O	in	_	0	SENT_9	[p2l888t917r972b994],
4	recent	JJ	O	recent	amod	5	SENT_9	[p2l1014t933r1281b995],
5	studies	NNS	O	study	prep_in	11	SENT_9	[p2l1319t916r1621b995],
6	in	IN	O	in	_	0	SENT_9	[p2l1664t917r1748b994],
7	the	DT	O	the	det	8	SENT_9	[p2l1791t916r1924b995],
8	journal	NN	O	journal	prep_in	5	SENT_9	[p2l1950t924r2147b1017, p2l15t1044r152b1140],
9	,	,	O	,	_	0	SENT_9	[p2l1950t924r2147b1017, p2l15t1044r152b1140],
10	there	EX	O	there	expl	11	SENT_9	[p2l194t1044r412b1123],
11	was	VBD	O	be	_	0	SENT_9	[p2l444t1071r607b1124],
12	no	DT	O	no	det	13	SENT_9	[p2l646t1070r752b1123],
13	improvement	NN	O	improvement	nsubj	11	SENT_9	[p2l789t1045r1366b1145],
14	in	IN	O	in	_	0	SENT_9	[p2l1397t1045r1481b1122],
15	mortality	NN	O	mortality	prep_in	13	SENT_9	[p2l1518t1044r1924b1145],
16	with	IN	O	with	_	0	SENT_9	[p2l1952t1044r2148b1124],
17	prophylactic	NN	O	prophylactic	nn	19	SENT_9	[p2l11t1172r544b1273],
18	cardiac	JJ	O	cardiac	amod	19	SENT_9	[p2l605t1172r903b1251],
19	resynchronization	NN	O	resynchronization	prep_with	11	SENT_9	[p2l958t1172r1734b1273],
20	,	,	O	,	_	0	SENT_9	[p2l958t1172r1734b1273],
21	as	IN	O	as	_	0	SENT_9	[p2l1796t1199r1879b1251],
22	compared	VBN	O	compare	prepc_as	11	SENT_9	[p2l1939t1198r2147b1251, p2l11t1300r246b1401],
23	with	IN	O	with	pcomp	22	SENT_9	[p2l277t1300r467b1379],
24	standard	JJ	O	standard	amod	26	SENT_9	[p2l504t1300r885b1379],
25	ICD	NN	O	icd	nn	26	SENT_9	[p2l923t1306r1087b1379],
26	therapy	NN	O	therapy	pobj	23	SENT_9	[p2l1128t1300r1465b1401],
27	.	.	O	.	_	0	SENT_9	[p2l1128t1300r1465b1401],

1	With	IN	O	with	_	0	SENT_10	[p2l138t1428r352b1507],
2	respect	NN	O	respect	_	0	SENT_10	[p2l399t1445r709b1529],
3	to	TO	O	to	_	0	SENT_10	[p2l752t1445r834b1507],
4	the	DT	O	the	det	5	SENT_10	[p2l882t1428r1016b1507],
5	comments	NNS	O	comment	prep_with_respect_to	22	SENT_10	[p2l1064t1445r1515b1507],
6	of	IN	O	of	_	0	SENT_10	[p2l1565t1428r1665b1507],
7	Kleijn	NNP	LOCATION	Kleijn	prep_of	5	SENT_10	[p2l1692t1428r1943b1529],
8	and	CC	O	and	_	0	SENT_10	[p2l1989t1428r2148b1507],
9	van	NNP	PERSON	van	nn	11	SENT_10	[p2l7t1582r158b1635],
10	der	FW	PERSON	der	nn	11	SENT_10	[p2l195t1556r332b1635],
11	Veldt	NNP	PERSON	Veldt	prep_with_respect_to	22	SENT_10	[p2l363t1556r582b1635],
12	regarding	VBG	O	regard	_	0	SENT_10	[p2l614t1556r1041b1657],
13	downstream	JJ	O	downstream	amod	15	SENT_10	[p2l1074t1556r1618b1636],
14	tissue	NN	O	tissue	nn	15	SENT_10	[p2l1656t1557r1903b1635],
15	scarring	NN	O	scarring	prep_regarding	11	SENT_10	[p2l1941t1583r2147b1635, p2l12t1685r211b1785],
16	:	:	O	:	_	0	SENT_10	[p2l1941t1583r2147b1635, p2l12t1685r211b1785],
17	this	DT	O	this	det	18	SENT_10	[p2l265t1684r426b1763],
18	problem	NN	O	problem	nsubjpass	22	SENT_10	[p2l477t1684r837b1785],
19	has	VBZ	O	have	aux	22	SENT_10	[p2l887t1684r1032b1763],
20	not	RB	O	not	neg	22	SENT_10	[p2l1084t1701r1228b1763],
21	been	VBN	O	be	auxpass	22	SENT_10	[p2l1273t1684r1475b1763],
22	shown	VBN	O	show	_	0	SENT_10	[p2l1527t1684r1810b1764],
23	during	IN	O	during	_	0	SENT_10	[p2l1861t1684r2152b1785],
24	the	DT	O	the	det	26	SENT_10	[p2l12t1812r146b1891],
25	long	JJ	O	long	amod	26	SENT_10	[p2l192t1812r385b1913],
26	experience	NN	O	experience	prep_during	22	SENT_10	[p2l430t1813r888b1913],
27	with	IN	O	with	_	0	SENT_10	[p2l931t1812r1128b1891],
28	epicardial	JJ	O	epicardial	amod	33	SENT_10	[p2l1177t1812r1603b1913],
29	or	CC	O	or	_	0	SENT_10	[p2l1651t1838r1740b1891],
30	infracla	JJ	O	infracla	amod	33	SENT_10	[p2l1784t1812r2147b1891],
31	—	NN	O	—	nn	33	SENT_10	[p2l1784t1812r2147b1891],
32	vicular	JJ	O	vicular	amod	33	SENT_10	[p2l7t1940r305b2019],
33	devices	NNS	O	device	prep_with	26	SENT_10	[p2l343t1940r650b2019],
34	or	CC	O	or	_	0	SENT_10	[p2l692t1966r782b2019],
35	more	RBR	O	more	advmod	36	SENT_10	[p2l819t1966r1039b2019],
36	recently	RB	DATE	recently	conj_or	22	SENT_10	[p2l1080t1940r1422b2041],
37	with	IN	O	with	_	0	SENT_10	[p2l1453t1940r1650b2020],
38	the	DT	O	the	det	40	SENT_10	[p2l1690t1940r1823b2019],
39	subcutaneous	JJ	O	subcutaneous	amod	40	SENT_10	[p2l1866t1940r2147b2019, p2l12t2085r350b2147],
40	ICD	NN	O	icd	prep_with	36	SENT_10	[p2l394t2074r580b2147],
41	.	.	O	.	_	0	SENT_10	[p2l394t2074r580b2147],

1	Subcutaneous	NNP	O	Subcutaneous	nn	2	SENT_11	[p2l631t2068r1231b2147],
2	ICDs	NNS	O	icd	nsubjpass	5	SENT_11	[p2l1276t2074r1483b2147],
3	are	VBP	O	be	auxpass	5	SENT_11	[p2l1528t2095r1658b2147],
4	well	RB	O	well	advmod	5	SENT_11	[p2l1698t2068r1877b2148],
5	tolerated	VBN	O	tolerate	_	0	SENT_11	[p2l1921t2068r2147b2147, p2l11t2196r190b2275],

1	and	CC	O	and	cc	4	SENT_12	[p2l247t2196r406b2275],
2	are	VBP	O	be	cop	4	SENT_12	[p2l463t2223r593b2275],
3	somewhat	RB	O	somewhat	advmod	4	SENT_12	[p2l652t2196r1097b2276],
4	smaller	JJR	O	smaller	_	0	SENT_12	[p2l1151t2196r1472b2275],
5	than	IN	O	than	_	0	SENT_12	[p2l1527t2196r1725b2275],
6	previous	JJ	O	previous	amod	7	SENT_12	[p2l1781t2197r2145b2297],
7	iterations	NNS	O	iteration	prep_than	4	SENT_12	[p2l11t2326r410b2404],
8	of	IN	O	of	_	0	SENT_12	[p2l443t2325r543b2404],
9	infraclavicular	JJ	O	infraclavicular	amod	10	SENT_12	[p2l555t2325r1170b2404],
10	devices	NNS	O	device	prep_of	7	SENT_12	[p2l1199t2325r1499b2404],
11	that	WDT	O	that	nsubjpass	14	SENT_12	[p2l1533t2325r1703b2404],
12	have	VBP	O	have	aux	14	SENT_12	[p2l1729t2325r1917b2404],
13	been	VBN	O	be	auxpass	14	SENT_12	[p2l1949t2325r2148b2404],
14	used	VBN	O	use	rcmod	7	SENT_12	[p2l12t2453r212b2532],
15	successfully	RB	O	successfully	advmod	14	SENT_12	[p2l270t2453r802b2554],
16	for	IN	O	for	_	0	SENT_12	[p2l854t2453r981b2532],
17	more	JJR	DURATION	more	mwe	18	SENT_12	[p2l1034t2479r1258b2532],
18	than	IN	DURATION	than	quantmod	19	SENT_12	[p2l1315t2453r1516b2532],
19	a	DT	DURATION	a	num	20	SENT_12	[p2l1573t2480r1617b2532],
20	decade	NN	DURATION	decade	prep_for	14	SENT_12	[p2l1673t2453r1996b2532],
21	.	.	O	.	_	0	SENT_12	[p2l1673t2453r1996b2532],

1	In	IN	O	in	_	0	SENT_13	[p2l2057t2461r2148b2531],
2	summary	NN	O	summary	prep_in	26	SENT_13	[p2l13t2607r440b2682],
3	,	,	O	,	_	0	SENT_13	[p2l13t2607r440b2682],
4	although	IN	O	although	mark	10	SENT_13	[p2l481t2581r870b2682],
5	the	DT	O	the	det	7	SENT_13	[p2l906t2581r1039b2660],
6	subcutaneous	JJ	O	subcutaneous	amod	7	SENT_13	[p2l1077t2581r1669b2660],
7	ICD	NN	O	icd	nsubj	10	SENT_13	[p2l1706t2587r1870b2660],
8	is	VBZ	O	be	cop	10	SENT_13	[p2l1905t2582r1972b2660],
9	not	RB	O	not	neg	10	SENT_13	[p2l2010t2598r2153b2660],
10	suitable	JJ	O	suitable	advcl	26	SENT_13	[p2l13t2709r347b2788],
11	for	IN	O	for	_	0	SENT_13	[p2l383t2709r507b2788],
12	every	DT	O	every	det	14	SENT_13	[p2l541t2735r764b2810],
13	ICD	NN	O	icd	nn	14	SENT_13	[p2l794t2715r958b2788],
14	candidate	NN	O	candidate	prep_for	10	SENT_13	[p2l995t2709r1438b2805],
15	,	,	O	,	_	0	SENT_13	[p2l995t2709r1438b2805],
16	its	PRP$	O	its	poss	19	SENT_13	[p2l1478t2710r1577b2788],
17	low	JJ	O	low	amod	19	SENT_13	[p2l1614t2709r1771b2788],
18	surgical	JJ	O	surgical	amod	19	SENT_13	[p2l1805t2709r2148b2810],
19	risk	NN	O	risk	nsubj	26	SENT_13	[p2l12t2837r177b2917],
20	and	CC	O	and	_	0	SENT_13	[p2l207t2837r365b2916],
21	avoidance	NN	O	avoidance	nsubj	26	SENT_13	[p2l400t2837r824b2916],
22	of	IN	O	of	_	0	SENT_13	[p2l860t2837r961b2916],
23	transvenous	JJ	O	transvenous	amod	25	SENT_13	[p2l978t2854r1499b2916],
24	lead	NN	O	lead	nn	25	SENT_13	[p2l1535t2837r1709b2916],
25	problems	NNS	O	problem	prep_of	21	SENT_13	[p2l1743t2837r2145b2938],
26	make	VBP	O	make	_	0	SENT_13	[p2l12t2965r246b3045],
27	it	PRP	O	it	nsubj	30	SENT_13	[p2l294t2966r353b3044],
28	a	DT	O	a	det	30	SENT_13	[p2l395t2992r439b3044],
29	rational	JJ	O	rational	amod	30	SENT_13	[p2l485t2965r823b3044],
30	choice	NN	O	choice	xcomp	26	SENT_13	[p2l871t2965r1142b3044],
31	for	IN	O	for	_	0	SENT_13	[p2l1190t2965r1314b3044],
32	many	JJ	O	many	amod	33	SENT_13	[p2l1358t2991r1599b3066],
33	patients	NNS	O	patient	prep_for	30	SENT_13	[p2l1640t2966r1983b3066],
34	requiring	VBG	O	require	partmod	33	SENT_13	[p2l2033t2991r2147b3044, p2l12t3094r334b3194],
35	targeted	VBN	O	target	dep	34	SENT_13	[p2l371t3093r729b3194],
36	protection	NN	O	protection	dobj	35	SENT_13	[p2l766t3094r1214b3194],
37	from	IN	O	from	_	0	SENT_13	[p2l1253t3093r1465b3172],
38	sudden	JJ	O	sudden	amod	39	SENT_13	[p2l1507t3093r1813b3172],
39	death	NN	O	death	prep_from	35	SENT_13	[p2l1854t3093r2116b3172],
40	.	.	O	.	_	0	SENT_13	[p2l1854t3093r2116b3172],

1	Gust	NNP	PERSON	Gust	nn	3	SENT_14	[p2l14t3236r224b3310],
2	H.	NNP	PERSON	H.	nn	3	SENT_14	[p2l262t3237r354b3310],
3	Bardy	NNP	PERSON	Bardy	_	0	SENT_14	[p2l398t3230r660b3335],
4	,	,	O	,	_	0	SENT_14	[p2l398t3230r660b3335],
5	M.D.	NNP	ORGANIZATION	M.D.	nn	7	SENT_14	[p2l704t3237r912b3310],
6	Seattle	NNP	ORGANIZATION	Seattle	nn	7	SENT_14	[p2l13t3379r242b3440],
7	Institute	NNP	ORGANIZATION	Institute	dep	3	SENT_14	[p2l272t3384r549b3440],
8	for	IN	ORGANIZATION	for	_	0	SENT_14	[p2l572t3378r666b3440],
9	Cardiac	JJ	ORGANIZATION	cardiac	amod	11	SENT_14	[p2l688t3379r941b3440],
10	Research	NNP	ORGANIZATION	Research	nn	11	SENT_14	[p2l969t3379r1265b3440],
11	Seattle	NNP	ORGANIZATION	Seattle	prep_for	7	SENT_14	[p2l12t3463r260b3534],
12	,	,	O	,	_	0	SENT_14	[p2l12t3463r260b3534],
13	WA	NNP	LOCATION	WA	nn	14	SENT_14	[p2l286t3467r402b3524],
14	gbardy@sicr.org	NN	O	gbardy@sicr.org	dep	3	SENT_14	[p2l12t3547r570b3627],

1	Warren	NNP	PERSON	Warren	nn	3	SENT_15	[p2l10t3696r328b3770],
2	M.	NNP	PERSON	M.	nn	3	SENT_15	[p2l373t3696r476b3769],
3	Smith	NNP	PERSON	Smith	_	0	SENT_15	[p2l514t3689r795b3784],
4	,	,	O	,	_	0	SENT_15	[p2l514t3689r795b3784],
5	M.B.	NNP	PERSON	M.B.	appos	3	SENT_15	[p2l840t3696r1034b3769],

1	Auckland	NNP	LOCATION	Auckland	nn	4	SENT_16	[p3l9t37r321b98],
2	City	NNP	LOCATION	City	nn	4	SENT_16	[p3l350t41r478b116],
3	Hospital	NNP	LOCATION	Hospital	nn	4	SENT_16	[p3l506t37r786b116],
4	Auckland	NNP	LOCATION	Auckland	_	0	SENT_16	[p3l9t124r342b195],
5	,	,	O	,	_	0	SENT_16	[p3l9t124r342b195],
6	New	NNP	LOCATION	New	nn	7	SENT_16	[p3l376t129r524b185],
7	Zealand	NNP	LOCATION	Zealand	appos	4	SENT_16	[p3l546t124r812b184],

1	Andrew	NNP	PERSON	Andrew	nn	3	SENT_17	[p3l10t266r349b347],
2	A.	NNP	PERSON	A.	nn	3	SENT_17	[p3l376t271r459b346],
3	Grace	NNP	PERSON	Grace	_	0	SENT_17	[p3l497t272r774b361],
4	,	,	O	,	_	0	SENT_17	[p3l497t272r774b361],
5	M.B.	NNP	O	M.B.	nn	7	SENT_17	[p3l819t273r1039b361],
6	,	,	O	,	_	0	SENT_17	[p3l819t273r1039b361],
7	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_17	[p3l1084t266r1314b346],
8	.	.	O	.	_	0	SENT_17	[p3l1084t266r1314b346],

1	Cambridge	NNP	ORGANIZATION	Cambridge	nn	3	SENT_18	[p3l12t416r383b496],
2	University	NNP	ORGANIZATION	University	nn	3	SENT_18	[p3l412t421r750b495],
3	Cambridge	NNP	ORGANIZATION	Cambridge	_	0	SENT_18	[p3l12t512r402b592],
4	,	,	O	,	_	0	SENT_18	[p3l12t512r402b592],
5	United	NNP	LOCATION	United	nn	6	SENT_18	[p3l433t512r652b573],
6	Kingdom	NNP	LOCATION	Kingdom	appos	3	SENT_18	[p3l686t512r983b592],

1	Since	IN	O	since	_	0	SENT_19	[p3l99t664r271b723],
2	publication	NN	O	publication	prep_since	9	SENT_19	[p3l303t664r680b740],
3	of	IN	O	of	_	0	SENT_19	[p3l713t663r790b723],
4	their	PRP$	O	they	poss	5	SENT_19	[p3l809t664r966b723],
5	article	NN	O	article	prep_of	2	SENT_19	[p3l996t664r1221b736],
6	,	,	O	,	_	0	SENT_19	[p3l996t664r1221b736],
7	the	DT	O	the	det	8	SENT_19	[p3l1259t664r1361b723],
8	authors	NNS	O	author	nsubj	9	SENT_19	[p3l1393t664r1642b724],
9	report	VBP	O	report	_	0	SENT_19	[p3l1677t676r1883b740],
10	no	DT	O	no	det	13	SENT_19	[p3l1912t683r1992b723],
11	further	JJ	O	further	amod	13	SENT_19	[p3l2027t663r2148b724, p3l11t761r145b820],
12	potential	JJ	O	potential	amod	13	SENT_19	[p3l168t761r467b837],
13	conflict	NN	O	conflict	dobj	9	SENT_19	[p3l492t760r752b820],
14	of	IN	O	of	_	0	SENT_19	[p3l774t760r851b820],
15	interest	NN	O	interest	prep_of	13	SENT_19	[p3l862t761r1130b820],
16	.	.	O	.	_	0	SENT_19	[p3l862t761r1130b820],

1	1	LS	NUMBER	1	_	0	SENT_20	[p3l13t974r63b1025],
2	.	.	O	.	_	0	SENT_20	[p3l13t974r63b1025],

1	Kilingsworth	NNP	O	Kilingsworth	nn	2	SENT_21	[p3l140t966r582b1043],
2	CR	NN	O	cr	_	0	SENT_21	[p3l614t970r728b1038],
3	,	,	O	,	_	0	SENT_21	[p3l614t970r728b1038],
4	Litovsky	NNP	PERSON	Litovsky	nn	5	SENT_21	[p3l763t966r1040b1042],
5	S	NNP	O	S	appos	2	SENT_21	[p3l1070t970r1122b1038],
6	,	,	O	,	_	0	SENT_21	[p3l1070t970r1122b1038],
7	Melnick	NNP	ORGANIZATION	Melnick	nn	8	SENT_21	[p3l1156t966r1426b1026],
8	SB	NN	ORGANIZATION	sb	appos	5	SENT_21	[p3l1456t970r1553b1038],
9	,	,	O	,	_	0	SENT_21	[p3l1456t970r1553b1038],
10	Vance	NNP	ORGANIZATION	Vance	nn	11	SENT_21	[p3l1586t971r1780b1026],
11	FL	NN	ORGANIZATION	fl	appos	5	SENT_21	[p3l1810t971r1908b1038],
12	,	,	O	,	_	0	SENT_21	[p3l1810t971r1908b1038],
13	Ideker	NNP	O	Ideker	nn	14	SENT_21	[p3l1943t966r2151b1026],
14	RE	NNP	O	RE	appos	5	SENT_21	[p3l10t1067r121b1134],
15	,	,	O	,	_	0	SENT_21	[p3l10t1067r121b1134],
16	Walcott	NNP	PERSON	Walcott	nn	17	SENT_21	[p3l149t1062r408b1121],
17	GP	NNP	O	GP	appos	5	SENT_21	[p3l430t1066r537b1121],
18	.	.	O	.	_	0	SENT_21	[p3l430t1066r537b1121],

1	Heart	NNP	O	Heart	nn	2	SENT_22	[p3l566t1067r756b1121],
2	rhythm	NN	O	rhythm	_	0	SENT_22	[p3l778t1062r1022b1137],
3	2010	CD	DATE	2010	num	2	SENT_22	[p3l1048t1062r1466b1137],
4	;	:	O	;	_	0	SENT_22	[p3l1048t1062r1466b1137],
5	7	CD	NUMBER	7	dep	2	SENT_22	[p3l1048t1062r1466b1137],
6	:	:	O	:	_	0	SENT_22	[p3l1048t1062r1466b1137],
7	Suppl	NNP	O	Suppl	dep	2	SENT_22	[p3l1048t1062r1466b1137],
8	5	CD	NUMBER	5	num	7	SENT_22	[p3l1493t1066r1725b1121],
9	:	:	O	:	_	0	SENT_22	[p3l1493t1066r1725b1121],
10	S186	NN	O	s186	dep	7	SENT_22	[p3l1493t1066r1725b1121],
11	.	.	O	.	_	0	SENT_22	[p3l1493t1066r1725b1121],

1	abstract	JJ	O	abstract	_	0	SENT_23	[p3l1755t1062r2038b1121],
2	.	.	O	.	_	0	SENT_23	[p3l1755t1062r2038b1121],

1	2	LS	NUMBER	2	_	0	SENT_24	[p3l10t1167r64b1219],
2	.	.	O	.	_	0	SENT_24	[p3l10t1167r64b1219],

1	Poole	NNP	PERSON	Poole	nn	2	SENT_25	[p3l140t1159r319b1219],
2	JE	NNP	O	JE	_	0	SENT_25	[p3l344t1164r434b1232],
3	,	,	O	,	_	0	SENT_25	[p3l344t1164r434b1232],
4	Johnson	NNP	PERSON	Johnson	nn	5	SENT_25	[p3l464t1159r742b1228],
5	GW	NNP	O	GW	appos	2	SENT_25	[p3l774t1163r910b1232],
6	,	,	O	,	_	0	SENT_25	[p3l774t1163r910b1232],
7	Hellkamp	NNP	PERSON	Hellkamp	nn	8	SENT_25	[p3l947t1159r1273b1235],
8	AS	NNP	O	AS	appos	2	SENT_25	[p3l1304t1163r1409b1231],
9	,	,	O	,	_	0	SENT_25	[p3l1304t1163r1409b1231],
10	et	FW	O	et	nn	11	SENT_25	[p3l1448t1172r1507b1218],
11	al.	FW	O	al.	appos	2	SENT_25	[p3l1535t1159r1610b1219],
12	.	.	O	.	_	0	SENT_25	[p3l1535t1159r1610b1219],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_26	[p3l1647t1160r2005b1236],
2	importance	NN	O	importance	_	0	SENT_26	[p3l2037t1160r2148b1218, p3l10t1268r310b1330],
3	of	IN	O	of	_	0	SENT_26	[p3l339t1255r416b1314],
4	defibrillator	NN	O	defibrillator	nn	5	SENT_26	[p3l432t1255r847b1314],
5	shocks	NNS	O	shock	prep_of	2	SENT_26	[p3l876t1255r1103b1315],
6	in	IN	O	in	_	0	SENT_26	[p3l1133t1256r1198b1313],
7	patients	NNS	O	patient	prep_in	2	SENT_26	[p3l1225t1256r1495b1330],
8	with	IN	O	with	_	0	SENT_26	[p3l1522t1255r1674b1315],
9	heart	NN	O	heart	nn	10	SENT_26	[p3l1704t1255r1882b1314],
10	failure	NN	O	failure	prep_with	7	SENT_26	[p3l1906t1255r2145b1315],
11	.	.	O	.	_	0	SENT_26	[p3l1906t1255r2145b1315],

1	N	NN	O	n	nn	2	SENT_27	[p3l9t1357r66b1412],
2	EnglJ	NN	O	englj	nsubj	3	SENT_27	[p3l91t1352r287b1429],
3	Med	VBD	O	med	_	0	SENT_27	[p3l309t1352r451b1412],
4	2008	CD	DATE	2008	dobj	3	SENT_27	[p3l478t1356r1068b1424],
5	;	:	O	;	_	0	SENT_27	[p3l478t1356r1068b1424],
6	359:1009	CD	NUMBER	359:1009	number	7	SENT_27	[p3l478t1356r1068b1424],
7	—	CD	NUMBER	—	dep	4	SENT_27	[p3l478t1356r1068b1424],
8	17	CD	NUMBER	17	dep	7	SENT_27	[p3l478t1356r1068b1424],
9	.	.	O	.	_	0	SENT_27	[p3l478t1356r1068b1424],

1	3	LS	NUMBER	3	_	0	SENT_28	[p3l11t1455r62b1507],
2	.	.	O	.	_	0	SENT_28	[p3l11t1455r62b1507],

1	Reddy	NNP	PERSON	Reddy	nn	2	SENT_29	[p3l139t1448r345b1523],
2	VY	NNP	O	VY	_	0	SENT_29	[p3l366t1453r471b1519],
3	,	,	O	,	_	0	SENT_29	[p3l366t1453r471b1519],
4	Reynolds	NNP	PERSON	Reynolds	nn	5	SENT_29	[p3l502t1448r803b1523],
5	MR	NN	PERSON	mr	appos	2	SENT_29	[p3l830t1453r965b1520],
6	,	,	O	,	_	0	SENT_29	[p3l830t1453r965b1520],
7	Neuzil	NNP	PERSON	Neuzil	nn	8	SENT_29	[p3l995t1448r1213b1508],
8	P	NN	O	p	appos	2	SENT_29	[p3l1239t1453r1290b1519],
9	,	,	O	,	_	0	SENT_29	[p3l1239t1453r1290b1519],
10	et	FW	O	et	nn	11	SENT_29	[p3l1322t1461r1381b1507],
11	al.	FW	O	al.	appos	2	SENT_29	[p3l1404t1448r1479b1507],
12	.	.	O	.	_	0	SENT_29	[p3l1404t1448r1479b1507],

1	Prophylactic	JJ	O	prophylactic	amod	3	SENT_30	[p3l1509t1448r1919b1523],
2	catheter	NN	O	catheter	nn	3	SENT_30	[p3l1946t1448r2148b1507, p3l11t1558r99b1604],
3	ablation	NN	O	ablation	_	0	SENT_30	[p3l125t1545r395b1605],
4	for	IN	O	for	_	0	SENT_30	[p3l423t1545r518b1605],
5	the	DT	O	the	det	6	SENT_30	[p3l544t1545r646b1604],
6	prevention	NN	O	prevention	prep_for	3	SENT_30	[p3l674t1546r1028b1621],
7	of	IN	O	of	_	0	SENT_30	[p3l1056t1545r1133b1605],
8	defibrillator	NN	O	defibrillator	nn	9	SENT_30	[p3l1148t1545r1553b1605],
9	therapy	NN	O	therapy	prep_of	3	SENT_30	[p3l1580t1545r1839b1621],
10	.	.	O	.	_	0	SENT_30	[p3l1580t1545r1839b1621],

1	N	NN	O	n	nn	2	SENT_31	[p3l1870t1550r1926b1605],
2	EnglJ	NN	O	englj	nsubj	3	SENT_31	[p3l1953t1545r2151b1622],
3	Med	VBD	O	med	_	0	SENT_31	[p3l9t1641r151b1700],
4	2007	CD	DATE	2007	dobj	3	SENT_31	[p3l177t1645r764b1712],
5	;	:	O	;	_	0	SENT_31	[p3l177t1645r764b1712],
6	357:2657	CD	NUMBER	357:2657	number	7	SENT_31	[p3l177t1645r764b1712],
7	—	CD	NUMBER	—	dep	4	SENT_31	[p3l177t1645r764b1712],
8	65	CD	NUMBER	65	dep	7	SENT_31	[p3l177t1645r764b1712],
9	.	.	O	.	_	0	SENT_31	[p3l177t1645r764b1712],

1	4	LS	NUMBER	4	_	0	SENT_32	[p3l9t1745r63b1796],
2	.	.	O	.	_	0	SENT_32	[p3l9t1745r63b1796],

1	Wathen	NNP	PERSON	Wathen	nn	2	SENT_33	[p3l138t1737r392b1796],
2	MS	NN	O	m	_	0	SENT_33	[p3l413t1741r534b1809],
3	,	,	O	,	_	0	SENT_33	[p3l413t1741r534b1809],
4	DeGroot	NNP	PERSON	DeGroot	nn	5	SENT_33	[p3l560t1741r849b1796],
5	PJ	NNP	PERSON	PJ	appos	2	SENT_33	[p3l867t1742r945b1809],
6	,	,	O	,	_	0	SENT_33	[p3l867t1742r945b1809],
7	Sweeney	NNP	PERSON	Sweeney	nn	8	SENT_33	[p3l974t1741r1254b1812],
8	MO	NNP	DURATION	MO	appos	2	SENT_33	[p3l1271t1741r1407b1809],
9	,	,	O	,	_	0	SENT_33	[p3l1271t1741r1407b1809],
10	et	FW	O	et	nn	11	SENT_33	[p3l1435t1750r1494b1796],
11	al.	FW	O	al.	appos	2	SENT_33	[p3l1513t1737r1587b1796],
12	.	.	O	.	_	0	SENT_33	[p3l1513t1737r1587b1796],

1	Prospective	JJ	O	prospective	nsubj	2	SENT_34	[p3l1614t1738r1991b1812],
2	randomized	VBN	O	randomize	dep	31	SENT_34	[p3l2015t1756r2148b1796, p3l12t1834r299b1894],
3	multicenter	JJ	O	multicenter	amod	4	SENT_34	[p3l337t1834r721b1894],
4	trial	NN	O	trial	dobj	2	SENT_34	[p3l756t1834r894b1893],
5	of	IN	O	of	_	0	SENT_34	[p3l931t1834r1008b1894],
6	empirical	JJ	O	empirical	amod	8	SENT_34	[p3l1032t1834r1344b1910],
7	antitachycardia	NN	O	antitachycardium	nn	8	SENT_34	[p3l1382t1834r1894b1910],
8	pacing	NN	O	pacing	prep_of	4	SENT_34	[p3l1929t1835r2152b1911],
9	versus	CC	O	versus	prep	8	SENT_34	[p3l8t1950r213b1990],
10	shocks	NNS	O	shock	dep	9	SENT_34	[p3l248t1930r471b1991],
11	for	IN	O	for	_	0	SENT_34	[p3l505t1930r599b1990],
12	spontaneous	JJ	O	spontaneous	amod	15	SENT_34	[p3l631t1943r1050b2006],
13	rapid	JJ	O	rapid	amod	15	SENT_34	[p3l1084t1930r1252b2006],
14	ventricular	JJ	O	ventricular	amod	15	SENT_34	[p3l1281t1930r1644b1991],
15	tachycardia	NN	O	tachycardia	prep_for	10	SENT_34	[p3l1674t1930r2055b2006],
16	in	IN	O	in	_	0	SENT_34	[p3l2085t1931r2149b1989],
17	patients	NNS	O	patient	prep_in	15	SENT_34	[p3l10t2029r268b2104],
18	with	IN	O	with	_	0	SENT_34	[p3l294t2028r442b2088],
19	implantable	JJ	O	implantable	amod	22	SENT_34	[p3l469t2028r857b2104],
20	cardioverter	NN	O	cardioverter	nn	22	SENT_34	[p3l886t2028r1748b2088],
21	—	NN	O	—	nn	22	SENT_34	[p3l886t2028r1748b2088],
22	deﬁbrillators	NNS	O	deﬁbrillators	prep_with	17	SENT_34	[p3l886t2028r1748b2088],
23	:	:	O	:	_	0	SENT_34	[p3l886t2028r1748b2088],
24	Pacing	VBG	O	pace	csubj	28	SENT_34	[p3l1779t2029r1996b2105],
25	Fast	JJ	O	fast	amod	27	SENT_34	[p3l2020t2033r2153b2087],
26	Ventricular	JJ	O	ventricular	amod	27	SENT_34	[p3l8t2124r367b2184],
27	Tachycardia	NN	O	tachycardia	dobj	24	SENT_34	[p3l381t2124r767b2199],
28	Reduces	VBZ	O	reduce	parataxis	2	SENT_34	[p3l784t2124r1047b2187],
29	Shock	NN	O	shock	nn	30	SENT_34	[p3l1070t2124r1263b2184],
30	Therapies	NNS	O	therapy	dobj	28	SENT_34	[p3l1277t2124r1588b2199],
31	(	VBP	O	(	_	0	SENT_34	[p3l1613t2125r1951b2193],
32	PainFREE	NN	O	painfree	nn	33	SENT_34	[p3l1613t2125r1951b2193],
33	RX	NN	MISC	rx	dobj	31	SENT_34	[p3l1971t2129r2057b2186],
34	II	CD	NUMBER	ii	num	33	SENT_34	[p3l2074t2129r2145b2193],
35	)	CD	NUMBER	)	num	37	SENT_34	[p3l2074t2129r2145b2193],
36	trial	NN	O	trial	nn	37	SENT_34	[p3l11t2220r149b2278],
37	results	NNS	O	result	nsubj	31	SENT_34	[p3l174t2220r412b2280],
38	.	.	O	.	_	0	SENT_34	[p3l174t2220r412b2280],

1	Circulation	NN	O	circulation	_	0	SENT_35	[p3l443t2220r815b2280],
2	2004	CD	DATE	2004	num	1	SENT_35	[p3l841t2224r1404b2291],
3	;	:	O	;	_	0	SENT_35	[p3l841t2224r1404b2291],
4	110:2591	CD	NUMBER	110:2591	number	5	SENT_35	[p3l841t2224r1404b2291],
5	—	CD	NUMBER	—	dep	1	SENT_35	[p3l841t2224r1404b2291],
6	6	CD	NUMBER	6	dep	5	SENT_35	[p3l841t2224r1404b2291],
7	.	.	O	.	_	0	SENT_35	[p3l841t2224r1404b2291],

1	5	CD	NUMBER	5	_	0	SENT_36	[p3l12t2324r62b2375],
2	.	.	O	.	_	0	SENT_36	[p3l12t2324r62b2375],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_37	[p3l141t2316r310b2375],
2	J	NNP	PERSON	J	_	0	SENT_37	[p3l335t2321r380b2388],
3	,	,	O	,	_	0	SENT_37	[p3l335t2321r380b2388],
4	Poole	NNP	PERSON	Poole	nn	5	SENT_37	[p3l417t2316r595b2375],
5	JE	NNP	O	JE	appos	2	SENT_37	[p3l622t2321r712b2388],
6	,	,	O	,	_	0	SENT_37	[p3l622t2321r712b2388],
7	Johnson	NNP	PERSON	Johnson	nn	8	SENT_37	[p3l743t2316r1021b2385],
8	GW	NNP	O	GW	appos	2	SENT_37	[p3l1055t2320r1190b2388],
9	,	,	O	,	_	0	SENT_37	[p3l1055t2320r1190b2388],
10	et	FW	O	et	nn	11	SENT_37	[p3l1229t2329r1289b2375],
11	al.	FW	O	al.	appos	2	SENT_37	[p3l1318t2316r1393b2375],
12	.	.	O	.	_	0	SENT_37	[p3l1318t2316r1393b2375],

1	Implications	NNS	O	implication	nsubj	6	SENT_38	[p3l1430t2316r1848b2391],
2	of	IN	O	of	_	0	SENT_38	[p3l1884t2316r1961b2375],
3	rapid	JJ	O	rapid	amod	5	SENT_38	[p3l1980t2316r2149b2391],
4	non	JJ	O	non	amod	5	SENT_38	[p3l11t2412r484b2472],
5	—	NN	O	—	prep_of	1	SENT_38	[p3l11t2412r484b2472],
6	sustained	VBD	O	sustain	_	0	SENT_38	[p3l11t2412r484b2472],
7	ventricular	JJ	O	ventricular	amod	8	SENT_38	[p3l517t2412r880b2472],
8	tachycardia	NN	O	tachycardia	dobj	6	SENT_38	[p3l914t2412r1295b2487],
9	in	IN	O	in	_	0	SENT_38	[p3l1329t2413r1393b2470],
10	ICD	NN	O	icd	nn	13	SENT_38	[p3l1428t2416r1553b2471],
11	heart	NN	O	heart	nn	13	SENT_38	[p3l1590t2412r1765b2471],
12	failure	NN	O	failure	nn	13	SENT_38	[p3l1797t2412r2011b2472],
13	patients	NNS	O	patient	prep_in	6	SENT_38	[p3l2046t2431r2148b2487, p3l11t2510r194b2568],
14	in	IN	O	in	_	0	SENT_38	[p3l221t2510r285b2568],
15	the	DT	O	the	det	18	SENT_38	[p3l312t2509r414b2568],
16	Sudden	NNP	O	Sudden	nn	18	SENT_38	[p3l442t2509r682b2569],
17	Cardiac	JJ	O	cardiac	amod	18	SENT_38	[p3l708t2509r960b2569],
18	Death	NN	O	death	prep_in	6	SENT_38	[p3l984t2509r1182b2568],
19	in	IN	O	in	_	0	SENT_38	[p3l1208t2510r1272b2568],
20	Heart	NNP	O	Heart	nn	22	SENT_38	[p3l1297t2514r1486b2568],
21	Failure	NN	O	failure	nn	22	SENT_38	[p3l1508t2509r1735b2569],
22	Trial	NN	O	trial	prep_in	18	SENT_38	[p3l1759t2509r1934b2569],
23	.	.	O	.	_	0	SENT_38	[p3l1759t2509r1934b2569],

1	Heart	NNP	O	Heart	nn	2	SENT_39	[p3l1964t2514r2153b2568],
2	Rhythm	NNP	O	Rhythm	_	0	SENT_39	[p3l10t2605r278b2680],
3	2010	CD	DATE	2010	num	5	SENT_39	[p3l304t2605r722b2680],
4	;	:	O	;	_	0	SENT_39	[p3l304t2605r722b2680],
5	7	CD	NUMBER	7	dep	2	SENT_39	[p3l304t2605r722b2680],
6	:	:	O	:	_	0	SENT_39	[p3l304t2605r722b2680],
7	Suppl	NNP	O	Suppl	dep	2	SENT_39	[p3l304t2605r722b2680],
8	5:854	CD	NUMBER	5:854	num	7	SENT_39	[p3l749t2609r941b2664],
9	.	.	O	.	_	0	SENT_39	[p3l749t2609r941b2664],

1	abstract	JJ	O	abstract	_	0	SENT_40	[p3l970t2605r1253b2664],
2	.	.	O	.	_	0	SENT_40	[p3l970t2605r1253b2664],

1	Interstitial	JJ	O	interstitial	amod	3	SENT_41	[p3l723t2756r982b2804],
2	Lung	NN	O	lung	nn	3	SENT_41	[p3l1009t2760r1135b2819],
3	Disease	NN	O	disease	_	0	SENT_41	[p3l1158t2757r1360b2804],
4	and	CC	O	and	_	0	SENT_41	[p3l1381t2756r1474b2804],
5	Geﬁtinib	NN	PERSON	geﬁtinib	conj_and	3	SENT_41	[p3l1497t2755r1724b2804],

1	TO	TO	O	to	aux	3	SENT_42	[p3l379t2881r422b2902],
2	THE	DT	O	the	det	3	SENT_42	[p3l435t2881r498b2902],
3	EDITOR	NN	O	editor	_	0	SENT_42	[p3l514t2881r644b2902],
4	:	:	O	:	_	0	SENT_42	[p3l514t2881r644b2902],
5	As	IN	O	as	mark	6	SENT_42	[p3l658t2875r699b2902],
6	reported	VBN	O	report	dep	3	SENT_42	[p3l713t2872r856b2911],
7	by	IN	O	by	_	0	SENT_42	[p3l869t2872r907b2911],
8	Maemondo	NNP	PERSON	Maemondo	nn	12	SENT_42	[p3l918t2872r1106b2903],
9	et	FW	O	et	nn	12	SENT_42	[p3l1121t2878r1151b2902],
10	al.	FW	O	al.	nn	12	SENT_42	[p3l1162t2872r1200b2903],
11	(	FW	O	(	nn	12	SENT_42	[p3l381t2924r466b2956],
12	June	NNP	DATE	June	prep_by	6	SENT_42	[p3l381t2924r466b2956],
13	24	CD	DATE	24	num	14	SENT_42	[p3l484t2923r522b2952],
14	issue	NN	O	issue	dobj	6	SENT_42	[p3l540t2921r656b2958],
15	)	CD	NUMBER	)	num	16	SENT_42	[p3l540t2921r656b2958],
16	,1	NN	O	,1	nsubj	44	SENT_42	[p3l540t2921r656b2958],
17	among	IN	O	among	_	0	SENT_42	[p3l674t2931r791b2960],
18	patients	NNS	O	patient	prep_among	16	SENT_42	[p3l806t2921r939b2960],
19	receiving	VBG	O	receive	partmod	18	SENT_42	[p3l957t2921r1109b2960],
20	gef1	NN	O	gef1	nn	22	SENT_42	[p3l1125t2921r1202b2960],
21	—	NN	O	—	nn	22	SENT_42	[p3l1125t2921r1202b2960],
22	tinib	NN	O	tinib	dobj	19	SENT_42	[p3l379t2970r458b3001],
23	for	IN	O	for	_	0	SENT_42	[p3l474t2970r522b3001],
24	non-small	JJ	O	non-small	amod	28	SENT_42	[p3l537t2970r787b3001],
25	—	NN	O	—	nn	28	SENT_42	[p3l537t2970r787b3001],
26	cell	NN	O	cell	nn	28	SENT_42	[p3l537t2970r787b3001],
27	lung	NN	O	lung	nn	28	SENT_42	[p3l802t2970r877b3009],
28	cancer	NN	O	cancer	prep_for	22	SENT_42	[p3l892t2980r1001b3000],
29	with	IN	O	with	_	0	SENT_42	[p3l1015t2970r1090b3001],
30	sensitive	JJ	O	sensitive	amod	31	SENT_42	[p3l1107t2970r1202b3000, p3l379t3019r437b3050],
31	mutations	NNS	O	mutation	prep_with	28	SENT_42	[p3l458t3019r626b3050],
32	of	IN	O	of	_	0	SENT_42	[p3l649t3019r687b3050],
33	the	DT	O	the	det	40	SENT_42	[p3l702t3019r753b3049],
34	epidermal	JJ	O	epidermal	amod	40	SENT_42	[p3l775t3019r942b3058],
35	growth	NN	O	growth	nn	40	SENT_42	[p3l963t3019r1085b3058],
36	factor	NN	O	factor	nn	40	SENT_42	[p3l1106t3019r1203b3050],
37	receptor	NN	O	receptor	nn	40	SENT_42	[p3l379t3074r517b3107],
38	(	CD	NUMBER	(	num	40	SENT_42	[p3l534t3070r663b3105],
39	EGFR	NN	ORGANIZATION	egfr	nn	40	SENT_42	[p3l534t3070r663b3105],
40	)	NN	O	)	prep_of	31	SENT_42	[p3l534t3070r663b3105],
41	,	,	O	,	_	0	SENT_42	[p3l534t3070r663b3105],
42	many	JJ	O	many	amod	43	SENT_42	[p3l681t3078r774b3107],
43	clinicians	NNS	O	clinician	appos	40	SENT_42	[p3l789t3068r949b3098],
44	pay	VBP	O	pay	rcmod	14	SENT_42	[p3l965t3078r1023b3107],
45	particular	JJ	O	particular	amod	46	SENT_42	[p3l1037t3068r1203b3107],
46	attention	NN	O	attention	dobj	44	SENT_42	[p3l379t3117r530b3148],
47	to	TO	O	to	_	0	SENT_42	[p3l542t3123r574b3148],
48	interstitial	JJ	O	interstitial	amod	50	SENT_42	[p3l587t3117r761b3147],
49	lung	NN	O	lung	nn	50	SENT_42	[p3l773t3117r848b3156],
50	disease	NN	O	disease	prep_to	44	SENT_42	[p3l860t3117r989b3154],
51	,	,	O	,	_	0	SENT_42	[p3l860t3117r989b3154],
52	which	WDT	O	which	nsubj	53	SENT_42	[p3l1002t3117r1104b3148],
53	has	VBZ	O	have	rcmod	50	SENT_42	[p3l1116t3117r1172b3147],
54	a	DT	O	a	det	56	SENT_42	[p3l1185t3127r1203b3147],
55	reported	VBN	O	report	amod	56	SENT_42	[p3l379t3166r521b3205],
56	incidence	NN	O	incidence	dobj	53	SENT_42	[p3l535t3166r692b3197],
57	of	IN	O	of	_	0	SENT_42	[p3l706t3166r745b3197],
58	4	CD	NUMBER	4	number	60	SENT_42	[p3l751t3168r771b3196],
59	to	TO	O	to	dep	60	SENT_42	[p3l784t3172r816b3197],
60	6	CD	PERCENT	6	num	61	SENT_42	[p3l831t3168r882b3197],
61	%	NN	PERCENT	%	prep_of	56	SENT_42	[p3l831t3168r882b3197],
62	in	IN	O	in	_	0	SENT_42	[p3l895t3166r927b3196],
63	Japan	NNP	LOCATION	Japan	prep_in	61	SENT_42	[p3l937t3169r1032b3205],
64	and	CC	O	and	_	0	SENT_42	[p3l1045t3166r1107b3197],
65	0.3	CD	NUMBER	0.3	num	66	SENT_42	[p3l1121t3168r1202b3197],
66	°	CD	NUMBER	°	conj_and	63	SENT_42	[p3l1121t3168r1202b3197],
67	/	:	O	/	punct	6	SENT_42	[p3l1121t3168r1202b3197],
68	o	NN	O	o	npadvmod	3	SENT_42	[p3l1121t3168r1202b3197],
69	in	IN	O	in	_	0	SENT_42	[p3l379t3215r412b3245],
70	the	DT	O	the	det	72	SENT_42	[p3l431t3215r482b3245],
71	United	NNP	LOCATION	United	nn	72	SENT_42	[p3l501t3215r613b3246],
72	States	NNPS	LOCATION	States	prep_in	3	SENT_42	[p3l633t3217r729b3246],
73	among	IN	O	among	_	0	SENT_42	[p3l749t3225r865b3254],
74	such	JJ	O	such	amod	75	SENT_42	[p3l884t3215r959b3246],
75	patients	NNS	O	patient	prep_among	3	SENT_42	[p3l978t3216r1120b3254],
76	.	.	O	.	_	0	SENT_42	[p3l978t3216r1120b3254],

1	The	DT	O	the	det	2	SENT_43	[p3l1140t3215r1202b3245],
2	authors	NNS	O	author	nsubj	3	SENT_43	[p3l1242t2872r1367b2903],
3	report	VBP	O	report	_	0	SENT_43	[p3l1382t2878r1486b2911],
4	the	DT	O	the	det	5	SENT_43	[p3l1499t2872r1551b2902],
5	occurrence	NN	O	occurrence	dobj	3	SENT_43	[p3l1566t2882r1749b2903],
6	of	IN	O	of	_	0	SENT_43	[p3l1764t2872r1803b2903],
7	six	CD	NUMBER	six	num	8	SENT_43	[p3l1811t2872r1857b2902],
8	cases	NNS	O	case	prep_of	5	SENT_43	[p3l1871t2882r1957b2902],
9	of	IN	O	of	_	0	SENT_43	[p3l1973t2872r2012b2903],
10	interstitial	JJ	O	interstitial	amod	16	SENT_43	[p3l2020t2872r2064b2902, p3l1242t2921r1383b2951],
11	lung	NN	O	lung	nn	16	SENT_43	[p3l1396t2921r1471b2960],
12	disease	NN	O	disease	nn	16	SENT_43	[p3l1484t2921r1604b2952],
13	(	CD	NUMBER	(	num	16	SENT_43	[p3l1620t2924r1688b2956],
14	one	CD	NUMBER	one	num	16	SENT_43	[p3l1620t2924r1688b2956],
15	fatal	JJ	O	fatal	amod	16	SENT_43	[p3l1702t2921r1787b2956],
16	)	NN	O	)	prep_of	8	SENT_43	[p3l1702t2921r1787b2956],
17	among	IN	O	among	_	0	SENT_43	[p3l1803t2931r1919b2960],
18	patients	NNS	O	patient	prep_among	16	SENT_43	[p3l1931t2921r2064b2960],
19	receiving	VBG	O	receive	partmod	18	SENT_43	[p3l1242t2970r1393b3009],
20	gefitinib	NN	O	gefitinib	nn	22	SENT_43	[p3l1409t2970r1553b3009],
21	(	CD	NUMBER	(	num	22	SENT_43	[p3l1572t2973r1644b3005],
22	rate	NN	O	rate	dobj	19	SENT_43	[p3l1572t2973r1644b3005],
23	of	IN	O	of	_	0	SENT_43	[p3l1661t2970r1700b3001],
24	death	NN	O	death	prep_of	22	SENT_43	[p3l1710t2970r1811b3007],
25	,	,	O	,	_	0	SENT_43	[p3l1710t2970r1811b3007],
26	16.7	CD	PERCENT	16.7	num	27	SENT_43	[p3l1831t2972r1950b3005],
27	%	NN	PERCENT	%	appos	24	SENT_43	[p3l1831t2972r1950b3005],
28	)	CD	NUMBER	)	dep	27	SENT_43	[p3l1831t2972r1950b3005],
29	.	.	O	.	_	0	SENT_43	[p3l1831t2972r1950b3005],

1	Using	VBG	O	use	dep	15	SENT_44	[p3l1968t2970r2066b3009],
2	data	NNS	O	datum	dobj	1	SENT_44	[p3l1242t3019r1313b3050],
3	on	IN	O	on	_	0	SENT_44	[p3l1326t3029r1367b3050],
4	adverse	JJ	O	adverse	amod	5	SENT_44	[p3l1379t3019r1501b3050],
5	events	NNS	O	event	prep_on	1	SENT_44	[p3l1514t3026r1616b3050],
6	from	IN	O	from	_	0	SENT_44	[p3l1630t3019r1712b3050],
7	the	DT	O	the	det	8	SENT_44	[p3l1724t3019r1776b3049],
8	Pharmaceuticals	NNS	ORGANIZATION	pharmaceutical	prep_from	5	SENT_44	[p3l1788t3019r2064b3050],
9	and	CC	ORGANIZATION	and	_	0	SENT_44	[p3l1242t3068r1302b3099],
10	Medical	JJ	ORGANIZATION	medical	amod	11	SENT_44	[p3l1313t3068r1444b3099],
11	Devices	NNPS	ORGANIZATION	Devices	prep_on	1	SENT_44	[p3l1455t3068r1579b3099],
12	Agency	NNP	ORGANIZATION	Agency	dep	11	SENT_44	[p3l1591t3070r1732b3107],
13	}	CD	NUMBER	}	num	12	SENT_44	[p3l1591t3070r1732b3107],
14	we	PRP	O	we	nsubj	15	SENT_44	[p3l1743t3078r1788b3099],
15	found	VBD	O	find	_	0	SENT_44	[p3l1800t3068r1897b3099],
16	839	CD	NUMBER	839	num	17	SENT_44	[p3l1909t3070r1966b3099],
17	cases	NNS	O	case	dobj	15	SENT_44	[p3l1979t3078r2064b3098],
18	of	IN	O	of	_	0	SENT_44	[p3l1242t3117r1281b3148],
19	interstitial	JJ	O	interstitial	amod	21	SENT_44	[p3l1285t3117r1459b3147],
20	lung	NN	O	lung	nn	21	SENT_44	[p3l1470t3117r1545b3156],
21	disease	NN	O	disease	prep_of	17	SENT_44	[p3l1555t3117r1676b3148],
22	among	IN	O	among	_	0	SENT_44	[p3l1687t3127r1803b3156],
23	patients	NNS	O	patient	prep_among	15	SENT_44	[p3l1813t3117r1945b3156],
24	receiving	VBG	O	receive	partmod	23	SENT_44	[p3l1957t3117r2064b3148, p3l1242t3166r1296b3205],
25	gefitinib	NN	O	gefitinib	dobj	24	SENT_44	[p3l1307t3166r1451b3205],
26	from	IN	O	from	_	0	SENT_44	[p3l1465t3166r1546b3197],
27	April	NNP	DATE	April	prep_from	24	SENT_44	[p3l1558t3166r1642b3205],
28	2004	CD	DATE	2004	num	27	SENT_44	[p3l1654t3168r1735b3197],
29	through	IN	O	through	_	0	SENT_44	[p3l1748t3166r1884b3205],
30	December	NNP	DATE	December	prep_through	24	SENT_44	[p3l1896t3166r2066b3197],
31	2009	CD	DATE	2009	num	30	SENT_44	[p3l1242t3217r1332b3252],
32	;	:	O	;	_	0	SENT_44	[p3l1242t3217r1332b3252],
33	of	IN	O	of	_	0	SENT_44	[p3l1348t3215r1387b3246],
34	these	DT	O	these	det	35	SENT_44	[p3l1394t3215r1481b3245],
35	patients	NNS	O	patient	prep_of	42	SENT_44	[p3l1495t3215r1637b3254],
36	,	,	O	,	_	0	SENT_44	[p3l1495t3215r1637b3254],
37	265	CD	PERCENT	265	number	38	SENT_44	[p3l1654t3217r1711b3246],
38	(	CD	PERCENT	(	appos	35	SENT_44	[p3l1728t3217r1849b3250],
39	31.6	CD	PERCENT	31.6	num	40	SENT_44	[p3l1728t3217r1849b3250],
40	%	NN	PERCENT	%	dep	38	SENT_44	[p3l1728t3217r1849b3250],
41	)	CD	NUMBER	)	nsubj	42	SENT_44	[p3l1728t3217r1849b3250],
42	died	VBD	O	die	parataxis	15	SENT_44	[p3l1866t3215r1945b3252],
43	,	,	O	,	_	0	SENT_44	[p3l1866t3215r1945b3252],
44	a	DT	O	a	det	45	SENT_44	[p3l1962t3225r1979b3245],
45	conNENGLjMED363	NN	O	connengljmed363	dobj	42	SENT_44	[p3l1993t3225r2064b3246, p3l882t3333r1142b3361],
46	;	:	O	;	_	0	SENT_44	[p3l1993t3225r2064b3246, p3l882t3333r1142b3361],
47	16	CD	NUMBER	16	dep	45	SENT_44	[p3l1993t3225r2064b3246, p3l882t3333r1142b3361],

1	NEJM.ORG	NN	O	nejm.org	nn	2	SENT_45	[p3l1178t3339r1302b3361],
2	ocToBER14	NN	O	october14	_	0	SENT_45	[p3l1337t3339r1564b3361],
3	,2	CD	NUMBER	,2	num	4	SENT_45	[p3l1337t3339r1564b3361],
4	o1o	NN	O	o1o	dep	2	SENT_45	[p3l1337t3339r1564b3361],
5	The	DT	O	the	det	8	SENT_45	[p3l879t3396r930b3420],
6	New	NNP	O	New	nn	8	SENT_45	[p3l939t3397r1001b3420],
7	England	NNP	O	England	nn	8	SENT_45	[p3l1010t3396r1121b3427],
8	Journal	NNP	O	Journal	dep	2	SENT_45	[p3l1130t3396r1227b3420],
9	of	IN	O	of	_	0	SENT_45	[p3l1237t3396r1266b3420],
10	Medicine	NNP	O	Medicine	prep_of	8	SENT_45	[p3l1273t3396r1398b3420],

1	Copyright	NN	O	copyright	_	0	SENT_46	[p3l672t3478r806b3509],
2	©	CD	NUMBER	©	num	3	SENT_46	[p3l815t3478r839b3502],
3	2010	CD	DATE	2010	dep	1	SENT_46	[p3l849t3478r914b3502],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	5	SENT_46	[p3l923t3478r1114b3502],
5	Medical	NNP	ORGANIZATION	Medical	dep	1	SENT_46	[p3l1124t3478r1232b3502],

1	CORRESPONDENCE	NN	O	correspondence	_	0	SENT_47	[p3l926t3584r1233b3603],

1	Society	NNP	O	Society	_	0	SENT_48	[p3l1243t3478r1348b3509],
2	.	.	O	.	_	0	SENT_48	[p3l1243t3478r1348b3509],

1	All	DT	O	all	det	2	SENT_49	[p3l1359t3478r1400b3502],
2	rights	NNS	O	rights	nsubj	3	SENT_49	[p3l1409t3478r1484b3509],
3	reserved	VBN	O	reserve	_	0	SENT_49	[p3l1494t3478r1612b3502],
4	.	.	O	.	_	0	SENT_49	[p3l1494t3478r1612b3502],

1	Rate	NN	O	rate	_	0	SENT_50	[p4l117t898r172b1039],
2	of	IN	O	of	_	0	SENT_50	[p4l111t800r172b876],
3	Death	NN	O	death	prep_of	1	SENT_50	[p4l111t596r172b786],
4	(	CD	PERCENT	(	num	5	SENT_50	[p4l115t458r191b565],
5	%	NN	PERCENT	%	dep	1	SENT_50	[p4l115t458r191b565],
6	)	CD	NUMBER	)	dep	5	SENT_50	[p4l115t458r191b565],

1	30-39	CD	NUMBER	30-39	num	2	SENT_51	[p4l401t1411r589b1465],
2	40-49	CD	NUMBER	40-49	_	0	SENT_51	[p4l684t1411r874b1465],
3	50-59	CD	NUMBER	50-59	num	4	SENT_51	[p4l971t1411r1160b1465],
4	60-69	CD	NUMBER	60-69	dep	2	SENT_51	[p4l1256t1411r1444b1465],
5	70-79	CD	NUMBER	70-79	number	6	SENT_51	[p4l1544t1411r1730b1465],
6	280	CD	NUMBER	280	num	36	SENT_51	[p4l1865t1411r1977b1465],
7	(	NN	O	(	nn	36	SENT_51	[p4l384t1498r605b1567],
8	N	NN	O	n	nn	36	SENT_51	[p4l384t1498r605b1567],
9	=	JJ	O	=	amod	36	SENT_51	[p4l384t1498r605b1567],
10	16	CD	NUMBER	16	number	11	SENT_51	[p4l384t1498r605b1567],
11	)	CD	NUMBER	)	num	36	SENT_51	[p4l384t1498r605b1567],
12	(	NN	O	(	nn	36	SENT_51	[p4l669t1498r891b1567],
13	N	NN	O	n	nn	36	SENT_51	[p4l669t1498r891b1567],
14	=	JJ	O	=	amod	36	SENT_51	[p4l669t1498r891b1567],
15	29	CD	NUMBER	29	number	16	SENT_51	[p4l669t1498r891b1567],
16	)	CD	NUMBER	)	num	36	SENT_51	[p4l669t1498r891b1567],
17	(	NN	O	(	nn	36	SENT_51	[p4l936t1497r1765b1567],
18	N	NN	O	n	nn	36	SENT_51	[p4l936t1497r1765b1567],
19	=	JJ	O	=	amod	36	SENT_51	[p4l936t1497r1765b1567],
20	140	CD	NUMBER	140	number	21	SENT_51	[p4l936t1497r1765b1567],
21	)	CD	NUMBER	)	num	36	SENT_51	[p4l936t1497r1765b1567],
22	(	NN	O	(	nn	36	SENT_51	[p4l936t1497r1765b1567],
23	N	NN	O	n	nn	36	SENT_51	[p4l936t1497r1765b1567],
24	=	JJ	O	=	amod	36	SENT_51	[p4l936t1497r1765b1567],
25	212	CD	NUMBER	212	number	26	SENT_51	[p4l936t1497r1765b1567],
26	)	CD	NUMBER	)	num	36	SENT_51	[p4l936t1497r1765b1567],
27	(	NN	O	(	nn	36	SENT_51	[p4l936t1497r1765b1567],
28	N	NN	O	n	nn	36	SENT_51	[p4l936t1497r1765b1567],
29	=	JJ	O	=	amod	36	SENT_51	[p4l936t1497r1765b1567],
30	305	CD	NUMBER	305	number	31	SENT_51	[p4l936t1497r1765b1567],
31	)	CD	NUMBER	)	num	36	SENT_51	[p4l936t1497r1765b1567],
32	(	NN	O	(	nn	36	SENT_51	[p4l1811t1497r2031b1567],
33	N	NN	O	n	nn	36	SENT_51	[p4l1811t1497r2031b1567],
34	=	JJ	O	=	amod	36	SENT_51	[p4l1811t1497r2031b1567],
35	81	CD	NUMBER	81	num	36	SENT_51	[p4l1811t1497r2031b1567],
36	)	NN	O	)	dep	4	SENT_51	[p4l1811t1497r2031b1567],

1	Age	NNP	O	Age	_	0	SENT_52	[p4l1079t1624r1204b1697],
2	(	CD	NUMBER	(	num	4	SENT_52	[p4l1231t1624r1331b1698],
3	yr	NN	DURATION	yr	nn	4	SENT_52	[p4l1231t1624r1331b1698],
4	)	NN	O	)	dep	1	SENT_52	[p4l1231t1624r1331b1698],

1	Figure	NNP	O	Figure	_	0	SENT_53	[p4l89t1846r308b1929],
2	1	CD	NUMBER	1	dep	1	SENT_53	[p4l339t1850r394b1909],
3	.	.	O	.	_	0	SENT_53	[p4l339t1850r394b1909],

1	Rate	NN	O	rate	_	0	SENT_54	[p4l429t1850r580b1909],
2	of	IN	O	of	_	0	SENT_54	[p4l606t1844r687b1909],
3	Death	NN	O	death	prep_of	1	SENT_54	[p4l704t1845r912b1909],
4	from	IN	O	from	_	0	SENT_54	[p4l941t1844r1106b1909],
5	Gefitinib-Associated	JJ	O	gefitinib-associated	amod	8	SENT_54	[p4l1138t1844r1867b1910],
6	Interstitial	JJ	O	interstitial	amod	8	SENT_54	[p4l89t1952r448b2016],
7	Lung	NN	O	lung	nn	8	SENT_54	[p4l483t1958r656b2036],
8	Disease	NN	O	disease	prep_from	1	SENT_54	[p4l686t1953r984b2016],
9	.	.	O	.	_	0	SENT_54	[p4l686t1953r984b2016],

1	The	DT	O	the	det	2	SENT_55	[p4l83t2080r215b2145],
2	proportion	NN	O	proportion	nsubj	5	SENT_55	[p4l248t2087r627b2164],
3	offatal	JJ	O	offatal	amod	4	SENT_55	[p4l662t2080r903b2145],
4	outcomes	NNS	O	outcome	dep	2	SENT_55	[p4l936t2093r1287b2145],
5	increased	VBD	O	increase	_	0	SENT_55	[p4l1321t2080r1655b2145],
6	among	IN	O	among	_	0	SENT_55	[p4l1690t2103r1937b2166],
7	older	JJR	O	older	amod	8	SENT_55	[p4l85t2188r269b2252],
8	patients	NNS	O	patient	prep_among	5	SENT_55	[p4l299t2194r581b2272],
9	in	IN	O	in	_	0	SENT_55	[p4l615t2194r671b2252],
10	an	DT	O	a	det	12	SENT_55	[p4l705t2210r782b2252],
11	age-dependent	JJ	O	age-dependent	amod	12	SENT_55	[p4l816t2188r1357b2273],
12	manner	NN	O	manner	prep_in	5	SENT_55	[p4l1388t2210r1673b2252],
13	.	.	O	.	_	0	SENT_55	[p4l1388t2210r1673b2252],

1	One	CD	NUMBER	one	num	3	SENT_56	[p4l1706t2192r1855b2252],
2	fatal	JJ	O	fatal	amod	3	SENT_56	[p4l1883t2187r2031b2252],
3	case	NN	O	case	nsubjpass	16	SENT_56	[p4l85t2317r240b2360],
4	that	WDT	O	that	nsubj	5	SENT_56	[p4l267t2295r407b2360],
5	occurred	VBD	O	occur	ccomp	3	SENT_56	[p4l435t2295r744b2360],
6	in	IN	O	in	_	0	SENT_56	[p4l780t2301r836b2359],
7	the	DT	O	the	det	9	SENT_56	[p4l866t2295r978b2360],
8	age	NN	O	age	nn	9	SENT_56	[p4l1008t2317r1128b2380],
9	group	NN	O	group	prep_in	5	SENT_56	[p4l1157t2317r1363b2380],
10	between	IN	O	between	_	0	SENT_56	[p4l1397t2295r1691b2360],
11	90	CD	NUMBER	90	nn	14	SENT_56	[p4l1726t2299r1809b2360],
12	and	CC	O	and	_	0	SENT_56	[p4l1839t2295r1963b2360],
13	99	CD	DURATION	99	conj_and	11	SENT_56	[p4l1997t2300r2076b2360],
14	years	NNS	NUMBER	year	prep_between	9	SENT_56	[p4l83t2425r263b2487],
15	was	VBD	O	be	auxpass	16	SENT_56	[p4l292t2425r425b2467],
16	included	VBN	O	include	_	0	SENT_56	[p4l460t2402r759b2467],
17	in	IN	O	in	_	0	SENT_56	[p4l795t2408r851b2465],
18	the	DT	O	the	det	19	SENT_56	[p4l882t2402r993b2467],
19	group	NN	O	group	prep_in	16	SENT_56	[p4l1023t2425r1229b2487],
20	of	IN	O	of	_	0	SENT_56	[p4l1259t2402r1336b2467],
21	patients	NNS	O	patient	prep_of	19	SENT_56	[p4l1356t2408r1639b2486],
22	who	WP	O	who	nsubj	27	SENT_56	[p4l1668t2402r1815b2467],
23	were	VBD	O	be	cop	27	SENT_56	[p4l1843t2425r2009b2467],
24	at	IN	DURATION	at	quantmod	26	SENT_56	[p4l87t2522r149b2574],
25	least	JJS	DURATION	least	mwe	24	SENT_56	[p4l180t2509r343b2574],
26	80	CD	DURATION	80	num	27	SENT_56	[p4l371t2514r455b2575],
27	years	NNS	NUMBER	year	rcmod	21	SENT_56	[p4l480t2532r661b2594],
28	of	IN	O	of	_	0	SENT_56	[p4l692t2509r769b2574],
29	age	NN	O	age	prep_of	27	SENT_56	[p4l788t2532r926b2594],
30	.	.	O	.	_	0	SENT_56	[p4l788t2532r926b2594],

1	Among	IN	O	among	_	0	SENT_57	[p4l955t2514r1217b2594],
2	839	CD	NUMBER	839	num	3	SENT_57	[p4l1246t2514r1366b2575],
3	cases	NNS	O	case	npadvmod	4	SENT_57	[p4l1396t2532r1587b2574],
4	ofinterstitial	JJ	O	ofinterstitial	amod	6	SENT_57	[p4l1619t2509r2070b2574],
5	lung	NN	O	lung	nn	6	SENT_57	[p4l89t2617r240b2702],
6	disease	NN	O	disease	prep_among	11	SENT_57	[p4l268t2617r549b2693],
7	,	,	O	,	_	0	SENT_57	[p4l268t2617r549b2693],
8	56	CD	NUMBER	56	num	9	SENT_57	[p4l583t2622r661b2681],
9	cases	NNS	O	case	nsubjpass	11	SENT_57	[p4l691t2639r882b2681],
10	were	VBD	O	be	auxpass	11	SENT_57	[p4l911t2639r1078b2681],
11	excluded	VBN	O	exclude	_	0	SENT_57	[p4l1107t2617r1417b2681],
12	because	IN	O	because	_	0	SENT_57	[p4l1454t2617r1740b2681],
13	of	IN	O	of	_	0	SENT_57	[p4l1769t2616r1847b2681],
14	missing	VBG	O	miss	amod	15	SENT_57	[p4l1867t2622r2052b2681, p4l88t2730r194b2809],
15	data	NNS	O	datum	prep_because_of	11	SENT_57	[p4l221t2724r371b2788],
16	regarding	VBG	O	regard	_	0	SENT_57	[p4l406t2724r742b2809],
17	age	NN	O	age	prep_regarding	15	SENT_57	[p4l771t2747r909b2809],
18	.	.	O	.	_	0	SENT_57	[p4l771t2747r909b2809],

1	siderably	RB	O	siderably	advmod	2	SENT_58	[p4l19t3073r400b3173],
2	higher	JJR	O	higher	amod	3	SENT_58	[p4l444t3073r725b3173],
3	rate	NN	O	rate	nsubj	6	SENT_58	[p4l771t3089r931b3151],
4	than	IN	O	than	_	0	SENT_58	[p4l981t3073r1177b3151],
5	that	DT	O	that	prep_than	3	SENT_58	[p4l1228t3073r1399b3151],
6	reported	VBN	O	report	_	0	SENT_58	[p4l1444t3073r1809b3173],
7	by	IN	O	by	_	0	SENT_58	[p4l1859t3073r1956b3173],
8	the	DT	O	the	det	9	SENT_58	[p4l2002t3073r2134b3151],
9	authors	NNS	O	author	prep_by	6	SENT_58	[p4l17t3200r363b3279],
10	.	.	O	.	_	0	SENT_58	[p4l17t3200r363b3279],

1	Elderly	JJ	O	elderly	amod	2	SENT_59	[p4l429t3200r724b3300],
2	patients	NNS	O	patient	nsubj	10	SENT_59	[p4l779t3201r1120b3300],
3	with	IN	O	with	_	0	SENT_59	[p4l1179t3200r1374b3279],
4	interstitial	JJ	O	interstitial	amod	6	SENT_59	[p4l1435t3200r1884b3278],
5	lung	NN	O	lung	nn	6	SENT_59	[p4l1944t3200r2138b3300],
6	disease	NN	O	disease	prep_with	2	SENT_59	[p4l18t3327r328b3405],
7	While	IN	O	while	mark	8	SENT_59	[p4l354t3327r590b3406],
8	receiving	VBG	O	receive	dep	10	SENT_59	[p4l620t3328r1009b3427],
9	gefitinib	NN	O	gefitinib	dobj	8	SENT_59	[p4l1036t3327r1407b3427],
10	tended	VBD	O	tend	_	0	SENT_59	[p4l1440t3327r1727b3405],
11	to	TO	O	to	aux	12	SENT_59	[p4l1758t3343r1840b3405],
12	have	VB	O	have	xcomp	10	SENT_59	[p4l1871t3327r2061b3406],
13	a	DT	O	a	det	15	SENT_59	[p4l2091t3354r2135b3405],
14	higher	JJR	O	higher	amod	15	SENT_59	[p4l17t3454r298b3554],
15	rate	NN	O	rate	dobj	12	SENT_59	[p4l344t3471r504b3532],
16	of	IN	O	of	_	0	SENT_59	[p4l554t3454r654b3532],
17	death	NN	O	death	prep_of	15	SENT_59	[p4l686t3454r922b3532],
18	than	IN	O	than	dep	19	SENT_59	[p4l972t3454r1168b3532],
19	did	VBD	O	do	advcl	12	SENT_59	[p4l1219t3454r1353b3532],
20	younger	JJR	O	younger	amod	21	SENT_59	[p4l1398t3479r1747b3554],
21	patients	NNS	O	patient	dobj	19	SENT_59	[p4l1791t3455r2132b3554],
22	(	CD	NUMBER	(	num	23	SENT_59	[p4l22t3582r201b3681],
23	Fig	NN	O	fig	nsubj	19	SENT_59	[p4l22t3582r201b3681],
24	.	.	O	.	_	0	SENT_59	[p4l22t3582r201b3681],

1	1	CD	NUMBER	1	_	0	SENT_60	[p4l248t3587r343b3672],
2	)	NN	O	)	dep	1	SENT_60	[p4l248t3587r343b3672],
3	.	.	O	.	_	0	SENT_60	[p4l248t3587r343b3672],

1	Although	IN	O	although	mark	6	SENT_61	[p4l383t3581r788b3681],
2	postmarketing	VBG	O	postmarket	amod	3	SENT_61	[p4l825t3581r1466b3681],
3	surveillance	NN	O	surveillance	nsubj	6	SENT_61	[p4l1502t3581r2014b3660],
4	in	IN	O	in	_	0	SENT_61	[p4l2051t3582r2134b3658],
5	Japan	NNP	LOCATION	Japan	prep_in	3	SENT_61	[p4l7t3715r251b3808],
6	showed	VBD	O	show	advcl	32	SENT_61	[p4l292t3708r614b3787],
7	that	IN	O	that	complm	18	SENT_61	[p4l654t3708r826b3786],
8	approximately	RB	O	approximately	quantmod	9	SENT_61	[p4l860t3708r1474b3808],
9	one	CD	DURATION	one	num	10	SENT_61	[p4l1510t3733r1660b3786],
10	quarter	NN	DURATION	quarter	nsubj	22	SENT_61	[p4l1700t3725r2016b3808],
11	of	IN	O	of	_	0	SENT_61	[p4l2053t3708r2153b3786],
12	gef1tinib	NN	O	gef1tinib	npadvmod	14	SENT_61	[p5l17t21r726b121],
13	—	CD	NUMBER	—	num	12	SENT_61	[p5l17t21r726b121],
14	treated	JJ	O	treated	amod	15	SENT_61	[p5l17t21r726b121],
15	patients	NNS	O	patient	prep_of	10	SENT_61	[p5l759t22r1100b121],
16	were	VBD	O	be	cop	18	SENT_61	[p5l1133t47r1334b100],
17	75	CD	DURATION	75	num	18	SENT_61	[p5l1370t29r1464b99],
18	years	NNS	NUMBER	year	ccomp	6	SENT_61	[p5l1498t47r1717b121],
19	of	IN	O	of	_	0	SENT_61	[p5l1754t21r1854b99],
20	age	NN	O	age	prep_of	18	SENT_61	[p5l1870t48r2013b121],
21	or	CC	O	or	_	0	SENT_61	[p5l2049t47r2137b99],
22	older	JJR	O	older	ccomp	6	SENT_61	[p5l18t148r292b243],
23	,3	CD	NUMBER	,3	dep	22	SENT_61	[p5l18t148r292b243],
24	the	DT	O	the	det	25	SENT_61	[p5l332t148r465b226],
25	study	NN	O	study	nsubj	32	SENT_61	[p5l505t148r734b248],
26	by	IN	O	by	_	0	SENT_61	[p5l768t148r865b248],
27	Maemondo	NNP	PERSON	Maemondo	prep_by	25	SENT_61	[p5l896t148r1380b226],
28	et	FW	O	et	nn	29	SENT_61	[p5l1421t165r1497b226],
29	al.	FW	O	al.	dep	27	SENT_61	[p5l1530t148r1627b226],
30	did	VBD	O	do	aux	32	SENT_61	[p5l1672t148r1806b226],
31	not	RB	O	not	neg	32	SENT_61	[p5l1844t165r1986b226],
32	include	VB	O	include	_	0	SENT_61	[p5l2019t149r2133b225, p5l18t275r240b354],
33	patients	NNS	O	patient	dobj	32	SENT_61	[p5l303t276r643b375],
34	who	WP	O	who	nsubj	36	SENT_61	[p5l705t275r888b354],
35	were	VBD	O	be	cop	36	SENT_61	[p5l950t301r1151b354],
36	older	JJR	O	older	rcmod	33	SENT_61	[p5l1216t275r1432b353],
37	than	IN	O	than	mark	41	SENT_61	[p5l1494t275r1690b353],
38	75	CD	DURATION	75	num	39	SENT_61	[p5l1756t283r1850b353],
39	years	NNS	NUMBER	year	nsubj	41	SENT_61	[p5l1913t301r2132b375],
40	(	RB	O	(	advmod	41	SENT_61	[p5l22t409r285b493],
41	mean	VBP	O	mean	ccomp	36	SENT_61	[p5l22t409r285b493],
42	age	NN	O	age	dobj	41	SENT_61	[p5l320t429r486b502],
43	,	,	O	,	_	0	SENT_61	[p5l320t429r486b502],
44	63.9	CD	NUMBER	63.9	appos	42	SENT_61	[p5l528t408r726b497],
45	;	:	O	;	_	0	SENT_61	[p5l528t408r726b497],
46	range	NN	O	range	dep	42	SENT_61	[p5l766t428r1029b502],
47	,	,	O	,	_	0	SENT_61	[p5l766t428r1029b502],
48	43	CD	NUMBER	43	appos	46	SENT_61	[p5l1069t408r1164b480],
49	to	TO	O	to	_	0	SENT_61	[p5l1205t419r1286b480],
50	75	CD	NUMBER	75	number	51	SENT_61	[p5l1324t409r1475b493],
51	)	CD	NUMBER	)	prep_to	41	SENT_61	[p5l1324t409r1475b493],
52	.	.	O	.	_	0	SENT_61	[p5l1324t409r1475b493],

1	Since	IN	O	since	mark	7	SENT_62	[p5l1520t403r1741b480],
2	more	JJR	O	more	amod	4	SENT_62	[p5l1777t428r1996b480],
3	elderly	JJ	O	elderly	amod	4	SENT_62	[p5l2033t402r2133b480, p5l18t529r226b629],
4	patients	NNS	O	patient	nsubjpass	7	SENT_62	[p5l272t530r613b629],
5	Would	MD	O	would	aux	7	SENT_62	[p5l662t529r927b608],
6	be	VB	O	be	auxpass	7	SENT_62	[p5l979t529r1076b607],
7	prescribed	VBN	O	prescribe	advcl	18	SENT_62	[p5l1126t529r1577b629],
8	geﬁtinib	NN	O	geﬁtinib	dobj	7	SENT_62	[p5l1628t529r1999b629],
9	in	IN	O	in	_	0	SENT_62	[p5l2051t530r2134b606],
10	regular	JJ	O	regular	amod	11	SENT_62	[p5l17t656r330b756],
11	practice	NN	O	practice	prep_in	8	SENT_62	[p5l359t657r719b756],
12	,	,	O	,	_	0	SENT_62	[p5l359t657r719b756],
13	their	PRP$	O	they	poss	15	SENT_62	[p5l758t656r962b734],
14	safety	NN	O	safety	nn	15	SENT_62	[p5l993t656r1245b756],
15	profile	NN	O	profile	nsubj	18	SENT_62	[p5l1272t656r1559b756],
16	could	MD	O	could	aux	18	SENT_62	[p5l1593t656r1826b735],
17	be	VB	O	be	cop	18	SENT_62	[p5l1860t656r1956b734],
18	different	JJ	O	different	_	0	SENT_62	[p5l1990t656r2133b734, p5l17t783r269b861],
19	from	IN	O	from	_	0	SENT_62	[p5l309t783r518b861],
20	that	DT	O	that	prep_from	18	SENT_62	[p5l564t783r735b861],
21	of	IN	O	of	_	0	SENT_62	[p5l776t783r876b861],
22	younger	JJR	O	younger	amod	23	SENT_62	[p5l898t809r1247b883],
23	patients	NNS	O	patient	prep_of	20	SENT_62	[p5l1287t784r1653b883],
24	.	.	O	.	_	0	SENT_62	[p5l1287t784r1653b883],

1	Could	MD	O	could	dep	4	SENT_63	[p5l1703t783r1956b862],
2	the	DT	O	the	det	3	SENT_63	[p5l2002t783r2134b861],
3	authors	NNS	O	author	nsubj	4	SENT_63	[p5l17t910r338b989],
4	share	VBP	O	share	_	0	SENT_63	[p5l377t910r604b988],
5	any	DT	O	any	det	7	SENT_63	[p5l639t936r788b1010],
6	clinical	JJ	O	clinical	amod	7	SENT_63	[p5l820t910r1132b988],
7	guidance	NN	O	guidance	dobj	4	SENT_63	[p5l1166t910r1558b1010],
8	in	IN	O	in	_	0	SENT_63	[p5l1592t911r1675b987],
9	the	DT	O	the	det	10	SENT_63	[p5l1710t910r1842b988],
10	use	NN	O	use	prep_in	7	SENT_63	[p5l1877t937r2017b989],
11	of	IN	O	of	_	0	SENT_63	[p5l2053t910r2152b988],
12	gefitinib	NN	O	gefitinib	prep_of	10	SENT_63	[p5l17t1037r388b1138],
13	among	IN	O	among	_	0	SENT_63	[p5l423t1063r722b1138],
14	elderly	JJ	O	elderly	amod	15	SENT_63	[p5l754t1038r1036b1138],
15	patients	NNS	O	patient	prep_among	4	SENT_63	[p5l1065t1035r1443b1138],
16	?	.	O	?	_	0	SENT_63	[p5l1065t1035r1443b1138],

1	Naoko	NNP	PERSON	Naoko	nn	2	SENT_64	[p5l26t1234r305b1313],
2	Murashige	NNP	PERSON	Murashige	_	0	SENT_64	[p5l346t1234r829b1339],
3	,	,	O	,	_	0	SENT_64	[p5l346t1234r829b1339],
4	M.D.	NNP	O	M.D.	nn	10	SENT_64	[p5l874t1241r1079b1313],
5	U	NNP	O	U	nn	10	SENT_64	[p5l21t1362r64b1418],
6	niversity	NNP	O	niversity	nn	10	SENT_64	[p5l78t1363r357b1437],
7	ofTokyo	NNP	O	ofTokyo	nn	10	SENT_64	[p5l380t1356r657b1437],
8	Tokyo	NNP	LOCATION	Tokyo	nn	10	SENT_64	[p5l15t1452r437b1530],
9	,	,	O	,	_	0	SENT_64	[p5l15t1452r437b1530],
10	Japan	NNP	LOCATION	Japan	appos	2	SENT_64	[p5l15t1452r437b1530],

1	Tetsuya	NNP	PERSON	Tetsuya	nn	2	SENT_65	[p5l15t1603r350b1701],
2	Tanimoto	NNP	PERSON	Tanimoto	_	0	SENT_65	[p5l381t1603r832b1690],
3	,	,	O	,	_	0	SENT_65	[p5l381t1603r832b1690],
4	M.D.	NNP	O	M.D.	appos	2	SENT_65	[p5l876t1603r1081b1675],

1	Cancer	NNP	ORGANIZATION	Cancer	_	0	SENT_66	[p5l18t1754r261b1814],
2	Institute	NNP	ORGANIZATION	Institute	nn	4	SENT_66	[p5l291t1755r577b1814],
3	ofthejapanese	NN	O	ofthejapanese	nn	4	SENT_66	[p5l605t1749r1144b1833],
4	Foundation	NNP	ORGANIZATION	Foundation	dep	1	SENT_66	[p5l1177t1749r1573b1814],
5	for	IN	ORGANIZATION	for	_	0	SENT_66	[p5l102t1851r199b1915],
6	Cancer	NNP	ORGANIZATION	Cancer	nn	7	SENT_66	[p5l224t1856r467b1915],
7	Research	NNP	ORGANIZATION	Research	prep_for	4	SENT_66	[p5l497t1851r805b1915],

1	Tokyo	NNP	LOCATION	Tokyo	_	0	SENT_67	[p5l15t1952r463b2037],
2	,	,	O	,	_	0	SENT_67	[p5l15t1952r463b2037],
3	Japan	NNP	LOCATION	Japan	appos	1	SENT_67	[p5l15t1952r463b2037],

1	Yasuo	NNP	PERSON	Yasuo	nn	2	SENT_68	[p5l15t2108r282b2180],
2	Oshima	NNP	PERSON	Oshima	_	0	SENT_68	[p5l317t2100r687b2194],
3	,	,	O	,	_	0	SENT_68	[p5l317t2100r687b2194],
4	M.D.	NNP	O	M.D.	nn	6	SENT_68	[p5l731t2108r963b2194],
5	,	,	O	,	_	0	SENT_68	[p5l731t2108r963b2194],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_68	[p5l1007t2100r1236b2180],
7	.	.	O	.	_	0	SENT_68	[p5l1007t2100r1236b2180],

1	University	NNP	O	University	nn	3	SENT_69	[p5l21t2257r357b2331],
2	ofTokyo	NNP	O	ofTokyo	nn	3	SENT_69	[p5l380t2251r657b2331],
3	Tokyo	NNP	LOCATION	Tokyo	_	0	SENT_69	[p5l15t2347r228b2427],
4	,	,	O	,	_	0	SENT_69	[p5l15t2347r228b2427],
5	Japan	NNP	LOCATION	Japan	appos	3	SENT_69	[p5l245t2353r437b2426],

1	Dr.	NNP	O	Dr.	nn	2	SENT_70	[p5l101t2458r198b2512],
2	Oshima	NNP	PERSON	Oshima	nsubj	3	SENT_70	[p5l233t2453r491b2512],
3	reports	VBZ	O	report	_	0	SENT_70	[p5l520t2466r755b2528],
4	receiving	VBG	O	receive	xcomp	3	SENT_70	[p5l787t2454r1085b2529],
5	a	DT	O	a	det	6	SENT_70	[p5l1113t2473r1146b2512],
6	stipend	NN	O	stipend	dobj	4	SENT_70	[p5l1176t2453r1417b2528],
7	from	IN	O	from	_	0	SENT_70	[p5l1448t2453r1608b2512],
8	Sanofi	NNP	ORGANIZATION	Sanofi	prep_from	4	SENT_70	[p5l1640t2453r2131b2525],
9	.	.	O	.	_	0	SENT_70	[p5l1640t2453r2131b2525],

1	—	NN	O	—	_	0	SENT_71	[p5l1640t2453r2131b2525],
2	.	.	O	.	_	0	SENT_71	[p5l1640t2453r2131b2525],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_72	[p5l1640t2453r2131b2525],
2	,	,	O	,	_	0	SENT_72	[p5l1640t2453r2131b2525],
3	the	DT	O	the	det	4	SENT_72	[p5l17t2549r118b2608],
4	manufacturer	NN	O	manufacturer	appos	1	SENT_72	[p5l151t2549r602b2608],
5	of	IN	O	of	_	0	SENT_72	[p5l633t2549r710b2608],
6	docetaxel	NN	O	docetaxel	prep_of	4	SENT_72	[p5l729t2549r1057b2621],
7	,	,	O	,	_	0	SENT_72	[p5l729t2549r1057b2621],
8	a	DT	O	a	det	9	SENT_72	[p5l1094t2569r1127b2608],
9	drug	NN	O	drug	appos	6	SENT_72	[p5l1160t2549r1315b2625],
10	that	WDT	O	that	nsubjpass	13	SENT_72	[p5l1346t2549r1477b2608],
11	is	VBZ	O	be	auxpass	13	SENT_72	[p5l1506t2550r1556b2608],
12	also	RB	O	also	advmod	13	SENT_72	[p5l1590t2549r1721b2608],
13	used	VBN	O	use	rcmod	9	SENT_72	[p5l1755t2549r1905b2608],
14	in	IN	O	in	_	0	SENT_72	[p5l1938t2550r2001b2607],
15	the	DT	O	the	det	16	SENT_72	[p5l2034t2549r2135b2608],
16	treatment	NN	O	treatment	prep_in	13	SENT_72	[p5l10t2658r335b2703],
17	of	IN	O	of	_	0	SENT_72	[p5l363t2645r438b2704],
18	some	DT	O	some	det	20	SENT_72	[p5l456t2664r627b2704],
19	lung	NN	O	lung	nn	20	SENT_72	[p5l658t2645r805b2721],
20	cancers	NNS	O	cancer	prep_of	16	SENT_72	[p5l834t2664r1099b2704],
21	.	.	O	.	_	0	SENT_72	[p5l834t2664r1099b2704],

1	No	DT	O	no	det	4	SENT_73	[p5l1133t2650r1227b2704],
2	other	JJ	O	other	amod	4	SENT_73	[p5l1259t2645r1434b2704],
3	potential	JJ	O	potential	amod	4	SENT_73	[p5l1462t2645r1760b2720],
4	conflict	NN	O	conflict	nsubjpass	12	SENT_73	[p5l1791t2645r2050b2704],
5	of	IN	O	of	_	0	SENT_73	[p5l2077t2645r2153b2704],
6	interest	NN	O	interest	prep_of	4	SENT_73	[p5l8t2742r260b2800],
7	relevant	JJ	O	relevant	amod	6	SENT_73	[p5l281t2741r544b2801],
8	to	TO	O	to	_	0	SENT_73	[p5l566t2754r628b2800],
9	this	DT	O	this	det	10	SENT_73	[p5l655t2741r777b2800],
10	letter	NN	O	letter	prep_to	7	SENT_73	[p5l803t2741r976b2800],
11	was	VBD	O	be	auxpass	12	SENT_73	[p5l997t2760r1121b2801],
12	reported	VBN	O	report	_	0	SENT_73	[p5l1148t2741r1447b2816],
13	.	.	O	.	_	0	SENT_73	[p5l1148t2741r1447b2816],

1	1	LS	NUMBER	1	_	0	SENT_74	[p5l12t2851r61b2902],
2	.	.	O	.	_	0	SENT_74	[p5l12t2851r61b2902],

1	Maemondo	NNP	O	Maemondo	nn	2	SENT_75	[p5l136t2843r507b2902],
2	M	NNP	O	M	_	0	SENT_75	[p5l531t2848r613b2915],
3	,	,	O	,	_	0	SENT_75	[p5l531t2848r613b2915],
4	Inoue	NNP	PERSON	Inoue	nn	5	SENT_75	[p5l641t2848r826b2903],
5	A	NNP	O	A	appos	2	SENT_75	[p5l849t2848r915b2915],
6	,	,	O	,	_	0	SENT_75	[p5l849t2848r915b2915],
7	Kobayashi	NNP	LOCATION	Kobayashi	nn	8	SENT_75	[p5l944t2843r1283b2918],
8	K	NNP	LOCATION	K	appos	2	SENT_75	[p5l1306t2848r1372b2915],
9	,	,	O	,	_	0	SENT_75	[p5l1306t2848r1372b2915],
10	et	FW	O	et	nn	11	SENT_75	[p5l1401t2856r1461b2902],
11	al.	FW	O	al.	appos	2	SENT_75	[p5l1480t2843r1556b2902],
12	.	.	O	.	_	0	SENT_75	[p5l1480t2843r1556b2902],

1	Gefitinib	NNP	O	Gefitinib	nsubj	9	SENT_76	[p5l1584t2843r1887b2902],
2	or	CC	O	or	_	0	SENT_76	[p5l1912t2862r1980b2902],
3	chemotherapy	NN	O	chemotherapy	nsubj	9	SENT_76	[p5l2003t2843r2138b2902, p5l9t2939r364b3014],
4	for	IN	O	for	_	0	SENT_76	[p5l390t2939r485b2998],
5	non-small-cell	JJ	O	non-small-cell	amod	7	SENT_76	[p5l512t2939r1006b2998],
6	lung	NN	O	lung	nn	7	SENT_76	[p5l1034t2939r1183b3015],
7	cancer	NN	O	cancer	prep_for	3	SENT_76	[p5l1210t2958r1425b2997],
8	with	IN	O	with	prep	7	SENT_76	[p5l1449t2939r1599b2998],
9	mutated	VBN	O	mutate	_	0	SENT_76	[p5l1628t2939r1899b2998],
10	EGFR	NN	ORGANIZATION	egfr	dobj	9	SENT_76	[p5l1928t2943r2134b3001],
11	.	.	O	.	_	0	SENT_76	[p5l1928t2943r2134b3001],

1	N	NN	O	n	nn	2	SENT_77	[p5l7t3040r64b3094],
2	EnglJ	NN	O	englj	nsubj	3	SENT_77	[p5l87t3035r283b3111],
3	Med	VBD	O	med	_	0	SENT_77	[p5l305t3035r447b3094],
4	2010	CD	DATE	2010	dobj	3	SENT_77	[p5l473t3039r1037b3106],
5	;	:	O	;	_	0	SENT_77	[p5l473t3039r1037b3106],
6	362:2380	CD	NUMBER	362:2380	num	7	SENT_77	[p5l473t3039r1037b3106],
7	-8	CD	NUMBER	-8	dep	4	SENT_77	[p5l473t3039r1037b3106],
8	.	.	O	.	_	0	SENT_77	[p5l473t3039r1037b3106],

1	2	LS	NUMBER	2	_	0	SENT_78	[p5l8t3138r62b3189],
2	.	.	O	.	_	0	SENT_78	[p5l8t3138r62b3189],

1	Pharmaceuticals	NNS	O	pharmaceutical	_	0	SENT_79	[p5l138t3131r684b3190],
2	and	CC	O	and	_	0	SENT_79	[p5l718t3131r838b3190],
3	Medical	JJ	ORGANIZATION	medical	amod	4	SENT_79	[p5l869t3131r1131b3190],
4	Devices	NNPS	ORGANIZATION	Devices	conj_and	1	SENT_79	[p5l1163t3132r1413b3190],
5	Agency	NNP	ORGANIZATION	Agency	dep	1	SENT_79	[p5l1445t3136r1697b3207],
6	.	.	O	.	_	0	SENT_79	[p5l1445t3136r1697b3207],

1	Information	NN	O	information	_	0	SENT_80	[p5l1734t3131r2139b3190],
2	on	IN	O	on	_	0	SENT_80	[p5l10t3246r90b3286],
3	case	NN	O	case	nn	4	SENT_80	[p5l117t3246r254b3286],
4	reports	NNS	O	report	prep_on	1	SENT_80	[p5l280t3240r515b3302],
5	with	IN	O	with	_	0	SENT_80	[p5l539t3227r689b3287],
6	suspected	VBN	O	suspect	amod	8	SENT_80	[p5l715t3227r1038b3302],
7	adverse	JJ	O	adverse	amod	8	SENT_80	[p5l1063t3227r1305b3287],
8	events	NNS	O	event	prep_with	4	SENT_80	[p5l1331t3240r1553b3287],
9	.	.	O	.	_	0	SENT_80	[p5l1331t3240r1553b3287],

1	(	NN	O	(	_	0	SENT_81	[p5l1586t3227r2138b3302],
2	http://WWw.info	NN	O	http://www.info	dep	1	SENT_81	[p5l1586t3227r2138b3302],
3	.	.	O	.	_	0	SENT_81	[p5l12t3323r1936b3400],

1	pmda	NN	O	pmda	_	0	SENT_82	[p5l12t3323r1936b3400],
2	.	.	O	.	_	0	SENT_82	[p5l12t3323r1936b3400],

1	go	VB	O	go	_	0	SENT_83	[p5l12t3323r1936b3400],
2	.	.	O	.	_	0	SENT_83	[p5l12t3323r1936b3400],

1	jp/fukusayou/menu	NN	O	jp/fukusayou/menu	nn	3	SENT_84	[p5l12t3323r1936b3400],
2	_	CD	NUMBER	_	num	3	SENT_84	[p5l12t3323r1936b3400],
3	ful	NN	O	ful	_	0	SENT_84	[p5l12t3323r1936b3400],
4	<	JJR	O	<	dep	3	SENT_84	[p5l12t3323r1936b3400],
5	usayou_attention	CD	NUMBER	usayou_attention	dep	4	SENT_84	[p5l12t3323r1936b3400],
6	.	.	O	.	_	0	SENT_84	[p5l12t3323r1936b3400],

1	html	NN	O	html	_	0	SENT_85	[p5l12t3323r1936b3400],
2	.	.	O	.	_	0	SENT_85	[p5l12t3323r1936b3400],
3	)	SYM	O	)	dep	1	SENT_85	[p5l12t3323r1936b3400],

1	3	LS	NUMBER	3	_	0	SENT_86	[p5l9t3428r59b3479],
2	.	.	O	.	_	0	SENT_86	[p5l9t3428r59b3479],

1	Yoshida	NNP	PERSON	Yoshida	nn	2	SENT_87	[p5l135t3420r395b3480],
2	S.	NNP	O	S.	_	0	SENT_87	[p5l421t3425r472b3480],
3	The	DT	O	the	det	4	SENT_87	[p5l499t3420r622b3479],
4	results	NNS	O	result	dep	2	SENT_87	[p5l646t3420r864b3480],
5	of	IN	O	of	_	0	SENT_87	[p5l891t3420r967b3480],
6	gefitinib	NN	O	gefitinib	nn	8	SENT_87	[p5l977t3420r1263b3497],
7	prospective	JJ	O	prospective	amod	8	SENT_87	[p5l1289t3421r1665b3496],
8	investigation	NN	O	investigation	prep_of	4	SENT_87	[p5l1689t3421r2135b3497],
9	.	.	O	.	_	0	SENT_87	[p5l1689t3421r2135b3497],

1	Med	NNP	O	Med	nn	3	SENT_88	[p5l7t3517r149b3576],
2	Drug	NNP	O	Drug	nn	3	SENT_88	[p5l174t3522r387b3593],
3	]	NNP	O	]	_	0	SENT_88	[p5l174t3522r387b3593],
4	2005	CD	DATE	2005	num	3	SENT_88	[p5l411t3521r924b3588],
5	;	:	O	;	_	0	SENT_88	[p5l411t3521r924b3588],
6	41:772	CD	NUMBER	41:772	number	7	SENT_88	[p5l411t3521r924b3588],
7	-89	CD	NUMBER	-89	dep	3	SENT_88	[p5l411t3521r924b3588],
8	.	.	O	.	_	0	SENT_88	[p5l411t3521r924b3588],

1	TO	TO	O	to	aux	3	SENT_89	[p6l8t127r120b183],
2	THE	DT	O	the	det	3	SENT_89	[p6l150t128r314b182],
3	EDITOR	NN	O	editor	csubj	30	SENT_89	[p6l352t127r689b183],
4	:	:	O	:	_	0	SENT_89	[p6l352t127r689b183],
5	The	DT	O	the	det	6	SENT_89	[p6l720t104r882b183],
6	incidence	NN	O	incidence	dep	3	SENT_89	[p6l913t104r1319b183],
7	of	IN	O	of	_	0	SENT_89	[p6l1352t104r1452b183],
8	interstitial	JJ	O	interstitial	amod	10	SENT_89	[p6l1465t104r1917b183],
9	lung	NN	O	lung	nn	10	SENT_89	[p6l1947t104r2141b205],
10	disease	NN	O	disease	prep_of	6	SENT_89	[p6l11t232r345b328],
11	,	,	O	,	_	0	SENT_89	[p6l11t232r345b328],
12	as	IN	O	as	mark	24	SENT_89	[p6l387t259r472b311],
13	reported	VBN	O	report	csubj	24	SENT_89	[p6l511t232r878b333],
14	by	IN	O	by	_	0	SENT_89	[p6l916t232r1013b333],
15	Maemondo	NNP	PERSON	Maemondo	prep_by	13	SENT_89	[p6l1043t232r1528b311],
16	et	FW	O	et	nn	17	SENT_89	[p6l1567t249r1645b311],
17	al.	FW	O	al.	dobj	13	SENT_89	[p6l1676t232r1799b328],
18	,	,	O	,	_	0	SENT_89	[p6l1676t232r1799b328],
19	among	IN	O	among	_	0	SENT_89	[p6l1841t258r2142b333],
20	patients	NNS	O	patient	prep_among	17	SENT_89	[p6l9t361r350b461],
21	receiving	VBG	O	receive	partmod	20	SENT_89	[p6l388t361r779b461],
22	gefitinib	NN	O	gefitinib	dobj	21	SENT_89	[p6l810t360r1183b461],
23	is	VBZ	O	be	cop	24	SENT_89	[p6l1219t361r1285b439],
24	similar	JJ	O	similar	dep	10	SENT_89	[p6l1324t360r1630b439],
25	to	TO	O	to	_	0	SENT_89	[p6l1663t377r1744b439],
26	the	DT	O	the	det	29	SENT_89	[p6l1781t360r1914b439],
27	inci	NN	O	incus	nn	29	SENT_89	[p6l1949t361r2136b439],
28	—	NN	O	—	nn	29	SENT_89	[p6l1949t361r2136b439],
29	dence	NN	O	dence	prep_to	3	SENT_89	[p6l11t488r256b567],
30	reported	VBN	O	report	_	0	SENT_89	[p6l301t488r668b589],
31	in	IN	O	in	_	0	SENT_89	[p6l713t489r796b566],
32	previous	JJ	O	previous	amod	33	SENT_89	[p6l840t489r1204b589],
33	studies	NNS	O	study	prep_in	30	SENT_89	[p6l1253t488r1578b567],
34	.	.	O	.	_	0	SENT_89	[p6l1253t488r1578b567],

1	It	PRP	O	it	dep	159	SENT_90	[p6l1627t496r1692b567],
2	is	VBZ	O	be	dep	159	SENT_90	[p6l1731t489r1798b567],
3	impor	JJ	O	impor	dep	159	SENT_90	[p6l1844t489r2136b589],
4	—	CD	NUMBER	—	dep	159	SENT_90	[p6l1844t489r2136b589],
5	tant	NN	O	tant	dep	159	SENT_90	[p6l11t633r187b695],
6	to	TO	O	to	dep	159	SENT_90	[p6l231t633r314b695],
7	be	VB	O	be	dep	159	SENT_90	[p6l365t616r463b695],
8	aware	JJ	O	aware	dep	159	SENT_90	[p6l512t643r766b696],
9	of	IN	O	of	dep	159	SENT_90	[p6l817t616r918b695],
10	this	DT	O	this	dep	159	SENT_90	[p6l949t616r1112b695],
11	serious	JJ	O	serious	dep	159	SENT_90	[p6l1165t617r1473b696],
12	adverse	JJ	O	adverse	dep	159	SENT_90	[p6l1523t616r1845b695],
13	effect	NN	O	effect	dep	159	SENT_90	[p6l1895t616r2143b695],
14	when	WRB	O	when	dep	159	SENT_90	[p6l6t744r240b824],
15	treating	VBG	O	treat	dep	159	SENT_90	[p6l281t745r624b845],
16	patients	NNS	O	patient	dep	159	SENT_90	[p6l661t745r1003b845],
17	with	IN	O	with	dep	159	SENT_90	[p6l1042t744r1238b823],
18	gefitinib	NN	O	gefitinib	dep	159	SENT_90	[p6l1280t744r1675b845],
19	,	,	O	,	_	0	SENT_90	[p6l1280t744r1675b845],
20	especially	RB	O	especially	dep	159	SENT_90	[p6l1722t744r2143b845],
21	in	IN	O	in	dep	159	SENT_90	[p6l10t873r93b950],
22	those	DT	O	those	dep	159	SENT_90	[p6l129t872r360b951],
23	with	IN	O	with	dep	159	SENT_90	[p6l391t872r587b952],
24	risk	NN	O	risk	dep	159	SENT_90	[p6l622t872r786b952],
25	factors	NNS	O	factor	dep	159	SENT_90	[p6l817t872r1132b968],
26	,	,	O	,	_	0	SENT_90	[p6l817t872r1132b968],
27	such	JJ	O	such	dep	159	SENT_90	[p6l1175t872r1368b951],
28	as	IN	O	as	dep	159	SENT_90	[p6l1403t899r1488b951],
29	old	JJ	O	old	dep	159	SENT_90	[p6l1527t872r1658b951],
30	age	NN	O	age	dep	159	SENT_90	[p6l1692t899r1858b973],
31	,	,	O	,	_	0	SENT_90	[p6l1692t899r1858b973],
32	a	DT	O	a	dep	159	SENT_90	[p6l1899t899r1944b951],
33	history	NN	O	history	dep	159	SENT_90	[p6l1977t872r2136b951, p6l11t1017r180b1101],
34	of	IN	O	of	dep	159	SENT_90	[p6l206t1000r305b1079],
35	smoking	NN	O	smoking	dep	159	SENT_90	[p6l319t1000r690b1101],
36	in	IN	O	in	dep	159	SENT_90	[p6l716t1001r799b1078],
37	those	DT	O	those	dep	159	SENT_90	[p6l829t1000r1056b1079],
38	with	IN	O	with	dep	159	SENT_90	[p6l1083t1000r1275b1079],
39	preexisting	VBG	O	preexist	dep	159	SENT_90	[p6l1304t1001r1780b1101],
40	interstitial	JJ	O	interstitial	dep	159	SENT_90	[p6l1806t1001r2136b1079, p6l11t1128r146b1207],
41	lung	NN	O	lung	dep	159	SENT_90	[p6l187t1128r377b1229],
42	disease	NN	O	disease	dep	159	SENT_90	[p6l417t1128r743b1224],
43	,	,	O	,	_	0	SENT_90	[p6l417t1128r743b1224],
44	or	CC	O	or	dep	159	SENT_90	[p6l792t1154r879b1207],
45	a	DT	O	a	dep	159	SENT_90	[p6l918t1155r963b1207],
46	poor	JJ	O	poor	dep	159	SENT_90	[p6l1002t1154r1202b1229],
47	performance	NN	O	performance	dep	159	SENT_90	[p6l1240t1128r1785b1229],
48	status	NN	O	status	dep	159	SENT_90	[p6l1829t1133r2139b1207],
49	}	CD	NUMBER	}	dep	159	SENT_90	[p6l1829t1133r2139b1207],
50	Although	IN	O	although	dep	159	SENT_90	[p6l6t1256r415b1357],
51	the	DT	O	the	dep	159	SENT_90	[p6l473t1256r605b1335],
52	authors	NNS	O	author	dep	159	SENT_90	[p6l663t1256r985b1335],
53	mention	VBP	O	mention	dep	159	SENT_90	[p6l1046t1257r1406b1335],
54	that	IN	O	that	dep	159	SENT_90	[p6l1463t1256r1636b1335],
55	interstitial	JJ	O	interstitial	dep	159	SENT_90	[p6l1687t1256r2139b1335],
56	lung	NN	O	lung	dep	159	SENT_90	[p6l9t1384r203b1485],
57	disease	NN	O	disease	dep	159	SENT_90	[p6l233t1384r544b1463],
58	can	MD	O	can	dep	159	SENT_90	[p6l577t1410r727b1463],
59	occur	VB	O	occur	dep	159	SENT_90	[p6l760t1410r1000b1463],
60	during	IN	O	during	dep	159	SENT_90	[p6l1030t1384r1319b1485],
61	the	DT	DURATION	the	dep	159	SENT_90	[p6l1349t1384r1482b1463],
62	first	JJ	DURATION	first	dep	159	SENT_90	[p6l1515t1384r1699b1463],
63	3	CD	DURATION	3	dep	159	SENT_90	[p6l1728t1390r1772b1463],
64	months	NNS	NUMBER	month	dep	159	SENT_90	[p6l1808t1384r2135b1463],
65	of	IN	O	of	dep	159	SENT_90	[p6l11t1512r111b1591],
66	treatment	NN	O	treatment	dep	159	SENT_90	[p6l125t1529r570b1608],
67	,	,	O	,	_	0	SENT_90	[p6l125t1529r570b1608],
68	the	DT	O	the	dep	159	SENT_90	[p6l609t1512r742b1591],
69	median	JJ	O	median	dep	159	SENT_90	[p6l774t1512r1099b1591],
70	time	NN	O	time	dep	159	SENT_90	[p6l1131t1513r1324b1591],
71	to	TO	O	to	dep	159	SENT_90	[p6l1357t1529r1439b1591],
72	onset	NN	O	onset	dep	159	SENT_90	[p6l1474t1529r1707b1591],
73	was	VBD	O	be	dep	159	SENT_90	[p6l1730t1539r1893b1592],
74	actually	RB	O	actually	dep	159	SENT_90	[p6l1926t1529r2136b1591, p6l10t1641r161b1742],
75	24	CD	DURATION	24	dep	159	SENT_90	[p6l200t1647r297b1720],
76	to	TO	DURATION	to	dep	159	SENT_90	[p6l341t1658r423b1720],
77	42	CD	DURATION	42	dep	159	SENT_90	[p6l465t1647r564b1720],
78	days	NNS	NUMBER	day	dep	159	SENT_90	[p6l607t1641r859b1742],
79	,2	CD	NUMBER	,2	dep	159	SENT_90	[p6l607t1641r859b1742],
80	and	CC	O	and	dep	159	SENT_90	[p6l901t1641r1059b1720],
81	interstitial	JJ	O	interstitial	dep	159	SENT_90	[p6l1100t1641r1552b1720],
82	lung	NN	O	lung	dep	159	SENT_90	[p6l1593t1641r1787b1742],
83	disease	NN	O	disease	dep	159	SENT_90	[p6l1827t1641r2138b1720],
84	developed	VBD	O	develop	dep	159	SENT_90	[p6l11t1769r427b1870],
85	in	IN	O	in	dep	159	SENT_90	[p6l452t1770r534b1847],
86	most	JJS	O	most	dep	159	SENT_90	[p6l561t1786r773b1848],
87	patients	NNS	O	patient	dep	159	SENT_90	[p6l793t1770r1125b1870],
88	within	IN	O	within	dep	159	SENT_90	[p6l1149t1769r1426b1848],
89	the	DT	DURATION	the	dep	159	SENT_90	[p6l1453t1769r1583b1848],
90	first	JJ	DURATION	first	dep	159	SENT_90	[p6l1610t1769r1788b1848],
91	4	CD	DURATION	4	dep	159	SENT_90	[p6l1808t1775r1858b1848],
92	weeks	NNS	NUMBER	week	dep	159	SENT_90	[p6l1880t1769r2135b1849],
93	of	IN	O	of	dep	159	SENT_90	[p6l11t1897r111b1976],
94	treatment	NN	O	treatment	dep	159	SENT_90	[p6l145t1914r591b1993],
95	,	,	O	,	_	0	SENT_90	[p6l145t1914r591b1993],
96	with	IN	O	with	dep	159	SENT_90	[p6l645t1897r840b1976],
97	possibly	RB	O	possibly	dep	159	SENT_90	[p6l891t1897r1245b1998],
98	rapid	JJ	O	rapid	dep	159	SENT_90	[p6l1293t1897r1512b1998],
99	progression	NN	O	progression	dep	159	SENT_90	[p6l1563t1898r2139b1998],
100	}	NN	O	}	dep	159	SENT_90	[p6l1563t1898r2139b1998],
101	Also	RB	O	also	dep	159	SENT_90	[p6l6t2025r221b2121],
102	,	,	O	,	_	0	SENT_90	[p6l6t2025r221b2121],
103	interstitial	JJ	O	interstitial	dep	159	SENT_90	[p6l265t2025r716b2104],
104	lung	NN	O	lung	dep	159	SENT_90	[p6l753t2025r947b2126],
105	disease	NN	O	disease	dep	159	SENT_90	[p6l982t2025r1293b2104],
106	can	MD	O	can	dep	159	SENT_90	[p6l1333t2051r1482b2104],
107	develop	VB	O	develop	dep	159	SENT_90	[p6l1522t2025r1845b2126],
108	in	IN	O	in	dep	159	SENT_90	[p6l1884t2026r1968b2103],
109	patients	NNS	O	patient	dep	159	SENT_90	[p6l2005t2051r2136b2126, p6l11t2154r247b2232],
110	Who	WP	O	who	dep	159	SENT_90	[p6l277t2153r460b2233],
111	are	VBP	O	be	dep	159	SENT_90	[p6l493t2179r622b2232],
112	retreated	VBN	O	retreat	dep	159	SENT_90	[p6l654t2153r1038b2232],
113	with	IN	O	with	dep	159	SENT_90	[p6l1066t2153r1262b2232],
114	gefitinib	NN	O	gefitinib	dep	159	SENT_90	[p6l1293t2153r1666b2254],
115	after	IN	O	after	dep	159	SENT_90	[p6l1699t2153r1901b2232],
116	a	DT	O	a	dep	159	SENT_90	[p6l1929t2180r1974b2232],
117	period	NN	O	period	dep	159	SENT_90	[p6l2003t2179r2136b2254, p6l10t2281r183b2360],
118	of	IN	O	of	dep	159	SENT_90	[p6l230t2281r331b2360],
119	interruption	NN	O	interruption	dep	159	SENT_90	[p6l358t2282r947b2382],
120	.3	NN	NUMBER	.3	dep	159	SENT_90	[p6l358t2282r947b2382],
121	Therefore	RB	O	therefore	dep	159	SENT_90	[p6l991t2281r1433b2377],
122	,	,	O	,	_	0	SENT_90	[p6l991t2281r1433b2377],
123	all	DT	O	all	dep	159	SENT_90	[p6l1484t2281r1589b2360],
124	patients	NNS	O	patient	dep	159	SENT_90	[p6l1633t2282r1975b2382],
125	receiving	VBG	O	receive	dep	159	SENT_90	[p6l2023t2307r2136b2360, p6l11t2410r317b2510],
126	gefitinib	NN	O	gefitinib	dep	159	SENT_90	[p6l343t2409r716b2510],
127	who	WP	O	who	dep	159	SENT_90	[p6l743t2409r926b2488],
128	present	VBP	DATE	present	dep	159	SENT_90	[p6l957t2426r1277b2510],
129	with	IN	O	with	dep	159	SENT_90	[p6l1298t2409r1494b2488],
130	an	DT	O	a	dep	159	SENT_90	[p6l1523t2435r1627b2488],
131	acute	JJ	O	acute	dep	159	SENT_90	[p6l1656t2426r1879b2488],
132	onset	NN	O	onset	dep	159	SENT_90	[p6l1910t2426r2144b2488],
133	of	IN	O	of	dep	159	SENT_90	[p6l11t2537r111b2616],
134	dyspnea	NN	O	dyspnea	dep	159	SENT_90	[p6l135t2537r504b2638],
135	,	,	O	,	_	0	SENT_90	[p6l135t2537r504b2638],
136	regardless	RB	O	regardless	dep	159	SENT_90	[p6l551t2537r991b2638],
137	of	IN	O	of	dep	159	SENT_90	[p6l1035t2537r1136b2616],
138	the	DT	O	the	dep	159	SENT_90	[p6l1160t2537r1293b2616],
139	presence	NN	O	presence	dep	159	SENT_90	[p6l1333t2563r1709b2638],
140	of	IN	O	of	dep	159	SENT_90	[p6l1752t2537r1852b2616],
141	cough	NN	O	cough	dep	159	SENT_90	[p6l1876t2537r2139b2638],
142	or	CC	O	or	dep	159	SENT_90	[p6l11t2691r99b2744],
143	low	JJ	O	low	dep	159	SENT_90	[p6l125t2665r553b2766],
144	—	NN	O	—	dep	159	SENT_90	[p6l125t2665r553b2766],
145	grade	NN	O	grade	dep	159	SENT_90	[p6l125t2665r553b2766],
146	fever	NN	O	fever	dep	159	SENT_90	[p6l582t2665r807b2761],
147	,	,	O	,	_	0	SENT_90	[p6l582t2665r807b2761],
148	should	MD	O	should	dep	159	SENT_90	[p6l843t2665r1130b2744],
149	be	VB	O	be	dep	159	SENT_90	[p6l1160t2665r1256b2744],
150	promptly	RB	O	promptly	dep	159	SENT_90	[p6l1284t2665r1681b2766],
151	evaluated	VBN	O	evaluate	dep	159	SENT_90	[p6l1707t2665r2133b2761],
152	,	,	O	,	_	0	SENT_90	[p6l1707t2665r2133b2761],
153	especially	RB	O	especially	dep	159	SENT_90	[p6l11t2793r431b2894],
154	during	IN	O	during	dep	159	SENT_90	[p6l476t2793r765b2894],
155	the	DT	DURATION	the	dep	159	SENT_90	[p6l811t2793r944b2872],
156	first	JJ	DURATION	first	dep	159	SENT_90	[p6l993t2793r1178b2872],
157	month	NN	DURATION	month	dep	159	SENT_90	[p6l1221t2793r1507b2872],
158	of	IN	O	of	dep	159	SENT_90	[p6l1557t2793r1657b2872],
159	treatment	NN	O	treatment	_	0	SENT_90	[p6l1687t2810r2132b2872],
160	.	.	O	.	_	0	SENT_90	[p6l1687t2810r2132b2872],

1	Physicians	NNP	MISC	Physicians	nsubjpass	4	SENT_91	[p6l8t2921r455b3022],
2	should	MD	O	should	aux	4	SENT_91	[p6l511t2921r799b3000],
3	be	VB	O	be	auxpass	4	SENT_91	[p6l852t2921r948b3000],
4	reminded	VBN	O	remind	_	0	SENT_91	[p6l1001t2921r1415b3000],
5	that	IN	O	that	complm	11	SENT_91	[p6l1467t2921r1641b3000],
6	interstitial	JJ	O	interstitial	amod	8	SENT_91	[p6l1687t2921r2139b3000],
7	lung	NN	O	lung	nn	8	SENT_91	[p6l9t3049r203b3150],
8	disease	NN	O	disease	nsubj	11	SENT_91	[p6l235t3049r547b3128],
9	may	MD	O	may	aux	11	SENT_91	[p6l581t3075r761b3150],
10	also	RB	O	also	advmod	11	SENT_91	[p6l791t3049r963b3128],
11	occur	VB	O	occur	ccomp	4	SENT_91	[p6l1000t3075r1240b3128],
12	after	IN	O	after	_	0	SENT_91	[p6l1272t3049r1474b3128],
13	chemotherapy	NN	O	chemotherapy	prep_after	11	SENT_91	[p6l1507t3049r2132b3150],
14	,	,	O	,	_	0	SENT_91	[p6l1507t3049r2132b3150],
15	although	IN	O	although	mark	19	SENT_91	[p6l10t3177r397b3278],
16	it	PRP	O	it	nsubjpass	19	SENT_91	[p6l431t3178r490b3256],
17	was	VBD	O	be	auxpass	19	SENT_91	[p6l516t3204r679b3256],
18	not	RB	O	not	neg	19	SENT_91	[p6l716t3194r858b3256],
19	reported	VBN	O	report	advcl	11	SENT_91	[p6l888t3177r1255b3278],
20	in	IN	O	in	_	0	SENT_91	[p6l1289t3178r1373b3255],
21	this	DT	O	this	det	23	SENT_91	[p6l1408t3177r1568b3256],
22	trial	NN	O	trial	nn	23	SENT_91	[p6l1606t3177r1847b3256],
23	.1	NN	NUMBER	.1	prep_in	19	SENT_91	[p6l1606t3177r1847b3256],

1	Ken-Hong	NNP	PERSON	Ken-Hong	nn	2	SENT_92	[p6l19t3321r460b3421],
2	Lim	NNP	PERSON	Lim	_	0	SENT_92	[p6l498t3321r676b3409],
3	,	,	O	,	_	0	SENT_92	[p6l498t3321r676b3409],
4	M.D.	NNP	PERSON	M.D.	nn	8	SENT_92	[p6l721t3321r928b3394],
5	Yuan-Hsin	NNP	PERSON	Yuan-Hsin	nn	8	SENT_92	[p6l8t3448r472b3522],
6	Chang	NNP	PERSON	Chang	nn	8	SENT_92	[p6l511t3442r813b3548],
7	,	,	O	,	_	0	SENT_92	[p6l511t3442r813b3548],
8	M.D.	NNP	O	M.D.	appos	2	SENT_92	[p6l857t3449r1064b3521],

1	Mackay	NNP	ORGANIZATION	Mackay	nn	4	SENT_93	[p7l15t25r264b105],
2	Memorial	NNP	ORGANIZATION	Memorial	nn	4	SENT_93	[p7l291t25r609b86],
3	Hospital	NNP	ORGANIZATION	Hospital	nn	4	SENT_93	[p7l642t25r921b104],
4	Taipei	NNP	ORGANIZATION	Taipei	_	0	SENT_93	[p7l7t125r225b197],
5	,	,	O	,	_	0	SENT_93	[p7l7t125r225b197],
6	Taiwan	NNP	LOCATION	Taiwan	nn	8	SENT_93	[p7l249t125r480b179],
7	|	NNP	O	|	nn	8	SENT_93	[p7l13t202r844b282],
8	imkenhong@gmai	NNP	O	imkenhong@gmai	appos	4	SENT_93	[p7l13t202r844b282],
9	|	NN	O	|	dep	8	SENT_93	[p7l13t202r844b282],
10	.	.	O	.	_	0	SENT_93	[p7l13t202r844b282],

1	com	NN	O	com	_	0	SENT_94	[p7l13t202r844b282],

1	No	DT	O	no	det	3	SENT_95	[p7l94t304r188b359],
2	potential	JJ	O	potential	amod	3	SENT_95	[p7l214t299r513b374],
3	conflict	NN	O	conflict	nsubjpass	11	SENT_95	[p7l539t299r798b358],
4	of	IN	O	of	_	0	SENT_95	[p7l821t299r897b358],
5	interest	NN	O	interest	prep_of	3	SENT_95	[p7l908t300r1160b358],
6	relevant	JJ	O	relevant	amod	5	SENT_95	[p7l1182t299r1444b359],
7	to	TO	O	to	_	0	SENT_95	[p7l1467t312r1529b358],
8	this	DT	O	this	det	9	SENT_95	[p7l1557t299r1679b358],
9	letter	NN	O	letter	prep_to	6	SENT_95	[p7l1705t299r1879b358],
10	was	VBD	O	be	auxpass	11	SENT_95	[p7l1899t319r2024b359],
11	reported	VBN	O	report	_	0	SENT_95	[p7l2051t319r2138b358, p7l8t385r244b460],
12	.	.	O	.	_	0	SENT_95	[p7l2051t319r2138b358, p7l8t385r244b460],

1	1	LS	NUMBER	1	_	0	SENT_96	[p7l12t495r61b546],
2	.	.	O	.	_	0	SENT_96	[p7l12t495r61b546],

1	Kudoh	NNP	PERSON	Kudoh	nn	2	SENT_97	[p7l138t487r354b548],
2	S	NNP	PERSON	S	_	0	SENT_97	[p7l380t491r431b558],
3	,	,	O	,	_	0	SENT_97	[p7l380t491r431b558],
4	Kato	NNP	PERSON	Kato	nn	5	SENT_97	[p7l459t492r610b548],
5	H	NNP	PERSON	H	appos	2	SENT_97	[p7l635t492r707b558],
6	,	,	O	,	_	0	SENT_97	[p7l635t492r707b558],
7	Nishiwaki	NNP	LOCATION	Nishiwaki	nn	8	SENT_97	[p7l734t487r1072b546],
8	Y	NN	O	y	appos	2	SENT_97	[p7l1092t492r1147b558],
9	,	,	O	,	_	0	SENT_97	[p7l1092t492r1147b558],
10	et	FW	O	et	nn	11	SENT_97	[p7l1176t500r1235b545],
11	al.	FW	O	al.	appos	2	SENT_97	[p7l1254t487r1329b546],
12	.	.	O	.	_	0	SENT_97	[p7l1254t487r1329b546],

1	Interstitial	JJ	O	interstitial	amod	3	SENT_98	[p7l1356t487r1708b545],
2	lung	NN	O	lung	nn	3	SENT_98	[p7l1730t487r1879b563],
3	disease	NN	O	disease	_	0	SENT_98	[p7l1901t487r2139b546],
4	in	IN	O	in	_	0	SENT_98	[p7l9t573r72b630],
5	Japanese	JJ	MISC	japanese	amod	6	SENT_98	[p7l90t577r381b647],
6	patients	NNS	O	patient	prep_in	3	SENT_98	[p7l406t573r668b647],
7	with	IN	O	with	_	0	SENT_98	[p7l691t572r841b631],
8	lung	NN	O	lung	nn	9	SENT_98	[p7l865t572r1014b648],
9	cancer	NN	O	cancer	prep_with	6	SENT_98	[p7l1036t591r1268b631],
10	:	:	O	:	_	0	SENT_98	[p7l1036t591r1268b631],
11	a	DT	O	a	det	12	SENT_98	[p7l1295t591r1329b630],
12	cohort	NN	O	cohort	dep	3	SENT_98	[p7l1353t572r1570b631],
13	and	CC	O	and	_	0	SENT_98	[p7l1590t572r1711b631],
14	nested	JJ	O	nested	amod	16	SENT_98	[p7l1735t572r1949b631],
15	casecontrol	NN	O	casecontrol	nn	16	SENT_98	[p7l1974t591r2138b630, p7l10t656r245b715],
16	study	NN	O	study	dep	3	SENT_98	[p7l272t656r459b731],
17	.	.	O	.	_	0	SENT_98	[p7l272t656r459b731],

1	Am	VBP	O	be	cop	2	SENT_99	[p7l486t661r649b725],
2	]	CD	NUMBER	]	dep	6	SENT_99	[p7l486t661r649b725],
3	Respir	NNP	O	Respir	nn	5	SENT_99	[p7l672t657r884b731],
4	Crit	NNP	O	Crit	nn	5	SENT_99	[p7l909t657r1033b715],
5	Care	NNP	O	Care	nsubj	6	SENT_99	[p7l1055t660r1203b715],
6	Med	VBD	O	med	_	0	SENT_99	[p7l1227t656r1368b715],
7	2008	CD	DATE	2008	dobj	6	SENT_99	[p7l1395t660r1985b727],
8	;	:	O	;	_	0	SENT_99	[p7l1395t660r1985b727],
9	177:1348	CD	NUMBER	177:1348	number	10	SENT_99	[p7l1395t660r1985b727],
10	—	CD	NUMBER	—	dep	7	SENT_99	[p7l1395t660r1985b727],
11	57	CD	NUMBER	57	dep	10	SENT_99	[p7l1395t660r1985b727],
12	.	.	O	.	_	0	SENT_99	[p7l1395t660r1985b727],

1	2	LS	NUMBER	2	_	0	SENT_100	[p7l8t748r62b799],
2	.	.	O	.	_	0	SENT_100	[p7l8t748r62b799],

1	Cohen	NNP	PERSON	Cohen	nn	2	SENT_101	[p7l139t741r349b800],
2	MH	NNP	O	MH	_	0	SENT_101	[p7l384t746r525b813],
3	,	,	O	,	_	0	SENT_101	[p7l384t746r525b813],
4	Williams	NNP	ORGANIZATION	Williams	nn	5	SENT_101	[p7l563t741r864b799],
5	GA	NNP	ORGANIZATION	GA	appos	2	SENT_101	[p7l902t745r1024b813],
6	,	,	O	,	_	0	SENT_101	[p7l902t745r1024b813],
7	Sridhara	NNP	O	Sridhara	nn	8	SENT_101	[p7l1067t741r1346b800],
8	R	NNP	O	R	appos	2	SENT_101	[p7l1381t746r1447b813],
9	,	,	O	,	_	0	SENT_101	[p7l1381t746r1447b813],
10	Chen	NNP	PERSON	Chen	nn	11	SENT_101	[p7l1488t741r1656b800],
11	G	NNP	PERSON	G	appos	2	SENT_101	[p7l1693t745r1764b813],
12	,	,	O	,	_	0	SENT_101	[p7l1693t745r1764b813],
13	Pazdur	NNP	ORGANIZATION	Pazdur	nn	18	SENT_101	[p7l1804t741r2035b800],
14	R.	NNP	ORGANIZATION	R.	nn	18	SENT_101	[p7l2069t746r2135b803],
15	FDA	NNP	ORGANIZATION	FDA	nn	18	SENT_101	[p7l8t831r149b884],
16	drug	NN	O	drug	nn	18	SENT_101	[p7l169t826r324b902],
17	approval	NN	O	approval	nn	18	SENT_101	[p7l342t826r624b901],
18	summary	NN	O	summary	appos	2	SENT_101	[p7l647t845r976b901],
19	:	:	O	:	_	0	SENT_101	[p7l647t845r976b901],
20	gefitinib	NN	O	gefitinib	nn	22	SENT_101	[p7l999t826r1286b902],
21	(	CD	NUMBER	(	num	22	SENT_101	[p7l1312t830r1605b894],
22	ZD1839	NN	O	zd1839	dep	2	SENT_101	[p7l1312t830r1605b894],
23	)	CD	NUMBER	)	number	24	SENT_101	[p7l1312t830r1605b894],
24	(	CD	NUMBER	(	num	27	SENT_101	[p7l1634t831r1872b894],
25	Iressa	NNP	O	Iressa	nn	27	SENT_101	[p7l1634t831r1872b894],
26	)	CD	NUMBER	)	num	27	SENT_101	[p7l1634t831r1872b894],
27	tablets	NNS	O	tablet	dep	22	SENT_101	[p7l1898t826r2134b885],
28	.	.	O	.	_	0	SENT_101	[p7l1898t826r2134b885],

1	Oncologist	NN	O	oncologist	_	0	SENT_102	[p7l9t919r372b995],
2	2003	CD	DATE	2003	num	1	SENT_102	[p7l394t923r838b990],
3	;	:	O	;	_	0	SENT_102	[p7l394t923r838b990],
4	8:303	CD	NUMBER	8:303	number	5	SENT_102	[p7l394t923r838b990],
5	-6	CD	NUMBER	-6	dep	1	SENT_102	[p7l394t923r838b990],
6	.	.	O	.	_	0	SENT_102	[p7l394t923r838b990],

1	3	LS	NUMBER	3	_	0	SENT_103	[p7l9t1012r59b1064],
2	.	.	O	.	_	0	SENT_103	[p7l9t1012r59b1064],

1	Inoue	NNP	O	Inoue	nn	2	SENT_104	[p7l138t1010r323b1065],
2	A	NNP	O	A	_	0	SENT_104	[p7l343t1010r410b1077],
3	,	,	O	,	_	0	SENT_104	[p7l343t1010r410b1077],
4	Saijo	NNP	LOCATION	Saijo	nn	5	SENT_104	[p7l438t1006r592b1080],
5	Y	NN	LOCATION	y	appos	2	SENT_104	[p7l613t1010r668b1076],
6	,	,	O	,	_	0	SENT_104	[p7l613t1010r668b1076],
7	Maemondo	NNP	O	Maemondo	nn	8	SENT_104	[p7l692t1005r1063b1064],
8	M	NNP	O	M	appos	2	SENT_104	[p7l1084t1010r1166b1077],
9	,	,	O	,	_	0	SENT_104	[p7l1084t1010r1166b1077],
10	et	FW	O	et	nn	11	SENT_104	[p7l1193t1018r1253b1064],
11	al.	FW	O	al.	appos	2	SENT_104	[p7l1271t1005r1345b1064],
12	.	.	O	.	_	0	SENT_104	[p7l1271t1005r1345b1064],

1	Severe	JJ	O	severe	_	0	SENT_105	[p7l1374t1009r1577b1065],
2	acute	JJ	O	acute	amod	4	SENT_105	[p7l1599t1018r1770b1065],
3	interstitial	JJ	O	interstitial	amod	4	SENT_105	[p7l1792t1005r2140b1064],
4	pneumonia	NN	O	pneumonia	dep	1	SENT_105	[p7l8t1091r385b1165],
5	and	CC	O	and	_	0	SENT_105	[p7l409t1090r530b1149],
6	gefitinib	NN	O	gefitinib	dep	1	SENT_105	[p7l555t1090r860b1166],
7	.	.	O	.	_	0	SENT_105	[p7l555t1090r860b1166],

1	Lancet	NNP	O	Lancet	_	0	SENT_106	[p7l888t1095r1108b1148],
2	2003	CD	DATE	2003	num	1	SENT_106	[p7l1131t1094r1641b1161],
3	;	:	O	;	_	0	SENT_106	[p7l1131t1094r1641b1161],
4	361:137	CD	NUMBER	361:137	number	5	SENT_106	[p7l1131t1094r1641b1161],
5	-9	CD	NUMBER	-9	dep	1	SENT_106	[p7l1131t1094r1641b1161],
6	.	.	O	.	_	0	SENT_106	[p7l1131t1094r1641b1161],

1	THE	DT	O	the	det	3	SENT_107	[p7l8t1352r173b1406],
2	AUTHORS	NNS	O	author	nn	3	SENT_107	[p7l217t1351r626b1407],
3	REPLY	NN	O	reply	_	0	SENT_107	[p7l677t1352r944b1407],
4	:	:	O	:	_	0	SENT_107	[p7l677t1352r944b1407],
5	With	IN	O	with	dep	13	SENT_107	[p7l992t1328r1205b1407],
6	respect	NN	O	respect	pobj	5	SENT_107	[p7l1254t1345r1563b1429],
7	to	TO	O	to	_	0	SENT_107	[p7l1608t1345r1690b1407],
8	the	DT	O	the	det	9	SENT_107	[p7l1740t1328r1874b1407],
9	comments	NNS	O	comment	prep_to	6	SENT_107	[p7l1923t1354r2136b1407, p7l10t1473r271b1535],
10	of	IN	O	of	_	0	SENT_107	[p7l319t1456r420b1535],
11	Murashige	NNP	O	Murashige	prep_of	9	SENT_107	[p7l443t1456r901b1557],
12	et	FW	O	et	nn	13	SENT_107	[p7l948t1473r1025b1535],
13	al.	FW	O	al.	dep	3	SENT_107	[p7l1065t1456r1162b1535],
14	and	CC	O	and	_	0	SENT_107	[p7l1213t1456r1371b1535],
15	Lim	NNP	PERSON	Lim	dep	3	SENT_107	[p7l1415t1457r1584b1534],
16	and	CC	O	and	_	0	SENT_107	[p7l1629t1456r1787b1535],
17	Chang	NNP	PERSON	Chang	conj_and	13	SENT_107	[p7l1832t1456r2134b1557],
18	:	:	O	:	_	0	SENT_107	[p7l1832t1456r2134b1557],

1	N	NN	O	n	nn	3	SENT_108	[p7l546t1642r560b1657],
2	ENGLJ	NN	O	englj	nn	3	SENT_108	[p7l575t1642r652b1664],
3	MED	NN	O	med	_	0	SENT_108	[p7l667t1642r719b1657],
4	363	CD	NUMBER	363	dep	3	SENT_108	[p7l729t1636r807b1664],
5	;	:	O	;	_	0	SENT_108	[p7l729t1636r807b1664],
6	16	CD	NUMBER	16	num	8	SENT_108	[p7l729t1636r807b1664],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_108	[p7l842t1642r966b1664],
8	OCTOBER1	NN	O	october1	dep	4	SENT_108	[p7l1002t1642r1131b1657],
9	,2	CD	NUMBER	,2	num	10	SENT_108	[p7l1153t1642r1228b1662],
10	o1o	NN	O	o1o	dep	8	SENT_108	[p7l1153t1642r1228b1662],
11	1579	CD	DATE	1579	dep	3	SENT_108	[p7l1940t1632r2016b1655],

1	The	DT	O	the	det	4	SENT_109	[p7l702t1675r753b1699],
2	New	NNP	O	New	nn	4	SENT_109	[p7l762t1676r824b1699],
3	England	NNP	O	England	nn	4	SENT_109	[p7l833t1675r944b1706],
4	Journal	NNP	O	Journal	_	0	SENT_109	[p7l952t1675r1050b1699],
5	of	IN	O	of	prep	4	SENT_109	[p7l1059t1675r1088b1699],
6	e	SYM	O	e	dep	5	SENT_109	[p7l1125t1683r1139b1699],
7	icine	FW	O	icine	dep	4	SENT_109	[p7l1156t1675r1220b1699],

1	Copyright	NN	O	copyright	_	0	SENT_110	[p7l494t1757r629b1788],
2	©	CD	NUMBER	©	num	6	SENT_110	[p7l638t1757r661b1781],
3	2010	CD	DATE	2010	num	6	SENT_110	[p7l671t1757r737b1781],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_110	[p7l746t1757r937b1781],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_110	[p7l947t1757r1055b1781],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_110	[p7l1065t1757r1170b1788],
7	.	.	O	.	_	0	SENT_110	[p7l1065t1757r1170b1788],

1	All	DT	O	all	det	2	SENT_111	[p7l1181t1757r1223b1781],
2	rights	NNS	O	rights	nsubj	3	SENT_111	[p7l1232t1757r1306b1788],
3	reserved	VBN	O	reserve	_	0	SENT_111	[p7l1316t1757r1435b1781],
4	.	.	O	.	_	0	SENT_111	[p7l1316t1757r1435b1781],

1	The	DT	O	the	det	4	SENT_112	[p7l673t1863r719b1884],
2	NEW	NNP	O	NEW	nn	4	SENT_112	[p7l737t1865r822b1884],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_112	[p7l841t1865r1030b1884],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_112	[p7l1049t1865r1228b1891],
5	of	IN	O	of	_	0	SENT_112	[p7l1248t1863r1276b1890],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_112	[p7l1288t1865r1487b1884],

1	we	PRP	O	we	nsubj	2	SENT_113	[p7l7t2112r125b2164],
2	agree	VBP	O	agree	_	0	SENT_113	[p7l156t2111r386b2186],
3	that	IN	O	that	complm	13	SENT_113	[p7l418t2085r590b2164],
4	interstitial	JJ	O	interstitial	amod	6	SENT_113	[p7l617t2085r1066b2164],
5	lung	NN	O	lung	nn	6	SENT_113	[p7l1096t2085r1289b2186],
6	disease	NN	O	disease	nsubj	13	SENT_113	[p7l1318t2085r1628b2164],
7	is	VBZ	O	be	cop	13	SENT_113	[p7l1659t2086r1725b2164],
8	the	DT	O	the	det	13	SENT_113	[p7l1759t2085r1892b2164],
9	most	RBS	O	most	advmod	10	SENT_113	[p7l1923t2102r2139b2164],
10	important	JJ	O	important	amod	13	SENT_113	[p7l11t2214r452b2314],
11	severe	JJ	O	severe	amod	13	SENT_113	[p7l485t2239r743b2292],
12	side	NN	O	side	nn	13	SENT_113	[p7l781t2213r946b2292],
13	effect	NN	O	effect	ccomp	2	SENT_113	[p7l983t2213r1225b2292],
14	induced	VBN	O	induce	partmod	13	SENT_113	[p7l1255t2213r1595b2292],
15	by	IN	O	by	_	0	SENT_113	[p7l1632t2213r1729b2314],
16	gefitinib	NN	O	gefitinib	agent	14	SENT_113	[p7l1761t2213r2133b2314],
17	and	CC	O	and	_	0	SENT_113	[p7l11t2341r169b2420],
18	that	IN	O	that	complm	21	SENT_113	[p7l222t2341r394b2420],
19	it	PRP	O	it	nsubj	21	SENT_113	[p7l441t2342r501b2420],
20	can	MD	O	can	aux	21	SENT_113	[p7l549t2367r698b2420],
21	appear	VB	O	appear	ccomp	2	SENT_113	[p7l750t2367r1043b2442],
22	at	IN	O	at	_	0	SENT_113	[p7l1092t2358r1171b2420],
23	any	DT	O	any	det	24	SENT_113	[p7l1218t2367r1368b2442],
24	time	NN	O	time	prep_at	21	SENT_113	[p7l1417t2342r1609b2420],
25	during	IN	O	during	_	0	SENT_113	[p7l1663t2341r1952b2442],
26	the	DT	O	the	det	28	SENT_113	[p7l2002t2341r2134b2420],
27	treatment	NN	O	treatment	nn	28	SENT_113	[p7l12t2486r436b2548],
28	period	NN	O	period	prep_during	21	SENT_113	[p7l467t2469r768b2570],
29	.	.	O	.	_	0	SENT_113	[p7l467t2469r768b2570],

1	Since	IN	O	since	mark	4	SENT_114	[p7l814t2470r1035b2548],
2	we	PRP	O	we	nsubj	4	SENT_114	[p7l1070t2496r1187b2549],
3	had	VBD	O	have	aux	4	SENT_114	[p7l1226t2469r1382b2548],
4	investigated	VBN	O	investigate	advcl	18	SENT_114	[p7l1419t2469r1934b2570],
5	this	DT	O	this	det	6	SENT_114	[p7l1973t2469r2133b2548],
6	toxicity	NN	O	toxicity	dobj	4	SENT_114	[p7l12t2598r330b2698],
7	ever	RB	O	ever	advmod	4	SENT_114	[p7l367t2623r538b2676],
8	since	IN	O	since	mark	12	SENT_114	[p7l578t2598r793b2676],
9	gefitinib	NN	O	gefitinib	nsubjpass	12	SENT_114	[p7l834t2597r1205b2698],
10	was	VBD	O	be	auxpass	12	SENT_114	[p7l1243t2624r1405b2676],
11	first	RB	ORDINAL	first	advmod	12	SENT_114	[p7l1449t2597r1633b2676],
12	used	VBN	O	use	advcl	4	SENT_114	[p7l1668t2597r1866b2676],
13	in	IN	O	in	_	0	SENT_114	[p7l1906t2598r1989b2675],
14	Japan	NNP	LOCATION	Japan	prep_in	12	SENT_114	[p7l2020t2605r2133b2689, p7l11t2730r291b2826],
15	,	,	O	,	_	0	SENT_114	[p7l2020t2605r2133b2689, p7l11t2730r291b2826],
16	”	CD	NUMBER	”	appos	14	SENT_114	[p7l2020t2605r2133b2689, p7l11t2730r291b2826],
17	We	PRP	O	we	nsubj	18	SENT_114	[p7l322t2752r439b2805],
18	paid	VBD	O	pay	_	0	SENT_114	[p7l473t2725r659b2826],
19	very	RB	O	very	advmod	20	SENT_114	[p7l689t2751r866b2826],
20	careful	JJ	O	careful	amod	21	SENT_114	[p7l897t2725r1196b2804],
21	attention	NN	O	attention	dobj	18	SENT_114	[p7l1230t2726r1618b2804],
22	to	TO	O	to	_	0	SENT_114	[p7l1653t2742r1734b2804],
23	this	DT	O	this	det	25	SENT_114	[p7l1771t2725r1930b2804],
24	side	JJ	O	side	amod	25	SENT_114	[p7l1969t2725r2133b2804],
25	effect	NN	O	effect	prep_to	18	SENT_114	[p7l12t2853r275b2949],
26	,	,	O	,	_	0	SENT_114	[p7l12t2853r275b2949],
27	including	VBG	O	include	_	0	SENT_114	[p7l320t2853r731b2954],
28	prevention	NN	O	prevention	prep_including	18	SENT_114	[p7l767t2854r1225b2954],
29	(	CD	NUMBER	(	num	28	SENT_114	[p7l1270t2853r1661b2954],
30	avoiding	VBG	O	avoid	partmod	28	SENT_114	[p7l1270t2853r1661b2954],
31	use	NN	O	use	dobj	30	SENT_114	[p7l1698t2880r1839b2932],
32	in	IN	O	in	_	0	SENT_114	[p7l1879t2854r1962b2931],
33	patients	NNS	O	patient	prep_in	31	SENT_114	[p7l2001t2879r2133b2954, p7l12t2982r248b3060],
34	with	IN	O	with	_	0	SENT_114	[p7l293t2981r488b3060],
35	risk	NN	O	risk	nn	36	SENT_114	[p7l534t2981r698b3061],
36	factors	NNS	O	factor	prep_with	33	SENT_114	[p7l740t2981r1030b3060],
37	for	IN	O	for	_	0	SENT_114	[p7l1079t2981r1202b3060],
38	interstitial	JJ	O	interstitial	amod	41	SENT_114	[p7l1245t2981r1694b3060],
39	lung	NN	O	lung	nn	41	SENT_114	[p7l1739t2981r1933b3082],
40	disease	NN	O	disease	nn	41	SENT_114	[p7l1977t2981r2133b3060, p7l12t3116r242b3205],
41	)	NN	O	)	prep_for	36	SENT_114	[p7l1977t2981r2133b3060, p7l12t3116r242b3205],
42	,	,	O	,	_	0	SENT_114	[p7l1977t2981r2133b3060, p7l12t3116r242b3205],
43	early	JJ	O	early	amod	47	SENT_114	[p7l313t3109r518b3210],
44	diagnosis	NN	O	diagnosis	nn	47	SENT_114	[p7l578t3109r989b3210],
45	(	NN	O	(	nn	47	SENT_114	[p7l1060t3109r1385b3200],
46	careful	JJ	O	careful	amod	47	SENT_114	[p7l1060t3109r1385b3200],
47	observation	NN	O	observation	dobj	30	SENT_114	[p7l1449t3109r1950b3188],
48	for	IN	O	for	_	0	SENT_114	[p7l2014t3109r2137b3188],
49	signs	NNS	O	sign	prep_for	47	SENT_114	[p7l13t3238r233b3338],
50	of	IN	O	of	_	0	SENT_114	[p7l273t3237r372b3316],
51	the	DT	O	the	det	52	SENT_114	[p7l391t3237r524b3316],
52	condition	NN	O	condition	prep_of	49	SENT_114	[p7l562t3237r972b3316],
53	and	CC	O	and	_	0	SENT_114	[p7l1009t3237r1166b3316],
54	appropriate	JJ	O	appropriate	amod	55	SENT_114	[p7l1203t3238r1697b3338],
55	examinations	NNS	O	examination	conj_and	52	SENT_114	[p7l1735t3238r2133b3316, p7l12t3365r274b3459],
56	)	RB	O	)	advmod	49	SENT_114	[p7l1735t3238r2133b3316, p7l12t3365r274b3459],
57	,	,	O	,	_	0	SENT_114	[p7l1735t3238r2133b3316, p7l12t3365r274b3459],
58	and	CC	O	and	_	0	SENT_114	[p7l328t3364r486b3442],
59	intensive	JJ	O	intensive	amod	60	SENT_114	[p7l535t3365r914b3443],
60	treatment	NN	O	treatment	conj_and	31	SENT_114	[p7l964t3381r1388b3442],
61	if	IN	O	if	mark	65	SENT_114	[p7l1432t3364r1509b3441],
62	the	DT	O	the	det	63	SENT_114	[p7l1541t3364r1674b3442],
63	condition	NN	O	condition	nsubj	65	SENT_114	[p7l1724t3364r2134b3442],
64	appeared	VBD	O	appear	cop	65	SENT_114	[p7l11t3492r403b3593],
65	(	CD	NUMBER	(	advcl	30	SENT_114	[p7l457t3499r651b3593],
66	e.g.	FW	O	e.g.	tmod	65	SENT_114	[p7l457t3499r651b3593],
67	,	,	O	,	_	0	SENT_114	[p7l457t3499r651b3593],
68	immediate	JJ	O	immediate	amod	71	SENT_114	[p7l704t3492r1165b3571],
69	glucocorticoid	NN	O	glucocorticoid	nn	71	SENT_114	[p7l1214t3492r1834b3593],
70	therapy	NN	O	therapy	nn	71	SENT_114	[p7l1882t3492r2133b3571, p7l11t3627r157b3721],
71	)	NN	O	)	appos	66	SENT_114	[p7l1882t3492r2133b3571, p7l11t3627r157b3721],
72	.	.	O	.	_	0	SENT_114	[p7l1882t3492r2133b3571, p7l11t3627r157b3721],

1	We	PRP	O	we	nsubj	2	SENT_115	[p7l208t3628r341b3699],
2	believe	VBP	O	believe	_	0	SENT_115	[p7l391t3620r682b3699],
3	that	IN	O	that	_	0	SENT_115	[p7l732t3620r904b3699],
4	our	PRP$	O	we	poss	6	SENT_115	[p7l948t3646r1094b3699],
5	heightened	VBN	O	heighten	amod	6	SENT_115	[p7l1139t3620r1616b3721],
6	awareness	NN	O	awareness	prep_that	2	SENT_115	[p7l1664t3646r2128b3716],
7	,	,	O	,	_	0	SENT_115	[p7l1664t3646r2128b3716],

1	prevention	NN	O	prevention	nsubj	5	SENT_116	[p8l11t21r491b121],
2	,	,	O	,	_	0	SENT_116	[p8l11t21r491b121],
3	and	CC	O	and	_	0	SENT_116	[p8l525t20r683b99],
4	treatment	NN	O	treatment	conj_and	1	SENT_116	[p8l711t37r1135b99],
5	resulted	VBD	O	result	_	0	SENT_116	[p8l1159t20r1501b99],
6	in	IN	O	in	_	0	SENT_116	[p8l1529t21r1612b98],
7	a	DT	O	a	det	9	SENT_116	[p8l1640t47r1685b99],
8	lower	JJR	O	lower	amod	9	SENT_116	[p8l1711t20r1948b99],
9	rate	NN	O	rate	prep_in	5	SENT_116	[p8l1974t37r2134b99],
10	of	IN	O	of	_	0	SENT_116	[p8l12t148r113b227],
11	death	NN	O	death	prep_of	9	SENT_116	[p8l135t148r372b227],
12	from	IN	O	from	_	0	SENT_116	[p8l412t148r622b227],
13	interstitial	JJ	O	interstitial	amod	15	SENT_116	[p8l661t148r1111b227],
14	lung	NN	O	lung	nn	15	SENT_116	[p8l1149t148r1342b249],
15	disease	NN	O	disease	prep_from	5	SENT_116	[p8l1380t148r1690b227],
16	than	IN	O	than	_	0	SENT_116	[p8l1730t148r1927b227],
17	that	DT	O	that	prep_than	5	SENT_116	[p8l1967t148r2139b227],
18	observed	VBN	O	observe	partmod	17	SENT_116	[p8l12t276r393b356],
19	in	IN	O	in	_	0	SENT_116	[p8l434t277r518b354],
20	the	DT	O	the	det	22	SENT_116	[p8l560t276r692b355],
21	general	JJ	O	general	amod	22	SENT_116	[p8l734t276r1051b377],
22	population	NN	O	population	prep_in	18	SENT_116	[p8l1091t276r1562b377],
23	treated	VBN	O	treat	partmod	22	SENT_116	[p8l1604t276r1902b355],
24	with	IN	O	with	_	0	SENT_116	[p8l1939t276r2134b355],
25	gefitinib	NN	O	gefitinib	prep_with	23	SENT_116	[p8l12t404r383b505],
26	in	IN	O	in	_	0	SENT_116	[p8l439t405r522b482],
27	Japan	NNP	LOCATION	Japan	prep_in	25	SENT_116	[p8l566t412r834b505],
28	.	.	O	.	_	0	SENT_116	[p8l566t412r834b505],

1	Recently	RB	DATE	recently	advmod	4	SENT_117	[p8l892t404r1274b505],
2	,	,	O	,	_	0	SENT_117	[p8l892t404r1274b505],
3	we	PRP	O	we	nsubj	4	SENT_117	[p8l1330t431r1448b483],
4	conducted	VBD	O	conduct	_	0	SENT_117	[p8l1503t404r1945b483],
5	another	DT	O	another	det	7	SENT_117	[p8l1998t430r2133b483, p8l12t532r236b611],
6	clinical	JJ	O	clinical	amod	7	SENT_117	[p8l266t532r571b611],
7	trial	NN	O	trial	dobj	4	SENT_117	[p8l603t532r777b611],
8	of	IN	O	of	_	0	SENT_117	[p8l809t532r908b611],
9	First-line	JJ	MISC	first-line	amod	10	SENT_117	[p8l921t532r1282b611],
10	geﬁtinib	NN	O	geﬁtinib	prep_of	7	SENT_117	[p8l1314t532r1676b633],
11	for	IN	O	for	_	0	SENT_117	[p8l1711t532r1831b611],
12	elderly	JJ	O	elderly	amod	13	SENT_117	[p8l1861t532r2138b633],
13	patients	NNS	O	patient	prep_for	10	SENT_117	[p8l11t661r352b761],
14	(	IN	O	(	_	0	SENT_117	[p8l388t667r514b751],
15	75	CD	DURATION	75	num	16	SENT_117	[p8l388t667r514b751],
16	years	NNS	NUMBER	year	prep_(	4	SENT_117	[p8l542t686r762b761],
17	of	IN	O	of	_	0	SENT_117	[p8l794t660r894b739],
18	age	NN	O	age	prep_of	16	SENT_117	[p8l904t687r1047b761],
19	or	CC	O	or	_	0	SENT_117	[p8l1078t686r1167b739],
20	older	JJR	O	older	amod	21	SENT_117	[p8l1194t660r1433b751],
21	)	NN	O	)	prep_(	4	SENT_117	[p8l1194t660r1433b751],
22	who	WP	O	who	nsubj	23	SENT_117	[p8l1463t660r1646b739],
23	had	VBD	O	have	rcmod	21	SENT_117	[p8l1677t660r1834b739],
24	EGFR	NN	O	egfr	dobj	23	SENT_117	[p8l1861t666r2133b744],
25	—	CD	NUMBER	—	num	24	SENT_117	[p8l1861t666r2133b744],
26	mutated	VBN	O	mutate	partmod	24	SENT_117	[p8l12t788r359b867],
27	non	JJ	O	non	amod	33	SENT_117	[p8l391t788r1019b867],
28	—	JJ	O	—	amod	33	SENT_117	[p8l391t788r1019b867],
29	small	JJ	O	small	amod	33	SENT_117	[p8l391t788r1019b867],
30	—	NN	O	—	nn	33	SENT_117	[p8l391t788r1019b867],
31	cell	NN	O	cell	nn	33	SENT_117	[p8l391t788r1019b867],
32	lung	NN	O	lung	nn	33	SENT_117	[p8l1049t788r1240b889],
33	cancer	NN	O	cancer	dobj	26	SENT_117	[p8l1269t814r1545b867],
34	in	IN	O	in	_	0	SENT_117	[p8l1573t789r1655b866],
35	which	WDT	O	which	rel	48	SENT_117	[p8l1682t788r1941b867],
36	1	CD	NUMBER	1	nsubj	48	SENT_117	[p8l1976t794r2020b866],
37	of	IN	O	of	_	0	SENT_117	[p8l2054t788r2152b867],
38	30	CD	NUMBER	30	num	39	SENT_117	[p8l13t922r112b995],
39	patients	NNS	O	patient	prep_of	36	SENT_117	[p8l168t917r510b1017],
40	with	IN	O	with	_	0	SENT_117	[p8l565t916r760b995],
41	interstitial	JJ	O	interstitial	amod	44	SENT_117	[p8l817t916r1267b995],
42	lung	NN	O	lung	nn	44	SENT_117	[p8l1324t916r1517b1017],
43	disease	NN	O	disease	nn	44	SENT_117	[p8l1572t916r1881b995],
44	(	NN	O	(	prep_with	39	SENT_117	[p8l1944t921r2129b1008],
45	3	CD	PERCENT	3	number	46	SENT_117	[p8l1944t921r2129b1008],
46	%	NN	PERCENT	%	amod	44	SENT_117	[p8l1944t921r2129b1008],
47	)	CD	NUMBER	)	tmod	39	SENT_117	[p8l1944t921r2129b1008],
48	died	VBD	O	die	rcmod	33	SENT_117	[p8l12t1044r257b1123],
49	.3	NN	NUMBER	.3	dobj	48	SENT_117	[p8l12t1044r257b1123],
50	Although	IN	O	although	mark	56	SENT_117	[p8l290t1044r697b1145],
51	even	RB	O	even	advmod	54	SENT_117	[p8l733t1070r922b1123],
52	this	DT	O	this	det	54	SENT_117	[p8l958t1044r1118b1123],
53	low	JJ	O	low	amod	54	SENT_117	[p8l1154t1044r1310b1123],
54	rate	NN	O	rate	nsubj	56	SENT_117	[p8l1341t1061r1501b1123],
55	is	VBZ	O	be	cop	56	SENT_117	[p8l1535t1045r1601b1123],
56	regrettable	JJ	O	regrettable	advcl	64	SENT_117	[p8l1639t1044r2129b1145],
57	,	,	O	,	_	0	SENT_117	[p8l1639t1044r2129b1145],
58	it	PRP	O	it	nsubj	64	SENT_117	[p8l11t1173r70b1251],
59	is	VBZ	O	be	cop	64	SENT_117	[p8l114t1173r180b1251],
60	probably	RB	O	probably	advmod	64	SENT_117	[p8l230t1172r607b1273],
61	an	DT	O	a	det	64	SENT_117	[p8l650t1198r753b1251],
62	acceptable	JJ	O	acceptable	amod	64	SENT_117	[p8l802t1172r1249b1273],
63	toxicity	NN	O	toxicity	nn	64	SENT_117	[p8l1299t1173r1616b1273],
64	risk	NN	O	risk	rcmod	49	SENT_117	[p8l1660t1172r1824b1252],
65	in	IN	O	in	_	0	SENT_117	[p8l1868t1173r1951b1250],
66	the	DT	O	the	det	67	SENT_117	[p8l2001t1172r2134b1251],
67	context	NN	O	context	prep_in	64	SENT_117	[p8l10t1328r330b1391],
68	of	IN	O	of	_	0	SENT_117	[p8l361t1311r462b1391],
69	other	JJ	O	other	amod	70	SENT_117	[p8l479t1311r709b1391],
70	chemotherapies	NNS	O	chemotherapy	prep_of	67	SENT_117	[p8l742t1311r1426b1413],
71	used	VBN	O	use	partmod	70	SENT_117	[p8l1464t1311r1662b1391],
72	in	IN	O	in	_	0	SENT_117	[p8l1697t1312r1781b1390],
73	such	JJ	O	such	amod	76	SENT_117	[p8l1818t1311r2013b1391],
74	an	DT	O	a	det	76	SENT_117	[p8l2048t1337r2152b1391],
75	elderly	JJ	O	elderly	amod	76	SENT_117	[p8l10t1451r295b1553],
76	population	NN	O	population	prep_in	71	SENT_117	[p8l326t1451r802b1553],
77	with	IN	O	with	_	0	SENT_117	[p8l834t1451r1031b1531],
78	advanced	JJ	O	advanced	amod	80	SENT_117	[p8l1067t1451r1467b1532],
79	non	JJ	O	non	amod	80	SENT_117	[p8l1503t1451r2152b1531],
80	—	NN	O	—	prep_with	76	SENT_117	[p8l1503t1451r2152b1531],
81	small	JJ	O	small	amod	85	SENT_117	[p8l1503t1451r2152b1531],
82	—	NN	O	—	nn	85	SENT_117	[p8l1503t1451r2152b1531],
83	cell	NN	O	cell	nn	85	SENT_117	[p8l1503t1451r2152b1531],
84	lung	NN	O	lung	nn	85	SENT_117	[p8l8t1589r204b1691],
85	cancer	NN	O	cancer	dep	80	SENT_117	[p8l236t1615r537b1669],
86	.	.	O	.	_	0	SENT_117	[p8l236t1615r537b1669],

1	Akira	NNP	PERSON	Akira	nn	2	SENT_118	[p8l7t1724r230b1804],
2	Inoue	NNP	PERSON	Inoue	_	0	SENT_118	[p8l272t1731r538b1819],
3	,	,	O	,	_	0	SENT_118	[p8l272t1731r538b1819],
4	M.D.	NNP	O	M.D.	nn	6	SENT_118	[p8l584t1731r818b1819],
5	,	,	O	,	_	0	SENT_118	[p8l584t1731r818b1819],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_118	[p8l863t1724r1094b1804],
7	.	.	O	.	_	0	SENT_118	[p8l863t1724r1094b1804],

1	Tohoku	NNP	ORGANIZATION	Tohoku	nn	4	SENT_119	[p8l6t1867r256b1929],
2	University	NNP	ORGANIZATION	University	nn	4	SENT_119	[p8l288t1873r627b1948],
3	Hospital	NNP	ORGANIZATION	Hospital	nn	4	SENT_119	[p8l655t1867r937b1947],
4	SendaLJapan	NNP	O	SendaLJapan	_	0	SENT_119	[p8l10t1964r466b2043],
5	akinoue@idac.tohoku.ac.jp	IN	O	akinoue@idac.tohoku.ac.jp	dep	4	SENT_119	[p8l10t2060r948b2141],

1	Kunihiko	NNP	PERSON	Kunihiko	nn	2	SENT_120	[p8l18t2198r400b2279],
2	Kobayashi	NNP	PERSON	Kobayashi	_	0	SENT_120	[p8l442t2198r907b2305],
3	,	,	O	,	_	0	SENT_120	[p8l442t2198r907b2305],
4	M.D.	NNP	O	M.D.	nn	6	SENT_120	[p8l952t2206r1186b2293],
5	,	,	O	,	_	0	SENT_120	[p8l952t2206r1186b2293],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_120	[p8l1231t2198r1462b2279],
7	.	.	O	.	_	0	SENT_120	[p8l1231t2198r1462b2279],

1	Saitama	NNP	ORGANIZATION	Saitama	nn	4	SENT_121	[p8l10t2348r281b2405],
2	Medical	NNP	ORGANIZATION	Medical	nn	4	SENT_121	[p8l312t2343r572b2405],
3	University	NNP	ORGANIZATION	University	nn	4	SENT_121	[p8l604t2349r944b2424],
4	Saitama	NNP	ORGANIZATION	Saitama	_	0	SENT_121	[p8l10t2445r511b2519],
5	,	,	O	,	_	0	SENT_121	[p8l10t2445r511b2519],
6	Japan	NNP	LOCATION	Japan	appos	4	SENT_121	[p8l10t2445r511b2519],

1	Toshihiro	NNP	PERSON	Toshihiro	nn	2	SENT_122	[p8l7t2577r431b2658],
2	Nukiwa	NNP	PERSON	Nukiwa	_	0	SENT_122	[p8l472t2577r821b2672],
3	,	,	O	,	_	0	SENT_122	[p8l472t2577r821b2672],
4	M.D.	NNP	O	M.D.	nn	6	SENT_122	[p8l866t2585r1100b2672],
5	,	,	O	,	_	0	SENT_122	[p8l866t2585r1100b2672],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_122	[p8l1145t2577r1376b2658],
7	.	.	O	.	_	0	SENT_122	[p8l1145t2577r1376b2658],

1	Tohoku	NNP	ORGANIZATION	Tohoku	nn	4	SENT_123	[p8l6t2721r256b2782],
2	University	NNP	ORGANIZATION	University	nn	4	SENT_123	[p8l288t2726r627b2800],
3	Hospital	NNP	ORGANIZATION	Hospital	nn	4	SENT_123	[p8l655t2721r937b2800],
4	Sendahjapan	NNP	ORGANIZATION	Sendahjapan	_	0	SENT_123	[p8l10t2817r466b2896],

1	Since	IN	O	since	_	0	SENT_124	[p8l97t2930r269b2989],
2	publication	NN	O	publication	prep_since	9	SENT_124	[p8l301t2929r679b3005],
3	of	IN	O	of	_	0	SENT_124	[p8l713t2929r790b2989],
4	their	PRP$	O	they	poss	5	SENT_124	[p8l809t2929r967b2989],
5	article	NN	O	article	prep_of	2	SENT_124	[p8l997t2929r1222b3002],
6	,	,	O	,	_	0	SENT_124	[p8l997t2929r1222b3002],
7	the	DT	O	the	det	8	SENT_124	[p8l1261t2929r1363b2989],
8	authors	NNS	O	author	nsubj	9	SENT_124	[p8l1395t2929r1644b2990],
9	report	VBP	O	report	_	0	SENT_124	[p8l1679t2942r1886b3005],
10	no	DT	O	no	det	13	SENT_124	[p8l1915t2949r1995b2989],
11	further	JJ	O	further	amod	13	SENT_124	[p8l2030t2929r2151b2989, p8l9t3026r143b3086],
12	potential	JJ	O	potential	amod	13	SENT_124	[p8l165t3026r466b3102],
13	conflict	NN	O	conflict	dobj	9	SENT_124	[p8l491t3026r752b3086],
14	of	IN	O	of	_	0	SENT_124	[p8l774t3026r851b3086],
15	interest	NN	O	interest	prep_of	13	SENT_124	[p8l862t3027r1131b3086],
16	.	.	O	.	_	0	SENT_124	[p8l862t3027r1131b3086],

1	1	LS	NUMBER	1	_	0	SENT_125	[p8l11t3186r61b3237],
2	.	.	O	.	_	0	SENT_125	[p8l11t3186r61b3237],

1	Inoue	NNP	O	Inoue	nn	2	SENT_126	[p8l138t3183r325b3238],
2	A	NNP	O	A	_	0	SENT_126	[p8l345t3183r412b3251],
3	,	,	O	,	_	0	SENT_126	[p8l345t3183r412b3251],
4	Saijo	NNP	LOCATION	Saijo	nn	5	SENT_126	[p8l441t3179r596b3254],
5	Y	NN	LOCATION	y	appos	2	SENT_126	[p8l616t3183r671b3251],
6	,	,	O	,	_	0	SENT_126	[p8l616t3183r671b3251],
7	Maemondo	NNP	O	Maemondo	nn	8	SENT_126	[p8l696t3178r1070b3238],
8	M	NNP	O	M	appos	2	SENT_126	[p8l1090t3183r1174b3251],
9	,	,	O	,	_	0	SENT_126	[p8l1090t3183r1174b3251],
10	et	FW	O	et	nn	11	SENT_126	[p8l1201t3191r1260b3237],
11	al.	FW	O	al.	appos	2	SENT_126	[p8l1279t3178r1354b3238],
12	.	.	O	.	_	0	SENT_126	[p8l1279t3178r1354b3238],

1	Severe	JJ	O	severe	_	0	SENT_127	[p8l1382t3182r1587b3238],
2	acute	JJ	O	acute	amod	4	SENT_127	[p8l1609t3191r1781b3238],
3	interstitial	JJ	O	interstitial	amod	4	SENT_127	[p8l1803t3178r2153b3237],
4	pneumonia	NN	O	pneumonia	dep	1	SENT_127	[p8l7t3277r387b3352],
5	and	CC	O	and	_	0	SENT_127	[p8l411t3276r532b3336],
6	gefitinib	NN	O	gefitinib	dep	1	SENT_127	[p8l558t3276r864b3353],
7	.	.	O	.	_	0	SENT_127	[p8l558t3276r864b3353],

1	Lancet	NNP	O	Lancet	_	0	SENT_128	[p8l894t3281r1115b3335],
2	2003	CD	DATE	2003	num	1	SENT_128	[p8l1137t3280r1651b3348],
3	;	:	O	;	_	0	SENT_128	[p8l1137t3280r1651b3348],
4	361:137	CD	NUMBER	361:137	number	5	SENT_128	[p8l1137t3280r1651b3348],
5	—	CD	NUMBER	—	dep	1	SENT_128	[p8l1137t3280r1651b3348],
6	9	CD	NUMBER	9	dep	5	SENT_128	[p8l1137t3280r1651b3348],
7	.	.	O	.	_	0	SENT_128	[p8l1137t3280r1651b3348],

1	2	LS	NUMBER	2	_	0	SENT_129	[p8l7t3381r62b3432],
2	.	.	O	.	_	0	SENT_129	[p8l7t3381r62b3432],

1	Kudoh	NNP	PERSON	Kudoh	nn	2	SENT_130	[p8l139t3373r355b3434],
2	S	NNP	PERSON	S	_	0	SENT_130	[p8l381t3377r433b3446],
3	,	,	O	,	_	0	SENT_130	[p8l381t3377r433b3446],
4	Kato	NNP	PERSON	Kato	nn	5	SENT_130	[p8l461t3378r614b3434],
5	H	NNP	PERSON	H	appos	2	SENT_130	[p8l638t3378r712b3445],
6	,	,	O	,	_	0	SENT_130	[p8l638t3378r712b3445],
7	Nishiwaki	NNP	LOCATION	Nishiwaki	nn	8	SENT_130	[p8l739t3373r1079b3433],
8	Y	NN	O	y	appos	2	SENT_130	[p8l1099t3378r1154b3446],
9	,	,	O	,	_	0	SENT_130	[p8l1099t3378r1154b3446],
10	et	FW	O	et	nn	11	SENT_130	[p8l1183t3386r1243b3432],
11	al.	FW	O	al.	appos	2	SENT_130	[p8l1262t3373r1338b3433],
12	.	.	O	.	_	0	SENT_130	[p8l1262t3373r1338b3433],

1	Interstitial	JJ	O	interstitial	amod	3	SENT_131	[p8l1365t3373r1719b3432],
2	lung	NN	O	lung	nn	3	SENT_131	[p8l1741t3373r1891b3450],
3	disease	NN	O	disease	_	0	SENT_131	[p8l1912t3373r2153b3433],
4	in	IN	O	in	_	0	SENT_131	[p8l8t3471r72b3529],
5	Japanese	JJ	MISC	japanese	amod	6	SENT_131	[p8l89t3475r384b3546],
6	patients	NNS	O	patient	prep_in	3	SENT_131	[p8l408t3471r673b3546],
7	with	IN	O	with	_	0	SENT_131	[p8l696t3470r846b3530],
8	lung	NN	O	lung	nn	9	SENT_131	[p8l870t3470r1019b3547],
9	cancer	NN	O	cancer	prep_with	6	SENT_131	[p8l1042t3489r1276b3530],
10	:	:	O	:	_	0	SENT_131	[p8l1042t3489r1276b3530],
11	a	DT	O	a	det	12	SENT_131	[p8l1304t3490r1337b3529],
12	cohort	NN	O	cohort	dep	3	SENT_131	[p8l1362t3470r1579b3530],
13	and	CC	O	and	_	0	SENT_131	[p8l1600t3470r1721b3530],
14	nested	JJ	O	nested	amod	16	SENT_131	[p8l1746t3470r1960b3530],
15	casecontrol	NN	O	casecontrol	nn	16	SENT_131	[p8l1986t3490r2152b3529, p8l10t3566r246b3626],
16	study	NN	O	study	dep	3	SENT_131	[p8l273t3566r461b3642],
17	.	.	O	.	_	0	SENT_131	[p8l273t3566r461b3642],

1	Am	VBP	O	be	cop	2	SENT_132	[p8l489t3571r652b3636],
2	]	CD	NUMBER	]	dep	6	SENT_132	[p8l489t3571r652b3636],
3	Respir	NNP	O	Respir	nn	5	SENT_132	[p8l676t3567r890b3642],
4	Crit	NNP	O	Crit	nn	5	SENT_132	[p8l913t3567r1039b3626],
5	Care	NNP	O	Care	nsubj	6	SENT_132	[p8l1061t3570r1210b3626],
6	Med	VBD	O	med	_	0	SENT_132	[p8l1234t3566r1377b3626],
7	2008	CD	DATE	2008	dobj	6	SENT_132	[p8l1403t3570r1997b3638],
8	;	:	O	;	_	0	SENT_132	[p8l1403t3570r1997b3638],
9	177:1348	CD	NUMBER	177:1348	number	10	SENT_132	[p8l1403t3570r1997b3638],
10	—	CD	NUMBER	—	dep	7	SENT_132	[p8l1403t3570r1997b3638],
11	57	CD	NUMBER	57	dep	10	SENT_132	[p8l1403t3570r1997b3638],
12	.	.	O	.	_	0	SENT_132	[p8l1403t3570r1997b3638],

1	3	LS	NUMBER	3	_	0	SENT_133	[p8l8t3671r59b3723],
2	.	.	O	.	_	0	SENT_133	[p8l8t3671r59b3723],

1	Minegishi	NNP	MISC	Minegishi	nn	2	SENT_134	[p8l137t3663r473b3740],
2	Y	NN	O	y	_	0	SENT_134	[p8l497t3668r552b3735],
3	,	,	O	,	_	0	SENT_134	[p8l497t3668r552b3735],
4	Maemondo	NNP	O	Maemondo	nn	5	SENT_134	[p8l581t3663r955b3723],
5	M	NNP	O	M	appos	2	SENT_134	[p8l981t3669r1063b3736],
6	,	,	O	,	_	0	SENT_134	[p8l981t3669r1063b3736],
7	Okinaga	NNP	O	Okinaga	nn	8	SENT_134	[p8l1094t3663r1376b3740],
8	S	NNP	O	S	appos	2	SENT_134	[p8l1404t3668r1456b3735],
9	,	,	O	,	_	0	SENT_134	[p8l1404t3668r1456b3735],
10	et	FW	O	et	nn	11	SENT_134	[p8l1488t3676r1548b3722],
11	al.	FW	O	al.	appos	2	SENT_134	[p8l1570t3663r1645b3723],
12	.	.	O	.	_	0	SENT_134	[p8l1570t3663r1645b3723],

1	First-line	JJ	O	first-line	amod	2	SENT_135	[p8l1676t3663r1972b3722],
2	geritinib	NN	O	geritinib	_	0	SENT_135	[p8l1999t3663r2151b3740, p9l9t17r168b77],

1	therapy	NN	O	therapy	dep	17	SENT_136	[p9l212t17r466b93],
2	for	IN	O	for	_	0	SENT_136	[p9l504t17r601b77],
3	elder	JJR	O	elder	npadvmod	4	SENT_136	[p9l641t17r807b77],
4	advanced	JJ	O	advanced	amod	11	SENT_136	[p9l847t17r1158b77],
5	non	JJ	O	non	amod	11	SENT_136	[p9l1200t17r1544b77],
6	—	NN	O	—	nn	11	SENT_136	[p9l1200t17r1544b77],
7	small	JJ	O	small	amod	11	SENT_136	[p9l1200t17r1544b77],
8	cell	NN	O	cell	nn	11	SENT_136	[p9l1586t17r1701b76],
9	lung	NN	O	lung	nn	11	SENT_136	[p9l1742t17r1894b94],
10	cancer	NN	O	cancer	nn	11	SENT_136	[p9l1934t36r2154b76],
11	patients	NNS	O	patient	prep_for	1	SENT_136	[p9l7t115r270b190],
12	with	IN	O	with	_	0	SENT_136	[p9l292t114r440b174],
13	epidermal	JJ	O	epidermal	amod	15	SENT_136	[p9l464t114r792b190],
14	growth	NN	O	growth	nn	15	SENT_136	[p9l815t114r1053b191],
15	factor	NN	O	factor	prep_with	11	SENT_136	[p9l1077t114r1267b174],
16	receptor	NN	O	receptor	nn	17	SENT_136	[p9l1288t127r1558b190],
17	mutations	NNS	O	mutation	_	0	SENT_136	[p9l1580t115r1927b174],
18	:	:	O	:	_	0	SENT_136	[p9l1580t115r1927b174],
19	multicenter	JJ	O	multicenter	amod	24	SENT_136	[p9l1954t114r2151b174, p9l10t223r217b269],
20	phase	NN	O	phase	nn	24	SENT_136	[p9l255t210r450b286],
21	II	CD	NUMBER	ii	num	24	SENT_136	[p9l490t215r542b269],
22	trial	NN	O	trial	nn	24	SENT_136	[p9l583t210r724b269],
23	(	CD	NUMBER	(	num	24	SENT_136	[p9l769t215r920b280],
24	NEJ	NN	O	nej	dep	27	SENT_136	[p9l769t215r920b280],
25	003	CD	NUMBER	003	num	27	SENT_136	[p9l960t214r1076b270],
26	study	NN	O	study	nn	27	SENT_136	[p9l1121t210r1341b286],
27	)	NN	O	)	parataxis	17	SENT_136	[p9l1121t210r1341b286],
28	.	.	O	.	_	0	SENT_136	[p9l1121t210r1341b286],

1	J	NNP	O	J	nn	3	SENT_137	[p9l1379t215r1407b280],
2	Clin	NNP	O	Clin	nn	3	SENT_137	[p9l1447t210r1586b270],
3	Oncol	NNP	O	Oncol	_	0	SENT_137	[p9l1628t210r1826b270],
4	2010	CD	DATE	2010	num	3	SENT_137	[p9l1868t214r2149b282],
5	;	:	O	;	_	0	SENT_137	[p9l1868t214r2149b282],
6	28	CD	NUMBER	28	dep	3	SENT_137	[p9l1868t214r2149b282],
7	:	:	O	:	_	0	SENT_137	[p9l1868t214r2149b282],
8	Suppl	NNP	O	Suppl	dep	6	SENT_137	[p9l10t308r388b384],
9	:7561	CD	NUMBER	:7561	num	8	SENT_137	[p9l10t308r388b384],
10	.	.	O	.	_	0	SENT_137	[p9l10t308r388b384],

1	abstract	JJ	O	abstract	_	0	SENT_138	[p9l434t308r717b368],
2	.	.	O	.	_	0	SENT_138	[p9l434t308r717b368],

1	(	NN	O	(	nn	3	SENT_139	[p9l768t308r2150b385],
2	http://meeting.ascopubs.org/cgi/content/	NN	O	http://meeting.ascopubs.org/cgi/content/	nn	3	SENT_139	[p9l768t308r2150b385],
3	abstract/28/15	NN	O	abstract/28/15	_	0	SENT_139	[p9l8t404r925b480],
4	_	CD	NUMBER	_	dep	3	SENT_139	[p9l8t404r925b480],
5	suppl/7561	NN	O	suppl/7561	dep	4	SENT_139	[p9l8t404r925b480],
6	.	.	O	.	_	0	SENT_139	[p9l8t404r925b480],
7	)	SYM	O	)	dep	3	SENT_139	[p9l8t404r925b480],

1	Dietary	JJ	O	dietary	amod	2	SENT_140	[p9l651t556r838b619],
2	Therapy	NN	O	therapy	_	0	SENT_140	[p9l857t555r1067b619],
3	in	IN	O	in	_	0	SENT_140	[p9l1089t556r1131b603],
4	Hypertension	NN	O	hypertension	prep_in	2	SENT_140	[p9l1159t556r1508b619],

1	TO	TO	O	to	aux	16	SENT_141	[p9l10t790r123b846],
2	THE	DT	O	the	det	3	SENT_141	[p9l167t791r332b845],
3	EDITOR	NN	O	editor	nn	16	SENT_141	[p9l384t790r722b846],
4	:	:	O	:	_	0	SENT_141	[p9l384t790r722b846],
5	Sacks	NNS	O	sack	dep	3	SENT_141	[p9l777t767r1012b847],
6	and	CC	O	and	_	0	SENT_141	[p9l1062t767r1221b846],
7	Campos	NNP	PERSON	Campos	conj_and	5	SENT_141	[p9l1271t773r1622b868],
8	(	CD	NUMBER	(	num	7	SENT_141	[p9l1679t774r1899b859],
9	June	NNP	DATE	June	tmod	5	SENT_141	[p9l1679t774r1899b859],
10	3	CD	DATE	3	num	9	SENT_141	[p9l1950t773r1994b846],
11	issue	NN	O	issue	nn	12	SENT_141	[p9l2046t768r2147b846, p9l13t900r217b987],
12	)	NN	O	)	dep	5	SENT_141	[p9l2046t768r2147b846, p9l13t900r217b987],
13	1	CD	NUMBER	1	num	14	SENT_141	[p9l2046t768r2147b846, p9l13t900r217b987],
14	review	NN	O	review	npadvmod	15	SENT_141	[p9l255t896r537b974],
15	dietary	JJ	O	dietary	amod	16	SENT_141	[p9l571t895r874b996],
16	therapy	NN	O	therapy	_	0	SENT_141	[p9l908t895r1232b996],
17	in	IN	O	in	_	0	SENT_141	[p9l1265t896r1348b973],
18	hypertension	NN	O	hypertension	prep_in	16	SENT_141	[p9l1387t895r1952b996],
19	and	CC	O	and	_	0	SENT_141	[p9l1989t895r2148b974],
20	recommend	VB	O	recommend	conj_and	16	SENT_141	[p9l12t1023r529b1102],
21	the	DT	O	the	det	23	SENT_141	[p9l570t1023r703b1102],
22	Dietary	NNP	MISC	Dietary	nn	23	SENT_141	[p9l743t1024r1063b1124],
23	Approaches	NNPS	MISC	Approaches	nsubj	25	SENT_141	[p9l1095t1023r1601b1124],
24	to	TO	O	to	aux	25	SENT_141	[p9l1644t1040r1726b1102],
25	Stop	VB	O	stop	xcomp	20	SENT_141	[p9l1770t1029r1957b1124],
26	Hypertension	NN	O	hypertension	nn	28	SENT_141	[p9l1999t1031r2147b1124, p9l11t1152r473b1252],
27	(	CD	NUMBER	(	num	28	SENT_141	[p9l520t1157r838b1243],
28	DASH	NN	O	dash	dobj	25	SENT_141	[p9l520t1157r838b1243],
29	)	CD	NUMBER	)	num	30	SENT_141	[p9l520t1157r838b1243],
30	diet	NN	O	diet	dep	37	SENT_141	[p9l886t1151r1050b1230],
31	with	IN	O	with	_	0	SENT_141	[p9l1082t1151r1278b1230],
32	low	JJ	O	low	amod	33	SENT_141	[p9l1319t1151r1476b1231],
33	sodium	NN	O	sodium	prep_with	30	SENT_141	[p9l1515t1151r1838b1230],
34	intake	NN	O	intake	dep	37	SENT_141	[p9l1879t1151r2148b1231],
35	(	CD	NUMBER	(	num	34	SENT_141	[p9l17t1285r167b1370],
36	1.5	CD	NUMBER	1.5	num	37	SENT_141	[p9l17t1285r167b1370],
37	g	NN	O	g	dep	25	SENT_141	[p9l203t1306r255b1380],
38	per	IN	O	per	_	0	SENT_141	[p9l283t1305r424b1380],
39	day	NN	DURATION	day	prep_per	37	SENT_141	[p9l455t1279r624b1380],
40	)	CD	NUMBER	)	num	39	SENT_141	[p9l455t1279r624b1380],
41	for	IN	O	for	_	0	SENT_141	[p9l662t1279r786b1358],
42	all	DT	O	all	det	43	SENT_141	[p9l815t1279r920b1358],
43	patients	NNS	O	patient	prep_for	25	SENT_141	[p9l951t1280r1295b1380],
44	with	IN	O	with	_	0	SENT_141	[p9l1325t1279r1521b1358],
45	hypertension	NN	O	hypertension	prep_with	43	SENT_141	[p9l1554t1279r2142b1380],
46	.	.	O	.	_	0	SENT_141	[p9l1554t1279r2142b1380],

1	However	RB	O	however	advmod	7	SENT_142	[p9l11t1415r408b1503],
2	,	,	O	,	_	0	SENT_142	[p9l11t1415r408b1503],
3	two	CD	NUMBER	two	num	4	SENT_142	[p9l464t1424r623b1487],
4	limitations	NNS	O	limitation	nsubjpass	7	SENT_142	[p9l673t1407r1148b1486],
5	should	MD	O	should	aux	7	SENT_142	[p9l1201t1407r1490b1487],
6	be	VB	O	be	auxpass	7	SENT_142	[p9l1540t1407r1638b1486],
7	addressed	VBN	O	address	_	0	SENT_142	[p9l1687t1407r2142b1486],
8	.	.	O	.	_	0	SENT_142	[p9l1687t1407r2142b1486],

1	First	RB	ORDINAL	first	advmod	39	SENT_143	[p9l11t1537r228b1632],
2	,	,	O	,	_	0	SENT_143	[p9l11t1537r228b1632],
3	as	IN	O	as	_	0	SENT_143	[p9l283t1563r369b1615],
4	an	DT	O	a	det	6	SENT_143	[p9l421t1562r525b1615],
5	important	JJ	O	important	amod	6	SENT_143	[p9l574t1537r1018b1637],
6	source	NN	O	source	prep_as	39	SENT_143	[p9l1065t1562r1344b1615],
7	of	IN	O	of	_	0	SENT_143	[p9l1396t1536r1496b1615],
8	dietary	JJ	O	dietary	amod	9	SENT_143	[p9l1529t1536r1832b1637],
9	iodine	NN	O	iodine	prep_of	6	SENT_143	[p9l1878t1536r2148b1615],
10	worldwide	RB	O	worldwide	advmod	6	SENT_143	[p9l7t1664r484b1760],
11	,	,	O	,	_	0	SENT_143	[p9l7t1664r484b1760],
12	iodized	VBN	O	iodize	partmod	6	SENT_143	[p9l530t1664r851b1743],
13	salt	NN	O	salt	nn	14	SENT_143	[p9l894t1664r1046b1743],
14	accounts	NNS	O	account	dobj	12	SENT_143	[p9l1082t1681r1461b1744],
15	for	IN	O	for	_	0	SENT_143	[p9l1505t1664r1629b1743],
16	75	CD	PERCENT	75	num	17	SENT_143	[p9l1669t1670r1853b1743],
17	%	NN	PERCENT	%	prep_for	12	SENT_143	[p9l1669t1670r1853b1743],
18	of	IN	O	of	_	0	SENT_143	[p9l1895t1664r1995b1743],
19	sodium	NN	O	sodium	nn	23	SENT_143	[p9l2020t1690r2147b1743, p9l12t1793r230b1873],
20	intake	NN	O	intake	nn	23	SENT_143	[p9l258t1793r576b1873],
21	.2	NN	NUMBER	.2	nn	23	SENT_143	[p9l258t1793r576b1873],
22	Low	JJ	O	low	amod	23	SENT_143	[p9l604t1801r785b1873],
23	intake	NN	O	intake	prep_of	17	SENT_143	[p9l809t1793r1066b1873],
24	of	IN	O	of	_	0	SENT_143	[p9l1096t1793r1194b1872],
25	salt	NN	O	salt	prep_of	23	SENT_143	[p9l1206t1793r1370b1889],
26	,	,	O	,	_	0	SENT_143	[p9l1206t1793r1370b1889],
27	which	WDT	O	which	nsubj	32	SENT_143	[p9l1400t1793r1655b1873],
28	is	VBZ	O	be	cop	32	SENT_143	[p9l1683t1794r1747b1872],
29	the	DT	O	the	det	32	SENT_143	[p9l1778t1793r1907b1872],
30	most	RBS	O	most	advmod	31	SENT_143	[p9l1936t1810r2153b1872],
31	common	JJ	O	common	amod	32	SENT_143	[p9l12t1948r397b2001],
32	approach	NN	O	approach	rcmod	25	SENT_143	[p9l428t1922r825b2023],
33	to	TO	O	to	aux	34	SENT_143	[p9l857t1939r939b2001],
34	reduce	VB	O	reduce	infmod	32	SENT_143	[p9l973t1922r1255b2001],
35	sodium	NN	O	sodium	nn	36	SENT_143	[p9l1288t1922r1612b2001],
36	intake	NN	O	intake	dobj	34	SENT_143	[p9l1643t1922r1935b2018],
37	,	,	O	,	_	0	SENT_143	[p9l1643t1922r1935b2018],
38	may	MD	O	may	aux	39	SENT_143	[p9l1972t1948r2152b2023],
39	result	VB	O	result	_	0	SENT_143	[p9l12t2050r263b2129],
40	in	IN	O	in	_	0	SENT_143	[p9l298t2051r382b2128],
41	iodine	NN	O	iodine	nn	42	SENT_143	[p9l423t2050r699b2129],
42	deficiency	NN	O	deficiency	prep_in	39	SENT_143	[p9l741t2050r1203b2151],
43	.	.	O	.	_	0	SENT_143	[p9l741t2050r1203b2151],

1	Moreover	RB	O	moreover	advmod	12	SENT_144	[p9l1247t2058r1683b2146],
2	,	,	O	,	_	0	SENT_144	[p9l1247t2058r1683b2146],
3	DASH	NN	O	dash	nn	4	SENT_144	[p9l1728t2056r1990b2129],
4	diets3	NN	O	diets3	nsubj	12	SENT_144	[p9l2032t2050r2147b2129, p9l12t2184r170b2257],
5	containing	VBG	O	contain	partmod	4	SENT_144	[p9l208t2179r690b2279],
6	reduced	VBN	O	reduce	amod	7	SENT_144	[p9l723t2178r1068b2257],
7	amounts	NNS	O	amount	dobj	5	SENT_144	[p9l1103t2195r1487b2257],
8	of	IN	O	of	_	0	SENT_144	[p9l1526t2178r1627b2257],
9	organ	NN	O	organ	nn	10	SENT_144	[p9l1645t2204r1900b2279],
10	meat	NN	O	meat	prep_of	7	SENT_144	[p9l1936t2195r2153b2257],
11	may	MD	O	may	aux	12	SENT_144	[p9l12t2332r194b2407],
12	result	VB	O	result	_	0	SENT_144	[p9l237t2306r487b2385],
13	in	IN	O	in	_	0	SENT_144	[p9l528t2307r613b2384],
14	deficiency	NN	O	deficiency	prep_in	12	SENT_144	[p9l661t2306r1109b2407],
15	of	IN	O	of	_	0	SENT_144	[p9l1152t2306r1254b2385],
16	some	DT	O	some	det	18	SENT_144	[p9l1284t2332r1512b2385],
17	essential	JJ	O	essential	amod	18	SENT_144	[p9l1561t2306r1947b2385],
18	elements	NNS	O	element	prep_of	14	SENT_144	[p9l1994t2306r2147b2385, p9l12t2451r278b2513],
19	such	JJ	O	such	_	0	SENT_144	[p9l323t2434r521b2513],
20	as	IN	O	as	_	0	SENT_144	[p9l562t2461r649b2513],
21	iron	NN	O	iron	prep_such_as	18	SENT_144	[p9l692t2435r872b2513],
22	and	CC	O	and	_	0	SENT_144	[p9l912t2434r1073b2513],
23	vitamin	NN	O	vitamin	nn	25	SENT_144	[p9l1109t2435r1452b2514],
24	A.	NN	O	a.	nn	25	SENT_144	[p9l1491t2442r1580b2513],
25	Second	NNP	DURATION	Second	prep_such_as	18	SENT_144	[p9l1629t2434r1965b2530],
26	,	,	O	,	_	0	SENT_144	[p9l1629t2434r1965b2530],
27	the	DT	O	the	det	28	SENT_144	[p9l2012t2434r2148b2513],
28	composition	NN	O	composition	nsubj	47	SENT_144	[p9l12t2564r563b2664],
29	of	IN	O	of	_	0	SENT_144	[p9l614t2563r715b2642],
30	the	DT	O	the	det	32	SENT_144	[p9l747t2563r882b2642],
31	DASH	NN	O	dash	nn	32	SENT_144	[p9l931t2569r1193b2642],
32	diet	NN	O	diet	prep_of	28	SENT_144	[p9l1244t2563r1410b2642],
33	(	RB	O	(	advmod	34	SENT_144	[p9l1460t2563r1648b2655],
34	low	JJ	O	low	amod	32	SENT_144	[p9l1460t2563r1648b2655],
35	in	IN	O	in	_	0	SENT_144	[p9l1693t2564r1778b2641],
36	fat	JJ	O	fat	prep_in	34	SENT_144	[p9l1827t2563r1943b2642],
37	and	CC	O	and	_	0	SENT_144	[p9l1987t2563r2148b2642],
38	carbohydrate	NN	O	carbohydrate	prep_in	34	SENT_144	[p9l12t2691r589b2792],
39	but	CC	O	but	_	0	SENT_144	[p9l625t2691r768b2770],
40	relatively	RB	O	relatively	advmod	41	SENT_144	[p9l799t2691r1196b2792],
41	high	JJ	O	high	conj_but	34	SENT_144	[p9l1228t2691r1427b2792],
42	in	IN	O	in	_	0	SENT_144	[p9l1462t2692r1547b2769],
43	protein	NN	O	protein	nn	44	SENT_144	[p9l1582t2692r1929b2792],
44	)	NN	O	)	prep_in	32	SENT_144	[p9l1582t2692r1929b2792],
45	may	MD	O	may	aux	47	SENT_144	[p9l1970t2717r2152b2792],
46	be	VB	O	be	cop	47	SENT_144	[p9l12t2819r111b2898],
47	problematic	JJ	O	problematic	conj_and	12	SENT_144	[p9l141t2819r671b2920],
48	in	IN	O	in	_	0	SENT_144	[p9l700t2820r785b2897],
49	patients	NNS	O	patient	prep_in	47	SENT_144	[p9l815t2820r1166b2920],
50	with	IN	O	with	_	0	SENT_144	[p9l1195t2819r1395b2898],
51	hypertensive	JJ	O	hypertensive	amod	52	SENT_144	[p9l1426t2819r1981b2920],
52	nephropathy	NN	O	nephropathy	prep_with	47	SENT_144	[p9l2012t2845r2147b2898, p9l11t2947r468b3048],
53	or	CC	O	or	_	0	SENT_144	[p9l495t2973r586b3026],
54	renal	JJ	O	renal	amod	55	SENT_144	[p9l614t2947r837b3026],
55	dysfunction	NN	O	dysfunction	prep_with	47	SENT_144	[p9l869t2947r1415b3048],
56	,	,	O	,	_	0	SENT_144	[p9l869t2947r1415b3048],
57	because	IN	O	because	mark	62	SENT_144	[p9l1453t2947r1798b3026],
58	protein	NN	O	protein	nn	59	SENT_144	[p9l1828t2948r2148b3048],
59	overload	NN	O	overload	nsubj	62	SENT_144	[p9l12t3075r382b3154],
60	may	MD	O	may	aux	62	SENT_144	[p9l437t3101r619b3176],
61	further	RB	O	further	advmod	62	SENT_144	[p9l669t3075r986b3154],
62	compromise	VB	O	compromise	advcl	47	SENT_144	[p9l1038t3076r1586b3176],
63	renal	JJ	O	renal	amod	64	SENT_144	[p9l1640t3075r1864b3154],
64	function	NN	O	function	dobj	62	SENT_144	[p9l1918t3075r2147b3154, p9l12t3204r186b3282],
65	and	CC	O	and	_	0	SENT_144	[p9l221t3203r382b3282],
66	aggravate	VB	O	aggravate	ccomp	72	SENT_144	[p9l417t3220r838b3304],
67	hypertension	NN	O	hypertension	nn	68	SENT_144	[p9l874t3203r1521b3304],
68	.4	NN	NUMBER	.4	dobj	66	SENT_144	[p9l874t3203r1521b3304],
69	Thus	RB	O	thus	advmod	66	SENT_144	[p9l1552t3203r1793b3299],
70	,	,	O	,	_	0	SENT_144	[p9l1552t3203r1793b3299],
71	we	PRP	O	we	nsubj	72	SENT_144	[p9l1830t3230r1949b3282],
72	recommend	VBP	O	recommend	conj_and	12	SENT_144	[p9l1985t3229r2147b3282, p9l13t3331r403b3410],
73	that	IN	O	that	complm	79	SENT_144	[p9l460t3331r636b3410],
74	dietary	JJ	O	dietary	amod	75	SENT_144	[p9l688t3331r998b3432],
75	therapy	NN	O	therapy	nsubj	79	SENT_144	[p9l1049t3331r1380b3432],
76	of	IN	O	of	_	0	SENT_144	[p9l1432t3331r1534b3410],
77	hypertension	NN	O	hypertension	prep_of	75	SENT_144	[p9l1571t3331r2148b3432],
78	should	MD	O	should	aux	79	SENT_144	[p9l13t3459r307b3538],
79	take	VB	O	take	ccomp	72	SENT_144	[p9l359t3459r542b3539],
80	adequate	JJ	O	adequate	amod	83	SENT_144	[p9l592t3459r985b3560],
81	essential	JJ	O	essential	amod	83	SENT_144	[p9l1036t3459r1422b3538],
82	nutrient	NN	O	nutrient	nn	83	SENT_144	[p9l1473t3460r1829b3538],
83	intake	NN	O	intake	dobj	79	SENT_144	[p9l1874t3459r2148b3539],
84	into	IN	O	into	_	0	SENT_144	[p9l11t3588r185b3666],
85	account	NN	O	account	prep_into	83	SENT_144	[p9l247t3604r615b3683],
86	,	,	O	,	_	0	SENT_144	[p9l247t3604r615b3683],
87	and	CC	O	and	_	0	SENT_144	[p9l681t3587r842b3666],
88	the	DT	O	the	det	89	SENT_144	[p9l904t3587r1039b3666],
89	appropriateness	NN	O	appropriateness	conj_and	83	SENT_144	[p9l1100t3588r1804b3688],
90	of	IN	O	of	_	0	SENT_144	[p9l1868t3587r1969b3666],
91	the	DT	O	the	prep_of	89	SENT_144	[p9l2013t3587r2148b3666],

1	DASH	NN	O	dash	nn	2	SENT_145	[p10l11t26r272b99],
2	diet	NN	O	diet	nsubjpass	10	SENT_145	[p10l348t20r515b99],
3	for	IN	O	for	_	0	SENT_145	[p10l584t20r710b99],
4	patients	NNS	O	patient	prep_for	2	SENT_145	[p10l780t21r1131b121],
5	with	IN	O	with	_	0	SENT_145	[p10l1203t20r1403b99],
6	other	JJ	O	other	amod	7	SENT_145	[p10l1478t20r1711b99],
7	diseases	NNS	O	disease	prep_with	4	SENT_145	[p10l1783t20r2146b99],
8	should	MD	O	should	aux	10	SENT_145	[p10l16t148r310b227],
9	be	VB	O	be	auxpass	10	SENT_145	[p10l357t148r455b227],
10	assessed	VBN	O	assess	_	0	SENT_145	[p10l502t148r880b227],
11	before	IN	O	before	mark	15	SENT_145	[p10l928t148r1203b227],
12	dietary	JJ	O	dietary	amod	13	SENT_145	[p10l1251t148r1560b249],
13	treatment	NN	O	treatment	nsubjpass	15	SENT_145	[p10l1603t165r2038b227],
14	is	VBZ	O	be	auxpass	15	SENT_145	[p10l2079t149r2145b227],
15	recommended	VBN	O	recommend	advcl	10	SENT_145	[p10l15t277r670b356],
16	.	.	O	.	_	0	SENT_145	[p10l15t277r670b356],

1	Di	NNP	PERSON	Di	nn	2	SENT_146	[p10l23t438r107b510],
2	Zeng	NNP	PERSON	Zeng	_	0	SENT_146	[p10l145t438r388b538],
3	,	,	O	,	_	0	SENT_146	[p10l145t438r388b538],
4	M.D.	NNP	PERSON	M.D.	nn	6	SENT_146	[p10l432t438r640b511],
5	Qiang-sun	NNP	PERSON	Qiang-sun	nn	6	SENT_146	[p10l17t566r473b667],
6	Zheng	NNP	PERSON	Zheng	appos	2	SENT_146	[p10l510t561r812b667],
7	,	,	O	,	_	0	SENT_146	[p10l510t561r812b667],
8	M.D.	NNP	O	M.D.	nn	10	SENT_146	[p10l857t568r1090b655],
9	,	,	O	,	_	0	SENT_146	[p10l857t568r1090b655],
10	Ph.D.	NNP	O	Ph.D.	appos	6	SENT_146	[p10l1135t561r1365b640],
11	.	.	O	.	_	0	SENT_146	[p10l1135t561r1365b640],

1	Dong-bo	NN	O	dong-bo	nn	2	SENT_147	[p10l23t696r399b802],
2	Ou	NN	LOCATION	ou	_	0	SENT_147	[p10l434t701r589b790],
3	,	,	O	,	_	0	SENT_147	[p10l434t701r589b790],
4	M.D.	NNP	ORGANIZATION	M.D.	nn	7	SENT_147	[p10l634t703r841b775],
5	Tangdu	NNP	ORGANIZATION	Tangdu	nn	7	SENT_147	[p10l11t838r258b918],
6	Hospital	NNP	ORGANIZATION	Hospital	nn	7	SENT_147	[p10l291t838r571b917],
7	Xi’an	NNP	O	Xi’an	appos	2	SENT_147	[p10l12t939r197b1006],
8	,	,	O	,	_	0	SENT_147	[p10l12t939r197b1006],
9	China	NNP	LOCATION	China	nn	10	SENT_147	[p10l225t934r416b995],
10	qiangsunzheng@gmai	NNS	O	qiangsunzheng@gmai	appos	2	SENT_147	[p10l15t1031r968b1111],
11	|	CD	NUMBER	|	dep	10	SENT_147	[p10l15t1031r968b1111],
12	.	.	O	.	_	0	SENT_147	[p10l15t1031r968b1111],

1	com	NN	O	com	_	0	SENT_148	[p10l15t1031r968b1111],

1	No	DT	O	no	det	3	SENT_149	[p10l99t1141r194b1196],
2	potential	JJ	O	potential	amod	3	SENT_149	[p10l220t1136r518b1211],
3	conflict	NN	O	conflict	nsubjpass	11	SENT_149	[p10l545t1136r805b1195],
4	of	IN	O	of	_	0	SENT_149	[p10l828t1136r903b1195],
5	interest	NN	O	interest	prep_of	3	SENT_149	[p10l916t1137r1167b1195],
6	relevant	JJ	O	relevant	amod	5	SENT_149	[p10l1189t1136r1453b1196],
7	to	TO	O	to	_	0	SENT_149	[p10l1475t1149r1537b1195],
8	this	DT	O	this	det	9	SENT_149	[p10l1565t1136r1688b1195],
9	letter	NN	O	letter	prep_to	6	SENT_149	[p10l1715t1136r1888b1195],
10	was	VBD	O	be	auxpass	11	SENT_149	[p10l1909t1155r2033b1196],
11	reported	VBN	O	report	_	0	SENT_149	[p10l2061t1155r2148b1195, p10l12t1232r250b1307],
12	.	.	O	.	_	0	SENT_149	[p10l2061t1155r2148b1195, p10l12t1232r250b1307],

1	1	LS	NUMBER	1	_	0	SENT_150	[p10l16t1401r65b1452],
2	.	.	O	.	_	0	SENT_150	[p10l16t1401r65b1452],

1	Sacks	NNP	O	Sacks	nn	2	SENT_151	[p10l146t1393r321b1452],
2	FM	NNP	O	FM	_	0	SENT_151	[p10l342t1398r461b1464],
3	,	,	O	,	_	0	SENT_151	[p10l342t1398r461b1464],
4	Campos	NNP	PERSON	Campos	nn	7	SENT_151	[p10l485t1397r748b1468],
5	H.	NNP	O	H.	nn	7	SENT_151	[p10l769t1398r842b1452],
6	Dietary	NNP	O	Dietary	nn	7	SENT_151	[p10l865t1394r1105b1468],
7	therapy	NN	O	therapy	appos	2	SENT_151	[p10l1122t1393r1365b1468],
8	in	IN	O	in	_	0	SENT_151	[p10l1381t1394r1444b1451],
9	hypertension	NN	O	hypertension	prep_in	7	SENT_151	[p10l1464t1393r1906b1468],
10	.	.	O	.	_	0	SENT_151	[p10l1464t1393r1906b1468],

1	N	NN	O	n	nn	3	SENT_152	[p10l1928t1398r1985b1452],
2	Engl	NNP	O	Engl	nn	3	SENT_152	[p10l2003t1393r2149b1469],
3	J	NNP	O	J	nsubj	4	SENT_152	[p10l6t1494r35b1557],
4	Med	VBD	O	med	_	0	SENT_152	[p10l57t1489r199b1548],
5	2010	CD	DATE	2010	dobj	4	SENT_152	[p10l225t1493r816b1560],
6	;	:	O	;	_	0	SENT_152	[p10l225t1493r816b1560],
7	362:2102	CD	NUMBER	362:2102	number	8	SENT_152	[p10l225t1493r816b1560],
8	—	CD	NUMBER	—	dep	5	SENT_152	[p10l225t1493r816b1560],
9	12	CD	NUMBER	12	dep	8	SENT_152	[p10l225t1493r816b1560],
10	.	.	O	.	_	0	SENT_152	[p10l225t1493r816b1560],

1	2	LS	NUMBER	2	_	0	SENT_153	[p10l13t1592r67b1643],
2	.	.	O	.	_	0	SENT_153	[p10l13t1592r67b1643],

1	Dietary	JJ	O	dietary	amod	2	SENT_154	[p10l142t1586r387b1660],
2	guidelines	NNS	O	guideline	_	0	SENT_154	[p10l425t1585r768b1661],
3	for	IN	O	for	_	0	SENT_154	[p10l811t1585r906b1644],
4	Americans	NNPS	MISC	Americans	prep_for	2	SENT_154	[p10l942t1586r1297b1643],
5	2005	CD	DATE	2005	dep	4	SENT_154	[p10l1340t1589r1515b1644],
6	.	.	O	.	_	0	SENT_154	[p10l1340t1589r1515b1644],

1	Washington	NNP	LOCATION	Washington	nn	3	SENT_155	[p10l1558t1585r1981b1661],
2	,	,	O	,	_	0	SENT_155	[p10l1558t1585r1981b1661],
3	DC	NNP	O	DC	_	0	SENT_155	[p10l2026t1589r2145b1644],
4	:	:	O	:	_	0	SENT_155	[p10l2026t1589r2145b1644],
5	Department	NNP	ORGANIZATION	Department	dep	3	SENT_155	[p10l13t1686r408b1756],
6	of	IN	ORGANIZATION	of	_	0	SENT_155	[p10l430t1681r506b1740],
7	Health	NNP	ORGANIZATION	Health	nn	10	SENT_155	[p10l517t1681r735b1739],
8	and	CC	ORGANIZATION	and	_	0	SENT_155	[p10l760t1681r880b1740],
9	Human	NNP	ORGANIZATION	Human	nn	10	SENT_155	[p10l904t1686r1149b1740],
10	Services	NNPS	ORGANIZATION	Services	prep_of	5	SENT_155	[p10l1176t1682r1452b1752],
11	,	,	O	,	_	0	SENT_155	[p10l1176t1682r1452b1752],
12	Department	NNP	ORGANIZATION	Department	appos	3	SENT_155	[p10l1480t1686r1876b1756],
13	of	IN	ORGANIZATION	of	_	0	SENT_155	[p10l1897t1681r1973b1740],
14	Agriculture	NNP	ORGANIZATION	Agriculture	prep_of	12	SENT_155	[p10l1982t1682r2148b1757, p10l15t1777r264b1836],
15	.	.	O	.	_	0	SENT_155	[p10l1982t1682r2148b1757, p10l15t1777r264b1836],

1	(	NN	O	(	nn	2	SENT_156	[p10l299t1777r1874b1853],
2	http://www.healthierus.gov/dietaryguidelines	NNS	O	http://www.healthierus.gov/dietaryguidelines	_	0	SENT_156	[p10l299t1777r1874b1853],
3	.	.	O	.	_	0	SENT_156	[p10l299t1777r1874b1853],
4	)	SYM	O	)	dep	2	SENT_156	[p10l299t1777r1874b1853],

1	3	LS	NUMBER	3	_	0	SENT_157	[p10l14t1881r64b1934],
2	.	.	O	.	_	0	SENT_157	[p10l14t1881r64b1934],

1	Sacks	NNP	O	Sacks	nn	2	SENT_158	[p10l146t1874r325b1934],
2	FM	NNP	O	FM	_	0	SENT_158	[p10l359t1879r479b1947],
3	,	,	O	,	_	0	SENT_158	[p10l359t1879r479b1947],
4	Obarzanek	NNP	PERSON	Obarzanek	nn	5	SENT_158	[p10l518t1874r881b1934],
5	E	NNP	O	E	appos	2	SENT_158	[p10l911t1879r970b1946],
6	,	,	O	,	_	0	SENT_158	[p10l911t1879r970b1946],
7	Windhauser	NNP	O	Windhauser	nn	8	SENT_158	[p10l1006t1874r1412b1934],
8	MM	NN	O	mm	appos	2	SENT_158	[p10l1441t1879r1592b1947],
9	,	,	O	,	_	0	SENT_158	[p10l1441t1879r1592b1947],
10	et	FW	O	et	nn	11	SENT_158	[p10l1630t1887r1690b1933],
11	al.	FW	O	al.	appos	2	SENT_158	[p10l1720t1874r1794b1934],
12	.	.	O	.	_	0	SENT_158	[p10l1720t1874r1794b1934],

1	Rationale	NN	O	rationale	_	0	SENT_159	[p10l1831t1874r2149b1937],
2	and	CC	O	and	_	0	SENT_159	[p10l14t1970r134b2029],
3	design	NN	O	design	conj_and	1	SENT_159	[p10l159t1970r374b2046],
4	of	IN	O	of	_	0	SENT_159	[p10l398t1970r474b2029],
5	the	DT	O	the	det	7	SENT_159	[p10l485t1970r587b2028],
6	Dietary	NNP	O	Dietary	nn	7	SENT_159	[p10l609t1971r854b2045],
7	Approaches	NNPS	O	Approaches	prep_of	1	SENT_159	[p10l872t1970r1259b2045],
8	to	TO	O	to	aux	9	SENT_159	[p10l1284t1983r1347b2029],
9	Stop	VB	O	stop	infmod	1	SENT_159	[p10l1373t1975r1515b2045],
10	Hypertension	NN	O	hypertension	nn	11	SENT_159	[p10l1540t1971r1988b2045],
11	trial	NN	O	trial	dobj	9	SENT_159	[p10l2011t1970r2149b2028],
12	(	CD	NUMBER	(	num	13	SENT_159	[p10l17t2071r282b2134],
13	DASH	NN	O	dash	dep	1	SENT_159	[p10l17t2071r282b2134],
14	)	CD	NUMBER	)	dep	13	SENT_159	[p10l17t2071r282b2134],
15	:	:	O	:	_	0	SENT_159	[p10l17t2071r282b2134],
16	a	DT	O	a	det	19	SENT_159	[p10l320t2085r354b2124],
17	multicenter	JJ	O	multicenter	amod	19	SENT_159	[p10l388t2066r771b2125],
18	controlled-feeding	JJ	O	controlled-feeding	amod	19	SENT_159	[p10l805t2066r1420b2142],
19	study	NN	O	study	dep	1	SENT_159	[p10l1454t2066r1631b2141],
20	of	IN	O	of	_	0	SENT_159	[p10l1663t2066r1739b2125],
21	dietary	JJ	O	dietary	amod	22	SENT_159	[p10l1761t2066r1994b2141],
22	patterns	NNS	O	pattern	prep_of	19	SENT_159	[p10l2025t2079r2148b2141, p10l14t2175r179b2221],
23	to	TO	O	to	_	0	SENT_159	[p10l207t2175r269b2221],
24	lower	JJR	O	lower	amod	26	SENT_159	[p10l295t2162r478b2222],
25	blood	NN	O	blood	nn	26	SENT_159	[p10l502t2162r688b2221],
26	pressure	NN	O	pressure	prep_to	22	SENT_159	[p10l714t2181r1012b2237],
27	.	.	O	.	_	0	SENT_159	[p10l714t2181r1012b2237],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_160	[p10l1040t2167r1179b2220],
2	Epidemiol	NNP	PERSON	Epidemiol	_	0	SENT_160	[p10l1204t2162r1539b2237],
3	1995	CD	DATE	1995	num	2	SENT_160	[p10l1567t2166r2040b2233],
4	;	:	O	;	_	0	SENT_160	[p10l1567t2166r2040b2233],
5	5:108	CD	NUMBER	5:108	number	6	SENT_160	[p10l1567t2166r2040b2233],
6	—	CD	NUMBER	—	dep	2	SENT_160	[p10l1567t2166r2040b2233],
7	18	CD	NUMBER	18	dep	6	SENT_160	[p10l1567t2166r2040b2233],
8	.	.	O	.	_	0	SENT_160	[p10l1567t2166r2040b2233],

1	4	LS	NUMBER	4	_	0	SENT_161	[p10l12t2266r66b2317],
2	.	.	O	.	_	0	SENT_161	[p10l12t2266r66b2317],

1	Fouque	NN	O	fouque	nn	2	SENT_162	[p10l142t2263r382b2333],
2	D	NN	O	d	_	0	SENT_162	[p10l407t2263r474b2330],
3	,	,	O	,	_	0	SENT_162	[p10l407t2263r474b2330],
4	Aparicio	NNP	PERSON	Aparicio	nn	5	SENT_162	[p10l501t2259r780b2333],
5	M.	NNP	PERSON	M.	appos	2	SENT_162	[p10l805t2263r888b2317],
6	Eleven	CD	PERSON	eleven	num	7	SENT_162	[p10l916t2258r1128b2318],
7	reasons	NNS	O	reason	nsubj	9	SENT_162	[p10l1153t2277r1405b2317],
8	to	TO	O	to	aux	9	SENT_162	[p10l1432t2271r1494b2317],
9	control	VB	O	control	infmod	5	SENT_162	[p10l1521t2258r1757b2317],
10	the	DT	O	the	det	12	SENT_162	[p10l1782t2258r1884b2317],
11	protein	NN	O	protein	nn	12	SENT_162	[p10l1909t2259r2149b2333],
12	intake	NN	O	intake	dobj	9	SENT_162	[p10l13t2354r219b2414],
13	of	IN	O	of	_	0	SENT_162	[p10l255t2354r331b2413],
14	patients	NNS	O	patient	prep_of	12	SENT_162	[p10l351t2355r614b2429],
15	with	IN	O	with	_	0	SENT_162	[p10l647t2354r797b2414],
16	chronic	JJ	O	chronic	amod	18	SENT_162	[p10l832t2354r1081b2413],
17	kidney	NN	O	kidney	nn	18	SENT_162	[p10l1116t2354r1338b2429],
18	disease	NN	O	disease	prep_with	9	SENT_162	[p10l1370t2354r1627b2413],
19	.	.	O	.	_	0	SENT_162	[p10l1370t2354r1627b2413],

1	Nat	NNP	PERSON	Nat	nn	4	SENT_163	[p10l1664t2359r1783b2414],
2	Clin	NNP	O	Clin	nn	4	SENT_163	[p10l1814t2354r1950b2413],
3	Pract	NNP	O	Pract	nn	4	SENT_163	[p10l1984t2359r2153b2413],
4	Nephrol	NNP	O	Nephrol	_	0	SENT_163	[p10l12t2450r283b2525],
5	2007	CD	DATE	2007	num	4	SENT_163	[p10l309t2454r786b2521],
6	;	:	O	;	_	0	SENT_163	[p10l309t2454r786b2521],
7	3:383	CD	NUMBER	3:383	number	8	SENT_163	[p10l309t2454r786b2521],
8	—	CD	NUMBER	—	dep	4	SENT_163	[p10l309t2454r786b2521],
9	92	CD	NUMBER	92	dep	8	SENT_163	[p10l309t2454r786b2521],
10	.	.	O	.	_	0	SENT_163	[p10l309t2454r786b2521],

1	TO	TO	O	to	aux	3	SENT_164	[p10l13t2712r125b2768],
2	THE	DT	O	the	det	3	SENT_164	[p10l155t2713r319b2767],
3	EDITOR	NN	O	editor	csubj	26	SENT_164	[p10l357t2712r694b2768],
4	:	:	O	:	_	0	SENT_164	[p10l357t2712r694b2768],
5	We	PRP	O	we	nsubj	7	SENT_164	[p10l725t2697r859b2768],
6	would	MD	O	would	aux	7	SENT_164	[p10l886t2689r1153b2769],
7	like	VB	O	like	dep	3	SENT_164	[p10l1184t2689r1340b2769],
8	to	TO	O	to	aux	9	SENT_164	[p10l1372t2706r1454b2768],
9	emphasize	VB	O	emphasize	xcomp	7	SENT_164	[p10l1488t2689r1947b2790],
10	that	IN	O	that	complm	20	SENT_164	[p10l1980t2689r2153b2768],
11	a	DT	O	a	det	13	SENT_164	[p10l14t2844r59b2896],
12	significant	JJ	O	significant	amod	13	SENT_164	[p10l97t2817r567b2918],
13	benefit	NN	O	benefit	nsubj	20	SENT_164	[p10l601t2817r907b2896],
14	of	IN	O	of	_	0	SENT_164	[p10l940t2817r1041b2896],
15	the	DT	O	the	det	19	SENT_164	[p10l1060t2817r1194b2896],
16	DASH	NN	O	dash	nn	19	SENT_164	[p10l1231t2823r1707b2918],
17	—	CD	NUMBER	—	num	19	SENT_164	[p10l1231t2823r1707b2918],
18	type	NN	O	type	nn	19	SENT_164	[p10l1231t2823r1707b2918],
19	diets	NNS	O	diet	prep_of	13	SENT_164	[p10l1746t2817r1949b2896],
20	discussed	VBN	O	discuss	ccomp	9	SENT_164	[p10l1990t2817r2147b2896, p10l15t2945r303b3024],
21	by	IN	O	by	_	0	SENT_164	[p10l353t2945r451b3046],
22	Sacks	NNP	O	Sacks	prep_by	3	SENT_164	[p10l499t2945r733b3025],
23	and	CC	O	and	_	0	SENT_164	[p10l785t2945r943b3024],
24	Campos	NNP	PERSON	Campos	prep_by	3	SENT_164	[p10l993t2951r1343b3046],
25	is	VBZ	O	be	cop	26	SENT_164	[p10l1394t2946r1461b3024],
26	attributable	JJ	O	attributable	_	0	SENT_164	[p10l1512t2945r2014b3024],
27	to	TO	O	to	_	0	SENT_164	[p10l2065t2962r2147b3024],
28	the	DT	O	the	det	31	SENT_164	[p10l15t3073r149b3152],
29	higher	JJR	O	higher	amod	31	SENT_164	[p10l181t3073r463b3174],
30	potassium	NN	O	potassium	nn	31	SENT_164	[p10l491t3074r942b3174],
31	content	NN	O	content	prep_to	26	SENT_164	[p10l975t3090r1300b3152],
32	of	IN	O	of	_	0	SENT_164	[p10l1327t3073r1427b3152],
33	these	DT	O	these	det	34	SENT_164	[p10l1441t3073r1666b3152],
34	diets	NNS	O	diet	prep_of	31	SENT_164	[p10l1699t3073r1926b3152],
35	.	.	O	.	_	0	SENT_164	[p10l1699t3073r1926b3152],

1	Am1580	NN	O	am1580	_	0	SENT_165	[p10l1961t3081r2147b3151, p10l149t3249r225b3272],

1	NENGLJ	NN	O	nenglj	nn	2	SENT_166	[p10l938t3259r1044b3281],
2	MED3	NN	O	med3	_	0	SENT_166	[p10l1059t3259r1132b3281],
3	;	:	O	;	_	0	SENT_166	[p10l1166t3259r1179b3279],
4	1	CD	NUMBER	1	num	6	SENT_166	[p10l1166t3259r1179b3279],
5	NEJM.ORG	NN	O	nejm.org	nn	6	SENT_166	[p10l1234t3259r1358b3281],
6	OCTOBER14	NN	O	october14	dep	2	SENT_166	[p10l1393t3259r1549b3281],
7	,	,	O	,	_	0	SENT_166	[p10l1393t3259r1549b3281],
8	2010	CD	DATE	2010	appos	6	SENT_166	[p10l1560t3259r1620b3275],

1	The	DT	O	the	det	4	SENT_167	[p10l935t3292r986b3316],
2	New	NNP	O	New	nn	4	SENT_167	[p10l995t3293r1057b3316],
3	Englan	NNP	O	Englan	nn	4	SENT_167	[p10l1066t3292r1160b3323],
4	ournal	NN	O	ournal	_	0	SENT_167	[p10l1199t3292r1283b3316],
5	of	IN	O	of	_	0	SENT_167	[p10l1293t3292r1322b3316],
6	Medicine	NN	MISC	medicine	prep_of	4	SENT_167	[p10l1329t3292r1454b3316],

1	Copyright	NN	O	copyright	_	0	SENT_168	[p10l728t3374r862b3405],
2	©	CD	NUMBER	©	num	6	SENT_168	[p10l871t3374r895b3398],
3	2010	CD	DATE	2010	num	6	SENT_168	[p10l905t3374r970b3398],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_168	[p10l979t3374r1170b3398],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_168	[p10l1180t3374r1288b3398],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_168	[p10l1299t3374r1404b3405],
7	.	.	O	.	_	0	SENT_168	[p10l1299t3374r1404b3405],

1	All	DT	O	all	det	2	SENT_169	[p10l1415t3374r1456b3398],
2	rights	NNS	O	rights	nsubj	3	SENT_169	[p10l1465t3374r1540b3405],
3	reserved	VBN	O	reserve	_	0	SENT_169	[p10l1550t3374r1668b3398],
4	.	.	O	.	_	0	SENT_169	[p10l1550t3374r1668b3398],

